data_6kr8_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6kr8 _Structure_validation_residue.Date_analyzed 2020-01-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 76' ' ' ALA . 1.9 pp . . . . . 0 CA--C 1.497 -1.073 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.22 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.624 0.25 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.55 -10.64 53.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.704 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.405 ' N ' ' CG1' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.704 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.487 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -41.42 56.65 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 124.597 1.186 . . . . 0.0 110.563 -171.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.417 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.188 0 CA-C-O 121.359 0.6 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.86 -39.14 93.08 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.1 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.487 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 75.4 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.98 -32.75 74.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.61 -45.2 76.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.08 135.97 56.86 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.609 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.5 mttt . . . . . 0 CA--C 1.495 -1.149 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 3.8 p -70.33 -43.92 69.29 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -42.54 96.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.54 -38.13 94.4 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 33.3 mt -70.17 -40.09 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 117.398 0.599 . . . . 0.0 110.817 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.663 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.41 -50.59 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.707 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.663 ' N ' HG23 ' A' ' 278' ' ' ILE . 16.7 ptm -63.33 -40.97 98.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.637 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.44 96.31 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.657 -0.306 . . . . 0.0 112.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.5 p -69.01 -49.38 58.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 117.84 0.82 . . . . 0.0 108.81 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.616 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.5 m-85 -53.98 -58.09 8.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.5 p -70.51 -46.68 63.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.589 ' O ' HG22 ' A' ' 314' ' ' ILE . 84.8 mt -72.04 -20.64 61.66 Favored 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 116.008 -4.182 . . . . 0.0 108.947 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.971 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -156.39 106.74 2.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.971 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.0 OUTLIER 139.13 -58.75 0.0 OUTLIER 'General case' 0 C--N 1.361 1.066 0 O-C-N 125.213 1.571 . . . . 0.0 111.769 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 68.2 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.2 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.856 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.67 93.73 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.71 -39.87 90.14 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.705 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.93 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 4.7 mt -55.18 -44.34 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.661 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.41 -35.91 92.37 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.923 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.69 -38.45 27.75 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.665 ' O ' HG12 ' A' ' 325' ' ' ILE . 9.3 m-85 -68.32 -32.72 73.05 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.334 0.653 . . . . 0.0 111.868 -170.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.471 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.3 m-20 -54.08 -48.44 94.1 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.621 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 53.4 Cg_exo -61.16 -34.71 88.65 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 121.22 1.471 . . . . 0.0 112.691 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.8 mt -69.6 -44.24 71.14 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.28 -63.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 123.153 0.581 . . . . 0.0 112.272 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -42.84 -36.28 1.44 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 120.032 3.345 . . . . 0.0 120.032 -177.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 40.2 m -88.29 40.76 0.97 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 124.745 1.218 . . . . 0.0 113.033 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -71.53 -21.75 61.86 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.503 1.121 . . . . 0.0 111.617 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -43.19 145.99 0.91 Allowed Pre-proline 0 C--N 1.375 1.676 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 91.3 m -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.68 3.737 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 47.5 pt . . . . . 0 CA--C 1.497 -1.067 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.165 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.68 -10.64 57.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.703 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.406 ' N ' ' CG1' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.703 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 CA--C 1.493 -1.228 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.721 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -41.42 67.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.563 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.482 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 121.293 0.568 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -60.7 -39.14 87.42 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 125.313 1.445 . . . . 0.0 107.673 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.5 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.2 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.465 ' HA ' ' CE2' ' A' ' 219' ' ' TYR . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 0.9 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.9 -32.67 74.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.26 -45.34 76.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 237' ' ' GLU . 46.7 t -64.17 134.49 54.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 236' ' ' SER . 56.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.65 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 CA--C 1.495 -1.152 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 34.0 p -70.37 -45.02 66.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.424 ' CD1' ' CD1' ' A' ' 219' ' ' TYR . 4.1 tt -61.6 -43.72 98.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 278' ' ' ILE . 0.2 OUTLIER -70.2 -40.06 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 117.407 0.604 . . . . 0.0 110.823 -177.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.656 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.45 -50.57 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.677 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.656 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.4 ptt? -63.34 -40.9 98.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.65 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.37 96.14 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 121.627 -0.32 . . . . 0.0 112.49 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.3 p -69.04 -49.45 57.45 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 117.822 0.811 . . . . 0.0 108.814 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.552 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 6.2 m-85 -54.06 -57.91 9.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.477 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.1 p -70.54 -46.71 63.08 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.632 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.4 tp -72.26 -20.55 61.51 Favored 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 115.926 -4.234 . . . . 0.0 108.997 -174.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.993 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.38 107.93 2.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.309 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.993 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.04 -59.41 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.044 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.97 -48.05 93.71 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.855 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.52 -40.01 89.91 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.786 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -41.89 98.81 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.924 ' O ' HG11 ' A' ' 317' ' ' VAL . 13.6 mm -55.87 -43.31 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.887 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.93 -35.91 92.7 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.924 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -89.7 -23.68 32.66 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.27 -32.68 73.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.308 0.643 . . . . 0.0 111.899 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 326' ' ' TYR . 2.5 m120 -54.13 -48.33 94.55 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.647 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 50.2 Cg_exo -61.21 -34.68 88.21 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 121.254 1.483 . . . . 0.0 112.705 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.3 mt -69.6 -44.32 70.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.763 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 14.3 mm -98.41 -64.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 123.191 0.596 . . . . 0.0 112.3 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.467 ' N ' ' O ' ' A' ' 322' ' ' ASN . 49.1 t80 -52.66 -62.09 1.87 Allowed 'General case' 0 C--N 1.353 0.721 0 N-CA-C 120.002 3.334 . . . . 0.0 120.002 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 73.3 m -57.6 81.72 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.748 1.219 . . . . 0.0 112.989 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 329' ' ' SER . 7.7 mmt180 -117.69 -20.97 8.7 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 124.502 1.121 . . . . 0.0 111.57 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 328' ' ' ARG . 47.7 t -44.31 145.99 1.27 Allowed Pre-proline 0 C--N 1.386 2.155 0 O-C-N 118.942 -2.349 . . . . 0.0 110.942 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.7 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 55' ' ' ILE . 3.1 tp . . . . . 0 CA--C 1.498 -1.046 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.145 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.804 0.335 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.17 -10.64 55.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.691 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 5.1 m -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.691 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.487 HD13 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.584 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.435 -1.202 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -41.42 69.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.563 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.206 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.64 -39.14 93.17 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 4.4 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.4 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.545 ' CE1' ' CD2' ' A' ' 282' ' ' PHE . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.731 HD12 ' CD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 79.9 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -29.38 68.48 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.56 -46.16 67.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 70.3 m -63.83 137.03 57.87 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.705 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 CA--C 1.494 -1.175 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 7.2 p -70.27 -45.01 67.25 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.552 HD21 ' O ' ' A' ' 275' ' ' LEU . 2.0 tm? -61.51 -43.84 98.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.56 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.14 93.83 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -70.21 -40.09 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 117.376 0.588 . . . . 0.0 110.805 -177.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.651 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.55 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.729 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.651 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.36 -40.94 98.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.36 -1.336 . . . . 0.0 111.626 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.44 96.28 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.208 -0.308 . . . . 0.0 112.446 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.5 p -69.06 -49.36 58.16 Favored 'General case' 0 CA--C 1.493 -1.22 0 O-C-N 121.801 -0.823 . . . . 0.0 108.816 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.731 ' CD2' HD12 ' A' ' 212' ' ' LEU . 1.9 m-85 -54.13 -57.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.491 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.6 p -70.49 -46.69 63.25 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.613 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 9.5 tp -73.44 -19.87 60.86 Favored 'General case' 0 N--CA 1.433 -1.315 1 O-C-N 116.009 -4.182 . . . . 0.0 109.014 -174.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.918 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.63 105.76 2.65 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.119 -178.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.918 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.0 OUTLIER 139.72 -59.59 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.646 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.88 -48.05 93.89 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.861 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 5.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 16.8 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.872 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.9 -39.35 88.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.803 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -41.89 99.3 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.927 ' O ' HG11 ' A' ' 317' ' ' VAL . 12.7 mm -56.13 -42.89 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -63.12 -35.91 92.73 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.927 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -72.94 -50.8 11.96 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.33 -32.72 73.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.827 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.474 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.9 m120 -54.15 -48.36 94.49 Favored Pre-proline 0 N--CA 1.436 -1.147 0 CA-C-O 118.484 -0.769 . . . . 0.0 112.629 -171.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 66.2 Cg_exo -61.18 -34.67 88.48 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 121.265 1.488 . . . . 0.0 112.702 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.59 -44.33 71.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.759 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.69 -68.52 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 123.176 0.59 . . . . 0.0 112.255 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -30.71 -39.24 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 119.984 3.327 . . . . 0.0 119.984 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 50.8 0.79 Allowed 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 124.755 1.222 . . . . 0.0 113.015 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -70.43 -5.88 31.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.549 1.14 . . . . 0.0 111.541 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.94 145.99 0.51 Allowed Pre-proline 0 C--N 1.359 0.996 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.0 t -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 1.8 pt . . . . . 0 CA--C 1.497 -1.08 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.146 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.781 0.324 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.0 -10.64 55.21 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 114.031 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.702 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.7 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.407 ' N ' ' CG1' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.702 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.492 -1.271 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -41.42 71.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.563 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 121.274 0.559 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.41 -39.14 92.31 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.461 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 2.4 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.88 -33.01 74.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.43 -45.42 76.1 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.18 135.91 56.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.562 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 44.2 mttt . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.6 p -70.24 -44.98 67.42 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 275' ' ' LEU . 15.4 tp -61.45 -43.88 98.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.06 -38.1 93.72 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.2 -40.12 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 117.384 0.592 . . . . 0.0 110.802 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.673 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.36 -50.62 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.661 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.673 ' N ' HG23 ' A' ' 278' ' ' ILE . 11.8 ptt? -63.42 -40.87 98.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.66 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.44 96.32 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.498 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.02 -49.46 57.49 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.553 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.6 m-85 -54.15 -57.83 9.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.498 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.46 -46.73 63.23 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 81.5 mt -71.55 -21.42 61.89 Favored 'General case' 0 N--CA 1.432 -1.348 1 O-C-N 115.892 -4.255 . . . . 0.0 108.962 -175.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.927 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.37 106.79 2.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.249 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.927 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.3 OUTLIER 138.72 -58.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.537 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.82 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.861 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.628 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 304' ' ' ARG . 4.4 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.541 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.622 ' HA ' HG13 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -60.59 -39.96 90.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.691 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -41.89 98.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.922 ' O ' HG11 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.61 -40.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.818 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.36 -35.91 92.55 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.922 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.77 -38.33 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -165.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.595 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.3 -32.8 73.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 123.363 0.665 . . . . 0.0 111.811 -170.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.473 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.0 m-20 -54.1 -48.32 94.5 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-O 118.499 -0.762 . . . . 0.0 112.665 -171.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.473 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 54.7 Cg_exo -61.19 -34.7 88.39 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 121.246 1.481 . . . . 0.0 112.724 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.4 mt -69.56 -44.29 71.19 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.791 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 321' ' ' PHE . 3.1 mm -95.55 -63.56 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 123.202 0.601 . . . . 0.0 112.233 -173.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.3 OUTLIER -43.65 -38.51 3.11 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -177.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 46.0 m -87.17 42.77 1.05 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.754 1.222 . . . . 0.0 113.04 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -73.26 -20.92 60.73 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 124.553 1.141 . . . . 0.0 111.555 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -42.86 145.99 0.82 Allowed Pre-proline 0 C--N 1.378 1.83 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 1.7 m -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.76 3.787 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.754 ' C ' ' O ' ' A' ' 54' ' ' VAL . 56.9 mt . . . . . 0 CA--C 1.497 -1.085 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.213 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.664 0.269 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.33 -10.64 60.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 64.0 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.289 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.492 -1.277 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -41.42 74.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.563 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.199 0 CA-C-O 121.231 0.539 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -61.96 -39.14 91.1 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.0 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.35 -33.36 75.78 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -67.31 -45.44 76.5 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 45.8 t -64.49 137.87 58.1 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.664 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.5 p -70.3 -45.0 67.17 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 275' ' ' LEU . 14.0 tp -61.49 -43.81 98.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.606 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 326' ' ' TYR . 20.0 mt -70.26 -40.08 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 117.394 0.597 . . . . 0.0 110.789 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.699 HG23 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.41 -50.52 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.724 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.699 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.2 ptt? -63.37 -40.93 98.6 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 118.411 -1.316 . . . . 0.0 111.662 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.62 -38.4 96.2 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 121.604 -0.332 . . . . 0.0 112.461 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.529 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.6 p -69.02 -49.39 58.04 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 121.789 -0.83 . . . . 0.0 108.804 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.546 ' HD2' HD12 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.08 -57.96 9.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.8 p -70.54 -46.72 63.04 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.3 tp -69.68 -22.35 63.44 Favored 'General case' 0 N--CA 1.432 -1.35 1 O-C-N 115.949 -4.219 . . . . 0.0 109.025 -176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 1.021 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -155.59 117.59 4.09 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.958 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 1.021 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 2.4 m95 131.88 -59.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.008 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.81 -48.05 94.02 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.861 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 4.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 43.4 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.891 ' O ' HG21 ' A' ' 314' ' ' ILE . 6.1 mp -62.03 -37.42 84.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.793 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -41.89 97.51 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 120.898 -1.126 . . . . 0.0 109.183 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 3.4 tp -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.966 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.577 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -79.03 -35.5 30.55 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -165.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.558 ' O ' HG12 ' A' ' 325' ' ' ILE . 5.4 m-85 -68.3 -32.74 73.1 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.339 0.656 . . . . 0.0 111.834 -171.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.2 m-20 -54.09 -48.36 94.38 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.628 -171.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.0 Cg_exo -61.2 -34.71 88.26 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.284 1.494 . . . . 0.0 112.695 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.59 -44.27 71.11 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.772 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.9 mm -90.73 -61.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 C-N-CA 123.236 0.614 . . . . 0.0 112.276 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -48.59 -22.1 0.7 Allowed 'General case' 0 C--N 1.353 0.746 0 N-CA-C 119.965 3.32 . . . . 0.0 119.965 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 67.5 m -83.05 19.53 1.4 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 124.752 1.221 . . . . 0.0 113.072 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 329' ' ' SER . 0.8 OUTLIER -57.59 -33.65 68.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 124.494 1.118 . . . . 0.0 111.55 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.58 145.99 3.89 Favored Pre-proline 0 C--N 1.378 1.819 0 C-N-CA 115.959 -2.297 . . . . 0.0 110.942 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.713 3.758 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 33.6 mm . . . . . 0 CA--C 1.498 -1.041 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.167 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.801 0.334 . . . . 0.0 110.568 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.38 -10.64 56.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.759 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 56.9 t -56.24 -40.5 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.363 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.759 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.848 HD13 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.549 ' CG ' ' CE1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -41.42 64.75 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 125.793 1.933 . . . . 0.0 110.563 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.189 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -66.38 -39.14 88.91 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 0.7 OUTLIER -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.535 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.91 ' HB2' ' HG ' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.88 -32.24 73.85 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -68.76 -44.44 73.72 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 t -78.62 83.16 4.82 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.535 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 43.0 mttt . . . . . 0 CA--C 1.495 -1.169 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 24.5 p -70.27 -45.01 67.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.91 ' HG ' ' HB2' ' A' ' 219' ' ' TYR . 5.0 mp -61.56 -43.77 98.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.99 -38.19 93.89 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 42.4 mt -70.15 -40.13 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.403 0.601 . . . . 0.0 110.78 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.678 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.34 -50.66 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.702 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.678 ' N ' HG23 ' A' ' 278' ' ' ILE . 11.6 ptt? -63.35 -40.95 98.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.632 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.46 96.34 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 121.621 -0.323 . . . . 0.0 112.456 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.1 p -69.0 -49.39 58.25 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 117.846 0.823 . . . . 0.0 108.848 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.7 m-85 -54.06 -57.92 9.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.549 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.2 p -70.53 -46.66 63.18 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 80.8 mt -71.04 -21.5 62.26 Favored 'General case' 0 N--CA 1.433 -1.31 1 O-C-N 115.965 -4.209 . . . . 0.0 109.003 -175.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.89 ' HB3' ' O ' ' A' ' 314' ' ' ILE . 0.8 OUTLIER -154.67 109.13 2.99 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.167 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.871 ' HA ' ' HE3' ' A' ' 286' ' ' TRP . 0.0 OUTLIER 137.09 -59.1 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.683 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.58 -48.05 94.47 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.861 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 299' ' ' GLN . 68.8 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 295' ' ' VAL . 9.4 pm0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 1.8 mp0 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.823 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.96 -39.26 88.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.776 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -41.89 99.37 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.907 ' O ' HG11 ' A' ' 317' ' ' VAL . 8.4 mm -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.851 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.62 -37.06 31.59 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -165.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.683 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.3 m-85 -68.22 -32.76 73.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 122.097 -0.649 . . . . 0.0 111.902 -170.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.471 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.4 m-80 -54.06 -48.37 94.27 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.66 -171.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.8 Cg_exo -61.19 -34.66 88.42 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 121.22 1.471 . . . . 0.0 112.697 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.63 -44.32 70.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.746 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.51 -64.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 123.216 0.606 . . . . 0.0 112.27 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.435 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -44.53 -33.14 1.64 Allowed 'General case' 0 C--N 1.352 0.715 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -177.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 75.1 m -89.52 39.06 0.93 Allowed 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.719 1.208 . . . . 0.0 113.071 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -69.04 -22.6 64.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.532 1.133 . . . . 0.0 111.549 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -45.25 145.99 1.68 Allowed Pre-proline 0 C--N 1.369 1.418 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.783 3.802 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 3.2 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.479 ' CG2' HG22 ' A' ' 73' ' ' THR . 47.5 pt . . . . . 0 CA--C 1.496 -1.105 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.197 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.957 0.408 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.11 -10.64 55.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.31 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.767 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.1 t -56.45 -40.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.34 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.04 -32.59 72.2 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.767 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.61 ' HZ ' ' H ' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.479 HG22 ' CG2' ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -54.13 -48.99 70.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -41.42 81.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.563 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.61 ' H ' ' HZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.194 0 CA-C-O 121.267 0.556 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -59.18 -39.14 81.63 Favored 'General case' 0 C--N 1.301 -1.505 2 O-C-N 129.642 4.339 . . . . 0.0 107.673 176.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.5 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 1.7 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.42 -33.56 76.24 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.64 -45.29 75.77 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.2 t -63.83 136.09 57.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.543 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.422 ' O ' HD13 ' A' ' 277' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 21.0 p -70.32 -44.95 67.21 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 276' ' ' GLY . 0.1 OUTLIER -61.53 -43.82 98.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.592 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.458 ' N ' ' CD2' ' A' ' 275' ' ' LEU . . . -66.04 -38.12 93.77 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 273' ' ' LYS . 23.1 mt -70.17 -40.11 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 117.389 0.595 . . . . 0.0 110.813 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.702 HG23 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.4 -50.6 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.666 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.702 ' N ' HG23 ' A' ' 278' ' ' ILE . 14.8 ptt? -63.32 -40.96 98.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.647 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.38 96.18 Favored Glycine 0 C--N 1.348 1.239 0 C-N-CA 121.606 -0.33 . . . . 0.0 112.492 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -69.05 -49.36 58.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.514 ' HD2' HD12 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.478 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.0 p -70.51 -46.7 63.18 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.3 mt -68.54 -23.07 64.47 Favored 'General case' 0 N--CA 1.432 -1.336 1 O-C-N 115.966 -4.209 . . . . 0.0 108.975 -176.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 1.066 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 1.3 p -156.87 115.52 3.32 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.257 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 1.066 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 3.0 m95 135.2 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.609 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.94 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.554 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 68.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.0 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.824 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.554 ' HB3' ' HD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.82 -39.5 89.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.751 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.89 99.27 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.907 ' O ' HG11 ' A' ' 317' ' ' VAL . 65.8 mt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.918 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.616 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.12 -37.08 29.69 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 325' ' ' ILE . 7.1 m-85 -68.21 -32.77 73.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.329 0.652 . . . . 0.0 111.872 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.5 m-20 -54.04 -48.45 94.0 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.639 -171.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.6 Cg_exo -61.14 -34.72 88.81 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 CA-C-N 121.258 1.485 . . . . 0.0 112.666 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.59 -44.34 70.98 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.6 mm -93.31 -63.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.211 0.604 . . . . 0.0 112.255 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -42.98 -34.39 0.98 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -177.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 79.1 p -88.61 35.93 0.78 Allowed 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 124.717 1.207 . . . . 0.0 113.009 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -67.37 -24.16 65.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.51 1.124 . . . . 0.0 111.597 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.62 145.99 1.37 Allowed Pre-proline 0 C--N 1.378 1.841 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.942 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 55.9 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.797 3.811 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.465 ' O ' ' CG2' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.07 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.102 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.32 -10.64 52.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.41 0.68 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.6 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.319 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 CA--C 1.492 -1.255 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.808 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 t80 . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.21 -41.42 70.25 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.563 -175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -63.82 -39.14 93.52 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 3.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.9 m170 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.498 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.37 -33.46 76.02 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.23 -45.11 77.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.8 m -64.5 140.96 58.92 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.639 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 19.1 p -70.31 -44.99 67.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 275' ' ' LEU . 16.8 tp -61.48 -43.81 98.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.14 93.78 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 34.7 mt -70.2 -40.07 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.365 0.582 . . . . 0.0 110.801 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.657 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.43 -50.56 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.671 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.657 ' N ' HG23 ' A' ' 278' ' ' ILE . 16.5 ptm -63.4 -40.92 98.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.588 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.41 96.24 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.01 -49.37 58.33 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.61 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.7 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.437 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.7 p -70.54 -46.64 63.2 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.5 tp -72.06 -20.57 61.65 Favored 'General case' 0 N--CA 1.432 -1.33 1 O-C-N 116.004 -4.185 . . . . 0.0 109.002 -174.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.97 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.64 107.72 2.84 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.186 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.97 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.17 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.647 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.67 -48.05 94.28 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.861 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.1 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 64.8 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.621 ' HA ' HG13 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -60.6 -39.94 89.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.736 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -41.89 98.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.911 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 0.9 OUTLIER -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.11 -37.71 28.1 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -165.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.649 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.29 -32.71 73.06 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.359 0.664 . . . . 0.0 111.864 -170.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.469 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.2 m-20 -54.16 -48.34 94.55 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-O 118.48 -0.772 . . . . 0.0 112.606 -171.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.7 Cg_exo -61.18 -34.66 88.49 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 121.252 1.483 . . . . 0.0 112.707 -176.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.7 mt -69.64 -44.3 70.87 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.743 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.8 mm -95.58 -63.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.248 0.619 . . . . 0.0 112.25 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.3 OUTLIER -43.42 -33.32 1.04 Allowed 'General case' 0 C--N 1.353 0.736 0 N-CA-C 119.987 3.329 . . . . 0.0 119.987 -177.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.5 p -86.64 36.2 0.7 Allowed 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.762 1.225 . . . . 0.0 113.014 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.07 -24.38 67.68 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.574 1.15 . . . . 0.0 111.51 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.38 145.99 3.59 Favored Pre-proline 0 C--N 1.377 1.762 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.942 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.69 3.744 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 35.9 pt . . . . . 0 CA--C 1.497 -1.071 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.178 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.02 -10.64 41.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.3 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.771 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 28.2 m -56.5 -40.26 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.307 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -60.96 -32.59 72.12 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.718 -0.793 . . . . 0.0 108.863 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.771 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.587 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -41.42 74.28 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.563 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.21 0 CA-C-O 121.357 0.598 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.56 -39.14 92.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.8 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.458 ' HA ' ' CE2' ' A' ' 219' ' ' TYR . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.69 -32.26 73.72 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -68.32 -46.97 68.79 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 43.6 t -62.52 136.89 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.571 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 277' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.5 p -70.29 -44.98 67.25 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 219' ' ' TYR . 5.1 tt -61.41 -43.86 98.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.581 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.15 93.69 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 273' ' ' LYS . 29.9 mt -70.14 -40.12 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 117.396 0.598 . . . . 0.0 110.791 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.695 HG23 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.44 -50.54 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.402 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.706 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.695 ' N ' HG23 ' A' ' 278' ' ' ILE . 16.5 ptm -63.37 -40.95 98.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.364 -1.334 . . . . 0.0 111.653 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.53 96.45 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.216 -0.302 . . . . 0.0 112.44 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -68.95 -49.34 58.81 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 121.822 -0.811 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.529 ' HD2' HD12 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.75 -58.26 7.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.493 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.54 -46.74 62.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.34 -22.73 63.74 Favored 'General case' 0 N--CA 1.432 -1.351 1 O-C-N 115.983 -4.198 . . . . 0.0 109.007 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.976 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.9 OUTLIER -156.18 113.86 3.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.238 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.976 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.3 m95 135.71 -58.91 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.83 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.861 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . 0.552 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.5 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.827 ' O ' HG22 ' A' ' 314' ' ' ILE . 0.1 OUTLIER -61.07 -39.19 88.95 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.684 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -41.89 99.61 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.433 -0.792 . . . . 0.0 109.183 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.907 ' O ' HG11 ' A' ' 317' ' ' VAL . 2.8 tt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.875 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.43 -35.62 36.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -166.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . 0.667 ' O ' HG12 ' A' ' 325' ' ' ILE . 11.5 m-85 -68.26 -32.75 73.16 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 123.345 0.658 . . . . 0.0 111.82 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.468 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.2 m-80 -54.09 -48.38 94.32 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.654 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 51.3 Cg_exo -61.19 -34.66 88.38 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.254 1.484 . . . . 0.0 112.715 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.65 -44.29 70.87 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.74 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 321' ' ' PHE . 2.1 mm -94.8 -64.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.237 0.615 . . . . 0.0 112.309 -173.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -43.44 -30.88 0.6 Allowed 'General case' 0 C--N 1.352 0.699 0 N-CA-C 119.979 3.326 . . . . 0.0 119.979 -177.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 81.7 p -93.03 36.1 1.05 Allowed 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.024 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -67.94 -23.09 65.03 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 124.531 1.132 . . . . 0.0 111.607 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.87 145.99 1.46 Allowed Pre-proline 0 C--N 1.374 1.649 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 88.4 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.743 3.777 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG12 HG12 ' A' ' 54' ' ' VAL . 1.6 mm . . . . . 0 CA--C 1.497 -1.075 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.188 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.722 0.296 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.31 -10.64 52.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 61.0 t -56.3 -40.45 66.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.328 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.876 HG21 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.952 HD13 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 CA--C 1.493 -1.235 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.679 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.43 -41.42 72.91 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 121.348 0.594 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.76 -39.14 93.23 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.6 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.656 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 75.6 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -65.69 -33.12 75.14 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.98 -45.64 77.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -64.09 131.62 48.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.551 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 88.0 m -70.3 -44.96 67.25 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.631 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.93 -38.21 93.99 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 277' ' ' ILE . 0.3 OUTLIER -70.19 -40.09 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 117.327 0.563 . . . . 0.0 110.805 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.54 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.673 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' MET . . . . . 0.623 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.47 -40.84 98.17 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.634 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.57 -38.44 96.29 Favored Glycine 0 C--N 1.348 1.218 0 C-N-CA 121.614 -0.327 . . . . 0.0 112.479 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.3 p -68.99 -49.37 58.44 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 117.813 0.806 . . . . 0.0 108.856 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.656 ' HD2' HD12 ' A' ' 212' ' ' LEU . 5.5 m-85 -54.05 -57.96 9.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.468 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.8 p -70.53 -46.72 63.07 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.667 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 83.1 mt -72.27 -20.17 61.57 Favored 'General case' 0 N--CA 1.432 -1.347 1 O-C-N 115.92 -4.238 . . . . 0.0 108.97 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' CYS . . . . . 0.903 ' HB2' ' HA2' ' A' ' 315' ' ' GLY . 0.8 OUTLIER -154.99 107.97 2.79 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.321 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.952 ' NE1' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER 138.45 -59.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.015 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.74 -48.05 94.15 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.861 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 1.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ARG . . . . . 0.653 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 6.5 mm-40 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 304' ' ' ARG . 5.3 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' TYR . . . . . 0.537 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.67 93.72 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.655 ' HA ' HG13 ' A' ' 314' ' ' ILE . 94.4 mt -61.25 -38.87 88.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.784 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -41.89 99.42 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ILE . . . . . 0.925 ' O ' HG11 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.49 -40.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.903 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.21 -35.91 92.57 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.925 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.97 13.73 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -163.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -68.29 -32.7 73.04 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.343 0.657 . . . . 0.0 111.886 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 8.3 m-20 -54.11 -48.44 94.16 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.597 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 62.0 Cg_exo -61.14 -34.7 88.87 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 121.273 1.49 . . . . 0.0 112.707 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.58 -44.31 71.06 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.777 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 8.8 mm -97.94 -70.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 123.211 0.604 . . . . 0.0 112.266 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -18.79 -57.49 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 120.03 3.344 . . . . 0.0 120.03 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 13.1 m -98.73 55.52 1.06 Allowed 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 124.738 1.215 . . . . 0.0 113.031 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -68.37 -0.7 5.17 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.485 1.114 . . . . 0.0 111.516 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.73 145.99 0.49 Allowed Pre-proline 0 CA--C 1.5 -0.977 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 12.9 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 21.0 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 76' ' ' ALA . 1.9 pp -153.67 161.6 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.22 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -141.98 -46.95 0.35 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.38 148.79 4.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 tt -61.57 109.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -173.56 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.374 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.76 138.14 58.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.098 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -121.1 92.49 3.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.423 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 95.1 mt-10 -139.44 38.04 2.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 22.0 ttt85 77.85 -13.65 0.93 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.424 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.55 -10.64 53.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.704 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.405 ' N ' ' CG1' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.704 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.41 ' C ' ' N ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' C ' ' H ' ' A' ' 135' ' ' ILE . 5.0 m-85 -53.33 -13.59 0.58 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 132' ' ' TYR . . . -75.45 48.65 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.537 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.446 ' H ' ' C ' ' A' ' 133' ' ' PHE . 1.3 mp -58.68 -14.31 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 122.696 0.398 . . . . 0.0 111.698 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.1 m 76.39 -132.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 124.396 1.06 . . . . 0.0 112.478 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 72.5 160.37 0.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 123.691 0.619 . . . . 0.0 109.962 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.97 -31.54 84.26 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.868 2.379 . . . . 0.0 112.296 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.417 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 54.9 p90 -144.74 136.66 25.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 139' ' ' PHE . 1.5 mmtm 167.16 -47.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -71.19 -48.42 51.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -41.42 56.65 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 124.597 1.186 . . . . 0.0 110.563 -171.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt 59.04 42.61 18.86 Favored 'General case' 0 CA--C 1.493 -1.235 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.027 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.22 173.53 0.11 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.82 -39.95 95.87 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.829 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.5 m -149.08 -78.2 0.15 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -145.24 149.9 35.73 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 117.817 -3.052 . . . . 0.0 109.731 -169.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.417 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . -70.87 -27.84 64.12 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.459 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.86 -39.14 93.08 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.1 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.487 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 75.4 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.98 -32.75 74.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.61 -45.2 76.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.08 135.97 56.86 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -171.46 115.44 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.609 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -59.87 145.36 45.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -84.1 129.61 34.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.644 0.259 . . . . 0.0 110.877 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 88.7 t80 59.81 87.35 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.156 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -67.51 154.37 41.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.2 m -57.75 -33.66 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 170.62 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 179.73 160.7 0.83 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.49 152.37 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 63.7 m -136.5 144.11 44.14 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -156.94 149.63 23.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.16 -29.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.365 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -152.32 -39.1 0.11 Allowed 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 115.123 -2.631 . . . . 0.0 111.491 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 64.21 41.91 5.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 52.3 -169.27 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 124.977 1.311 . . . . 0.0 108.417 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -105.06 -32.48 4.04 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 107.084 -2.406 . . . . 0.0 107.084 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -62.72 -39.56 94.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.3 158.23 0.13 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.438 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 177.7 -173.51 46.13 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 116.727 -2.654 . . . . 0.0 110.451 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 70.6 t60 76.56 -69.93 0.15 Allowed 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.71 166.85 38.22 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -108.91 -28.06 9.35 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 61.25 -179.46 0.11 Allowed 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -83.84 -9.75 58.54 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.9 t -57.63 -44.16 85.34 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.587 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 5.1 p -63.92 -29.56 70.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -66.11 -39.84 90.25 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.13 67.24 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 116.98 -1.888 . . . . 0.0 110.072 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.33 -72.55 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 127.59 2.356 . . . . 0.0 105.883 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.7 p -63.86 -33.11 74.96 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 125.986 2.054 . . . . 0.0 114.366 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . 0.302 0.0 OUTLIER -72.37 -50.2 28.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 116.164 -2.214 . . . . 0.0 110.672 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.01 -40.32 91.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -69.87 -38.52 76.42 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 7.6 mmtm -63.03 -45.76 90.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 116.945 -1.902 . . . . 0.0 108.865 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.59 85.73 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.71 -44.03 97.71 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -71.51 -37.84 71.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.567 -0.708 . . . . 0.0 111.844 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 3.8 p -70.33 -43.92 69.29 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.21 -42.54 96.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.54 -38.13 94.4 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 33.3 mt -70.17 -40.09 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 117.398 0.599 . . . . 0.0 110.817 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.663 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.41 -50.59 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.707 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.663 ' N ' HG23 ' A' ' 278' ' ' ILE . 16.7 ptm -63.33 -40.97 98.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.637 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.44 96.31 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.657 -0.306 . . . . 0.0 112.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.5 p -69.01 -49.38 58.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 117.84 0.82 . . . . 0.0 108.81 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.616 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.5 m-85 -53.98 -58.09 8.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.5 p -70.51 -46.68 63.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.589 ' O ' HG22 ' A' ' 314' ' ' ILE . 84.8 mt -72.04 -20.64 61.66 Favored 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 116.008 -4.182 . . . . 0.0 108.947 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.971 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -156.39 106.74 2.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.971 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.0 OUTLIER 139.13 -58.75 0.0 OUTLIER 'General case' 0 C--N 1.361 1.066 0 O-C-N 125.213 1.571 . . . . 0.0 111.769 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 68.2 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.2 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.856 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.67 93.73 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.71 -39.87 90.14 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.705 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.93 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 4.7 mt -55.18 -44.34 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.661 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.41 -35.91 92.37 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.923 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.69 -38.45 27.75 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.665 ' O ' HG12 ' A' ' 325' ' ' ILE . 9.3 m-85 -68.32 -32.72 73.05 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.334 0.653 . . . . 0.0 111.868 -170.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.471 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.3 m-20 -54.08 -48.44 94.1 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.621 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 53.4 Cg_exo -61.16 -34.71 88.65 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 121.22 1.471 . . . . 0.0 112.691 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.8 mt -69.6 -44.24 71.14 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.665 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.28 -63.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 123.153 0.581 . . . . 0.0 112.272 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.464 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -42.84 -36.28 1.44 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 120.032 3.345 . . . . 0.0 120.032 -177.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 40.2 m -88.29 40.76 0.97 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 124.745 1.218 . . . . 0.0 113.033 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -71.53 -21.75 61.86 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.503 1.121 . . . . 0.0 111.617 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -43.19 145.99 0.91 Allowed Pre-proline 0 C--N 1.375 1.676 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 91.3 m -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.68 3.737 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 47.5 pt -81.68 164.33 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.165 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m 45.15 85.56 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.77 -68.63 0.73 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.8 -28.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.3 m 58.0 17.1 4.15 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.417 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.99 -44.31 2.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.009 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -169.64 133.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.674 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -174.95 170.34 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -103.3 -0.05 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.743 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.68 -10.64 57.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.703 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.406 ' N ' ' CG1' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.703 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.72 -20.77 15.67 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.65 85.78 0.65 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.573 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.0 tt -91.98 22.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 122.747 0.419 . . . . 0.0 111.712 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.3 p 37.97 60.07 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 124.484 1.115 . . . . 0.0 112.538 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 t -157.71 136.83 8.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.26 -9.66 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.95 2.433 . . . . 0.0 112.042 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.87 -11.16 59.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.426 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -117.08 -50.25 2.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.255 0.55 . . . . 0.0 111.913 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -62.12 -53.84 49.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -41.42 67.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.563 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 145' ' ' LEU . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER 80.22 126.6 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.995 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 p -63.75 96.26 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp 49.02 -162.56 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.8 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.5 -52.35 65.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.615 ' C ' ' H ' ' A' ' 151' ' ' ARG . 48.5 mmtm -157.37 11.34 0.21 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.73 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.482 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . 72.53 -27.56 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.414 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 149' ' ' LYS . 61.2 mtt180 -60.7 -39.14 87.42 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 125.313 1.445 . . . . 0.0 107.673 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.5 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.2 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.532 HD12 ' CD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.465 ' HA ' ' CE2' ' A' ' 219' ' ' TYR . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 0.9 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.9 -32.67 74.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.26 -45.34 76.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 237' ' ' GLU . 46.7 t -64.17 134.49 54.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 236' ' ' SER . 56.9 tt0 178.81 135.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.65 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -87.02 -176.7 49.14 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -109.16 17.36 21.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.31 . . . . 0.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.47 -39.42 93.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.866 0.841 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -156.88 164.43 38.07 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.4 t -121.18 126.62 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -125.4 117.17 23.13 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -111.04 17.67 20.2 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.5 t 63.02 91.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.4 t -60.25 -45.15 94.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -178.54 -40.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.58 148.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.44 -39.54 93.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 115.118 -2.633 . . . . 0.0 111.443 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 74.36 59.28 0.08 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 53.2 t0 51.95 48.35 22.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 124.971 1.308 . . . . 0.0 108.39 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -66.64 147.64 49.88 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -139.52 134.09 31.75 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 12.4 t -148.54 151.59 35.37 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.362 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.18 4.79 83.01 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 116.775 -2.631 . . . . 0.0 110.425 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.34 -46.48 89.77 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.3 145.41 45.97 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 165.76 -56.34 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 260' ' ' ARG . 83.2 mtt85 -132.1 153.53 50.38 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 259' ' ' ARG . 27.2 ttp85 79.06 -65.87 0.2 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.7 t -57.49 -44.15 84.73 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 9.7 t -63.86 -29.61 70.78 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -66.11 -39.8 90.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -30.12 67.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.116 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.32 -72.57 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 127.603 2.361 . . . . 0.0 105.89 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.8 -33.16 75.05 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.987 2.054 . . . . 0.0 114.37 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -72.35 -50.23 28.34 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 116.107 -2.237 . . . . 0.0 110.631 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -65.99 -40.38 91.12 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -69.81 -38.45 76.6 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.321 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -45.73 90.71 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.86 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.6 85.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.76 -44.09 97.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -71.45 -37.8 71.37 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 121.566 -0.709 . . . . 0.0 111.866 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 34.0 p -70.37 -45.02 66.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.424 ' CD1' ' CD1' ' A' ' 219' ' ' TYR . 4.1 tt -61.6 -43.72 98.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.538 ' CG2' ' N ' ' A' ' 278' ' ' ILE . 0.2 OUTLIER -70.2 -40.06 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 117.407 0.604 . . . . 0.0 110.823 -177.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.656 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.45 -50.57 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.677 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.656 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.4 ptt? -63.34 -40.9 98.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.65 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.37 96.14 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 121.627 -0.32 . . . . 0.0 112.49 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.3 p -69.04 -49.45 57.45 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 117.822 0.811 . . . . 0.0 108.814 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.552 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 6.2 m-85 -54.06 -57.91 9.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.477 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.1 p -70.54 -46.71 63.08 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.632 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.4 tp -72.26 -20.55 61.51 Favored 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 115.926 -4.234 . . . . 0.0 108.997 -174.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.993 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.38 107.93 2.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.309 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.993 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.04 -59.41 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.044 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.97 -48.05 93.71 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.855 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.52 -40.01 89.91 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.786 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -41.89 98.81 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.924 ' O ' HG11 ' A' ' 317' ' ' VAL . 13.6 mm -55.87 -43.31 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.887 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.93 -35.91 92.7 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.924 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -89.7 -23.68 32.66 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.27 -32.68 73.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.308 0.643 . . . . 0.0 111.899 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 326' ' ' TYR . 2.5 m120 -54.13 -48.33 94.55 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.647 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 50.2 Cg_exo -61.21 -34.68 88.21 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 121.254 1.483 . . . . 0.0 112.705 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.3 mt -69.6 -44.32 70.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.763 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 14.3 mm -98.41 -64.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 123.191 0.596 . . . . 0.0 112.3 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.467 ' N ' ' O ' ' A' ' 322' ' ' ASN . 49.1 t80 -52.66 -62.09 1.87 Allowed 'General case' 0 C--N 1.353 0.721 0 N-CA-C 120.002 3.334 . . . . 0.0 120.002 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 73.3 m -57.6 81.72 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.748 1.219 . . . . 0.0 112.989 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 329' ' ' SER . 7.7 mmt180 -117.69 -20.97 8.7 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 124.502 1.121 . . . . 0.0 111.57 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 328' ' ' ARG . 47.7 t -44.31 145.99 1.27 Allowed Pre-proline 0 C--N 1.386 2.155 0 O-C-N 118.942 -2.349 . . . . 0.0 110.942 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.7 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 55' ' ' ILE . 3.1 tp -103.3 43.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.145 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.8 m -71.33 76.64 0.74 Allowed 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 50.04 84.74 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.13 -26.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -45.75 -28.48 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.283 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -104.17 166.47 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 58.12 83.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 17.5 mp0 -61.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.57 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 5.9 tpt180 77.22 -50.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.444 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.17 -10.64 55.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.691 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 5.1 m -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.691 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.487 HD13 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER -24.4 -72.37 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -171.13 100.48 0.21 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 118.291 -1.364 . . . . 0.0 110.549 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.57 -40.18 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 122.661 0.384 . . . . 0.0 111.662 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 29.2 p -121.24 156.75 31.79 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.458 1.098 . . . . 0.0 112.513 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.3 m 45.93 71.39 1.57 Allowed Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 124.375 1.047 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.34 48.72 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.922 2.415 . . . . 0.0 112.741 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.22 -49.84 76.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.217 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -76.61 -28.29 56.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.037 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -47.62 -53.72 13.94 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -41.42 69.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.563 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 tt -53.48 107.19 0.22 Allowed 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.036 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.1 m -170.33 -48.51 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -107.71 164.74 11.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 69.0 m 57.95 66.39 1.13 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 152' ' ' VAL . 59.2 mtmt -56.67 158.44 4.59 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.744 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.42 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . -59.12 -26.61 64.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.488 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.64 -39.14 93.17 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 4.4 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.4 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.545 ' CE1' ' CD2' ' A' ' 282' ' ' PHE . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.731 HD12 ' CD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 79.9 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -29.38 68.48 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.56 -46.16 67.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 70.3 m -63.83 137.03 57.87 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -176.33 132.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.705 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -152.27 153.1 24.69 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -135.56 123.25 22.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.54 94.5 0.08 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -151.82 30.82 0.57 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.45 157.16 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 172.15 -54.42 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -158.26 172.98 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.06 137.22 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.1 t -153.84 45.73 0.61 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 54.23 46.6 24.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.47 122.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.54 151.76 25.22 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 115.029 -2.668 . . . . 0.0 111.446 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -100.28 117.15 33.91 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.4 -40.15 95.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.067 1.347 . . . . 0.0 108.433 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -98.97 126.87 9.07 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -127.03 -36.71 2.15 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 90.0 m -133.38 137.07 45.67 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.439 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.36 56.79 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 116.702 -2.666 . . . . 0.0 110.394 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -65.08 162.98 15.75 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 59.15 -130.7 51.16 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -68.65 154.62 41.58 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -142.79 95.84 2.84 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.11 18.71 0.87 Allowed 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.7 m -58.85 -44.15 90.93 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 4.6 p -63.86 -29.63 70.8 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -66.14 -39.82 90.12 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -30.14 67.29 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 116.958 -1.897 . . . . 0.0 110.116 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.31 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.625 2.37 . . . . 0.0 105.856 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -33.14 75.03 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.985 2.053 . . . . 0.0 114.4 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -72.35 -50.19 28.57 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 116.126 -2.229 . . . . 0.0 110.679 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.0 -40.39 91.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -69.85 -38.4 76.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 118.804 -1.159 . . . . 0.0 109.361 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -63.15 -45.7 90.67 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 116.921 -1.911 . . . . 0.0 108.828 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.61 85.64 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.75 -44.07 97.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.42 -37.9 71.44 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.555 -0.715 . . . . 0.0 111.851 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 7.2 p -70.27 -45.01 67.25 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.552 HD21 ' O ' ' A' ' 275' ' ' LEU . 2.0 tm? -61.51 -43.84 98.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.56 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.14 93.83 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 277' ' ' ILE . 1.0 OUTLIER -70.21 -40.09 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 117.376 0.588 . . . . 0.0 110.805 -177.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.651 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.55 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.729 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.651 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.36 -40.94 98.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.36 -1.336 . . . . 0.0 111.626 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.44 96.28 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.208 -0.308 . . . . 0.0 112.446 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.5 p -69.06 -49.36 58.16 Favored 'General case' 0 CA--C 1.493 -1.22 0 O-C-N 121.801 -0.823 . . . . 0.0 108.816 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.731 ' CD2' HD12 ' A' ' 212' ' ' LEU . 1.9 m-85 -54.13 -57.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.491 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.6 p -70.49 -46.69 63.25 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.613 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 9.5 tp -73.44 -19.87 60.86 Favored 'General case' 0 N--CA 1.433 -1.315 1 O-C-N 116.009 -4.182 . . . . 0.0 109.014 -174.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.918 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.63 105.76 2.65 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.119 -178.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.918 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.0 OUTLIER 139.72 -59.59 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.646 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.88 -48.05 93.89 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.861 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 5.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 71.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 16.8 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.872 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.9 -39.35 88.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.803 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -41.89 99.3 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.927 ' O ' HG11 ' A' ' 317' ' ' VAL . 12.7 mm -56.13 -42.89 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.87 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -63.12 -35.91 92.73 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.927 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -72.94 -50.8 11.96 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.33 -32.72 73.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.827 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.474 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.9 m120 -54.15 -48.36 94.49 Favored Pre-proline 0 N--CA 1.436 -1.147 0 CA-C-O 118.484 -0.769 . . . . 0.0 112.629 -171.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.474 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 66.2 Cg_exo -61.18 -34.67 88.48 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 121.265 1.488 . . . . 0.0 112.702 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.59 -44.33 71.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.759 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.69 -68.52 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 123.176 0.59 . . . . 0.0 112.255 -174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -30.71 -39.24 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 119.984 3.327 . . . . 0.0 119.984 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 50.8 0.79 Allowed 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 124.755 1.222 . . . . 0.0 113.015 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -70.43 -5.88 31.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.549 1.14 . . . . 0.0 111.541 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.94 145.99 0.51 Allowed Pre-proline 0 C--N 1.359 0.996 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.0 t -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 1.8 pt -75.49 105.89 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.146 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -45.8 140.64 3.41 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.21 -60.79 1.6 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 tt -63.27 -28.9 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.6 m 57.87 51.44 9.09 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.77 -26.41 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -86.69 126.92 34.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.632 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 7.8 tt0 -93.63 -149.41 0.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 86.1 mtt180 73.24 -47.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.0 -10.64 55.21 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 114.031 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.702 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.7 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.407 ' N ' ' CG1' ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.702 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -43.56 102.56 0.03 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.11 156.66 24.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.539 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.23 -19.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 122.701 0.4 . . . . 0.0 111.631 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.512 ' O ' ' C ' ' A' ' 137' ' ' SER . 7.9 p -88.33 -150.72 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 124.387 1.055 . . . . 0.0 112.484 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.528 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -30.96 -61.43 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 137' ' ' SER . 17.5 Cg_endo -57.69 144.34 93.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.826 2.35 . . . . 0.0 112.191 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 58.28 -118.98 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.617 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 172.12 -33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.519 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 74.78 -54.23 0.67 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -41.42 71.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.563 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.01 146.27 14.89 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.7 -163.08 1.06 Allowed 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -58.81 -44.61 90.87 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.836 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 51.3 t -102.06 -104.17 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm 53.0 45.15 29.43 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 119.999 -1.688 . . . . 0.0 109.781 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.77 -57.67 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.462 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.41 -39.14 92.31 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.461 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 2.4 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.88 -33.01 74.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.43 -45.42 76.1 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.18 135.91 56.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -179.62 140.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.562 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 143.89 59.08 0.02 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -151.55 146.83 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 110.574 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 52.05 34.53 14.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.977 0.894 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -102.66 24.12 11.0 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.71 89.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -125.7 65.06 1.18 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 56.56 38.33 29.53 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.34 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.8 t -154.86 148.63 25.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 56.03 51.58 11.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 26.8 m -59.82 -30.22 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.328 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -81.26 136.03 35.77 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 115.126 -2.63 . . . . 0.0 111.536 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -120.49 -44.99 2.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 162.16 -48.02 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.991 1.316 . . . . 0.0 108.353 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.27 -162.4 35.71 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 107.081 -2.408 . . . . 0.0 107.081 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 54.93 40.48 32.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 95.4 m -113.53 127.94 56.26 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.432 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.47 72.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 116.647 -2.692 . . . . 0.0 110.457 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -98.44 118.13 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -129.22 34.83 2.73 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 73.63 -66.62 0.3 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -163.53 157.54 19.74 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -173.08 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.2 t -58.22 -44.18 88.08 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 5.8 p -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -66.1 -39.8 90.26 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 116.957 -1.897 . . . . 0.0 110.103 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.3 -72.52 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 127.592 2.357 . . . . 0.0 105.92 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 1.4 p -63.84 -33.15 75.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.982 2.051 . . . . 0.0 114.385 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.404 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 8.1 mttt -72.34 -50.23 28.36 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 116.111 -2.236 . . . . 0.0 110.634 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.02 -40.36 91.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -69.8 -38.46 76.64 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.34 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.14 -45.74 90.49 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 116.975 -1.89 . . . . 0.0 108.792 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.19 -46.64 85.43 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.76 -44.04 97.67 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -71.5 -37.88 71.21 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.549 -0.719 . . . . 0.0 111.788 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.6 p -70.24 -44.98 67.42 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 275' ' ' LEU . 15.4 tp -61.45 -43.88 98.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.06 -38.1 93.72 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 40.3 mt -70.2 -40.12 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 117.384 0.592 . . . . 0.0 110.802 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.673 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.36 -50.62 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.661 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.673 ' N ' HG23 ' A' ' 278' ' ' ILE . 11.8 ptt? -63.42 -40.87 98.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.66 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.44 96.32 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.498 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.02 -49.46 57.49 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.553 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.6 m-85 -54.15 -57.83 9.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.498 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.46 -46.73 63.23 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 81.5 mt -71.55 -21.42 61.89 Favored 'General case' 0 N--CA 1.432 -1.348 1 O-C-N 115.892 -4.255 . . . . 0.0 108.962 -175.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.927 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.37 106.79 2.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.249 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.927 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.3 OUTLIER 138.72 -58.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.537 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.82 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.861 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.628 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 304' ' ' ARG . 4.4 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.541 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.622 ' HA ' HG13 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -60.59 -39.96 90.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.691 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -41.89 98.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.922 ' O ' HG11 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.61 -40.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.818 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.36 -35.91 92.55 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.922 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.77 -38.33 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -165.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.595 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.3 -32.8 73.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 123.363 0.665 . . . . 0.0 111.811 -170.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.473 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.0 m-20 -54.1 -48.32 94.5 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-O 118.499 -0.762 . . . . 0.0 112.665 -171.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.473 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 54.7 Cg_exo -61.19 -34.7 88.39 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 121.246 1.481 . . . . 0.0 112.724 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.4 mt -69.56 -44.29 71.19 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.791 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 321' ' ' PHE . 3.1 mm -95.55 -63.56 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 123.202 0.601 . . . . 0.0 112.233 -173.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.461 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.3 OUTLIER -43.65 -38.51 3.11 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -177.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 46.0 m -87.17 42.77 1.05 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.754 1.222 . . . . 0.0 113.04 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -73.26 -20.92 60.73 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 124.553 1.141 . . . . 0.0 111.555 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -42.86 145.99 0.82 Allowed Pre-proline 0 C--N 1.378 1.83 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 1.7 m -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.76 3.787 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.754 ' C ' ' O ' ' A' ' 54' ' ' VAL . 56.9 mt 5.77 -95.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.213 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 55' ' ' ILE . 88.5 m 64.9 -70.49 0.09 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 55' ' ' ILE . . . 45.2 -155.45 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.477 ' HA ' HE22 ' A' ' 65' ' ' GLN . 24.7 pt -87.2 25.41 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.9 t -82.1 -69.44 0.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.242 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -130.78 -177.31 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 61.33 92.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -64.66 -19.33 65.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.384 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -67.91 -46.58 71.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -72.33 -10.64 60.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.477 HE22 ' HA ' ' A' ' 58' ' ' ILE . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 64.0 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.289 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER -39.59 -32.74 0.14 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 67.21 151.34 0.07 Allowed 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.542 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.56 23.95 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 122.711 0.404 . . . . 0.0 111.72 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.8 m -38.64 145.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.396 1.06 . . . . 0.0 112.533 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.615 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -52.44 -56.34 23.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 137' ' ' SER . 50.8 Cg_exo -29.99 -67.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.775 2.983 . . . . 0.0 113.142 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 52.2 p90 -179.45 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 139' ' ' PHE . 25.6 ttpt 78.94 52.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -177.44 -55.84 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -41.42 74.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.563 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.51 130.66 35.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.062 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.3 p -116.18 31.05 6.96 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp 63.21 30.53 15.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.743 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 44.8 t -129.16 -38.42 1.61 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.9 86.43 5.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 116.38 -3.95 . . . . 0.0 109.778 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.57 -59.71 0.07 Allowed 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.539 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -61.96 -39.14 91.1 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.0 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.35 -33.36 75.78 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -67.31 -45.44 76.5 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 45.8 t -64.49 137.87 58.1 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -169.27 116.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.664 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.79 -178.77 50.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -129.09 127.97 42.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 110.699 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -130.19 148.08 51.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.88 0.848 . . . . 0.0 109.202 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -100.27 111.74 24.03 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.55 29.3 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -61.23 -41.2 96.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -103.01 130.93 50.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.81 123.8 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.8 m -100.43 -33.03 10.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -130.44 149.6 52.04 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.51 122.77 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.333 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.05 153.01 37.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 115.156 -2.618 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -106.04 123.26 47.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -161.8 -179.5 7.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.004 1.322 . . . . 0.0 108.371 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.95 -59.54 2.4 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 107.133 -2.387 . . . . 0.0 107.133 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -62.26 -39.89 94.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 62.3 p -135.9 157.5 46.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.44 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 70.3 23.89 77.06 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 116.714 -2.66 . . . . 0.0 110.426 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -68.13 147.52 52.19 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -41.71 99.69 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.49 149.09 24.74 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -102.17 21.05 15.56 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.34 -38.84 92.73 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.9 t -57.87 -44.21 86.48 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 61.6 m -63.83 -29.63 70.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -66.22 -39.71 89.79 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.17 67.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 116.914 -1.914 . . . . 0.0 110.069 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.23 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 127.624 2.37 . . . . 0.0 105.885 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.79 -33.22 75.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 126.005 2.066 . . . . 0.0 114.357 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 7.5 pttt -72.3 -50.28 28.22 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 116.172 -2.211 . . . . 0.0 110.641 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.98 -40.39 91.16 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -69.83 -38.46 76.53 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.312 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -63.13 -45.72 90.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.977 -1.889 . . . . 0.0 108.813 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.53 85.81 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.81 -44.06 97.62 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -71.49 -37.84 71.25 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 121.586 -0.696 . . . . 0.0 111.831 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.5 p -70.3 -45.0 67.17 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 275' ' ' LEU . 14.0 tp -61.49 -43.81 98.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.606 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 326' ' ' TYR . 20.0 mt -70.26 -40.08 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 117.394 0.597 . . . . 0.0 110.789 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.699 HG23 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.41 -50.52 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.724 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.699 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.2 ptt? -63.37 -40.93 98.6 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 118.411 -1.316 . . . . 0.0 111.662 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.62 -38.4 96.2 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 121.604 -0.332 . . . . 0.0 112.461 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.529 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.6 p -69.02 -49.39 58.04 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 121.789 -0.83 . . . . 0.0 108.804 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.546 ' HD2' HD12 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.08 -57.96 9.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.8 p -70.54 -46.72 63.04 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.3 tp -69.68 -22.35 63.44 Favored 'General case' 0 N--CA 1.432 -1.35 1 O-C-N 115.949 -4.219 . . . . 0.0 109.025 -176.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 1.021 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -155.59 117.59 4.09 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.958 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 1.021 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 2.4 m95 131.88 -59.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.008 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.81 -48.05 94.02 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.861 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 4.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 43.4 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.891 ' O ' HG21 ' A' ' 314' ' ' ILE . 6.1 mp -62.03 -37.42 84.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.793 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -41.89 97.51 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 120.898 -1.126 . . . . 0.0 109.183 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 3.4 tp -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.966 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.577 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -79.03 -35.5 30.55 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -165.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.558 ' O ' HG12 ' A' ' 325' ' ' ILE . 5.4 m-85 -68.3 -32.74 73.1 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.339 0.656 . . . . 0.0 111.834 -171.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.2 m-20 -54.09 -48.36 94.38 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.628 -171.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.0 Cg_exo -61.2 -34.71 88.26 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.284 1.494 . . . . 0.0 112.695 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.59 -44.27 71.11 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.772 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.9 mm -90.73 -61.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 C-N-CA 123.236 0.614 . . . . 0.0 112.276 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.519 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -48.59 -22.1 0.7 Allowed 'General case' 0 C--N 1.353 0.746 0 N-CA-C 119.965 3.32 . . . . 0.0 119.965 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 67.5 m -83.05 19.53 1.4 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 124.752 1.221 . . . . 0.0 113.072 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 329' ' ' SER . 0.8 OUTLIER -57.59 -33.65 68.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 124.494 1.118 . . . . 0.0 111.55 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.58 145.99 3.89 Favored Pre-proline 0 C--N 1.378 1.819 0 C-N-CA 115.959 -2.297 . . . . 0.0 110.942 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.713 3.758 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 33.6 mm -158.8 133.03 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.167 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.8 p -115.49 -34.47 4.9 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.81 161.21 1.21 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 tp -66.6 131.47 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.0 m -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.358 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -75.84 96.87 3.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.602 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -139.38 157.54 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.583 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -131.66 56.76 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.566 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.72 -70.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.568 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.38 -10.64 56.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.759 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 56.9 t -56.24 -40.5 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.363 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.759 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.848 HD13 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.585 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.804 ' O ' ' C ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -27.38 130.85 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.804 ' C ' ' O ' ' A' ' 133' ' ' PHE . . . -11.08 104.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.549 -176.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 136' ' ' CYS . 0.7 OUTLIER -97.15 101.65 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 122.69 0.396 . . . . 0.0 111.621 -177.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 135' ' ' ILE . 5.3 p 156.32 -169.83 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.507 1.13 . . . . 0.0 112.442 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.35 164.88 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.81 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.821 2.347 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -150.79 124.37 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.527 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 52.51 27.48 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.582 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.549 ' CG ' ' CE1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -112.72 -51.85 2.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -41.42 64.75 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 125.793 1.933 . . . . 0.0 110.563 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.43 107.31 9.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.067 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 90.8 m -132.79 133.25 43.17 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt 61.98 -166.72 0.21 Allowed 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.776 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 16.2 p -65.94 156.38 33.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.51 0.671 . . . . 0.0 111.738 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 152' ' ' VAL . 87.6 tttt -178.94 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.97 -36.74 80.58 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.512 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -66.38 -39.14 88.91 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 0.7 OUTLIER -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.535 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.444 HD12 ' CD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.91 ' HB2' ' HG ' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.88 -32.24 73.85 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -68.76 -44.44 73.72 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 t -78.62 83.16 4.82 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -148.48 91.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 176.65 -169.07 41.4 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -91.38 126.59 36.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.575 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -78.16 146.02 35.31 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.892 0.853 . . . . 0.0 109.191 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -66.61 158.48 29.8 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.53 -54.38 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -172.12 -167.46 0.48 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.33 41.46 13.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.76 -54.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.2 p -70.6 160.91 31.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.99 -74.95 0.43 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 71.4 t -120.99 -57.08 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -81.3 145.61 30.81 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 115.126 -2.629 . . . . 0.0 111.475 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -130.17 144.73 51.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.68 -40.24 94.29 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.035 1.334 . . . . 0.0 108.411 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 174.19 179.06 44.57 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -96.69 -32.08 12.36 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 58.5 p -136.54 160.25 39.33 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.44 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 146.24 35.71 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 116.792 -2.623 . . . . 0.0 110.489 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -64.19 -40.01 95.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.31 148.56 21.97 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -157.37 162.23 39.05 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 54.36 37.76 28.18 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -102.75 -34.43 9.03 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.7 t -57.68 -44.16 85.57 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 12.2 t -63.85 -29.63 70.8 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -66.12 -39.81 90.18 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.14 67.25 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 116.899 -1.92 . . . . 0.0 110.133 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.25 -72.52 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.608 2.363 . . . . 0.0 105.927 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.85 -33.2 75.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 125.973 2.046 . . . . 0.0 114.365 -179.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 9.4 mttt -72.34 -50.19 28.66 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 116.135 -2.226 . . . . 0.0 110.671 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -69.91 -38.42 76.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.302 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -45.72 90.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 116.924 -1.911 . . . . 0.0 108.853 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.64 85.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.79 -44.05 97.64 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -71.44 -37.86 71.38 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 121.582 -0.699 . . . . 0.0 111.825 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 24.5 p -70.27 -45.01 67.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.91 ' HG ' ' HB2' ' A' ' 219' ' ' TYR . 5.0 mp -61.56 -43.77 98.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.99 -38.19 93.89 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 42.4 mt -70.15 -40.13 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.403 0.601 . . . . 0.0 110.78 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.678 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.34 -50.66 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.702 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.678 ' N ' HG23 ' A' ' 278' ' ' ILE . 11.6 ptt? -63.35 -40.95 98.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.632 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.46 96.34 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 121.621 -0.323 . . . . 0.0 112.456 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.1 p -69.0 -49.39 58.25 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 117.846 0.823 . . . . 0.0 108.848 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.574 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.7 m-85 -54.06 -57.92 9.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.549 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.2 p -70.53 -46.66 63.18 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 80.8 mt -71.04 -21.5 62.26 Favored 'General case' 0 N--CA 1.433 -1.31 1 O-C-N 115.965 -4.209 . . . . 0.0 109.003 -175.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.89 ' HB3' ' O ' ' A' ' 314' ' ' ILE . 0.8 OUTLIER -154.67 109.13 2.99 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.167 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.871 ' HA ' ' HE3' ' A' ' 286' ' ' TRP . 0.0 OUTLIER 137.09 -59.1 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.683 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.58 -48.05 94.47 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.861 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 299' ' ' GLN . 68.8 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 295' ' ' VAL . 9.4 pm0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 1.8 mp0 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.823 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.96 -39.26 88.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.776 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -41.89 99.37 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.907 ' O ' HG11 ' A' ' 317' ' ' VAL . 8.4 mm -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.851 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.62 -37.06 31.59 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -165.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.683 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.3 m-85 -68.22 -32.76 73.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 122.097 -0.649 . . . . 0.0 111.902 -170.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.471 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.4 m-80 -54.06 -48.37 94.27 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.66 -171.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.8 Cg_exo -61.19 -34.66 88.42 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 121.22 1.471 . . . . 0.0 112.697 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.63 -44.32 70.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.746 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.51 -64.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 123.216 0.606 . . . . 0.0 112.27 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.435 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -44.53 -33.14 1.64 Allowed 'General case' 0 C--N 1.352 0.715 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -177.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 75.1 m -89.52 39.06 0.93 Allowed 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.719 1.208 . . . . 0.0 113.071 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -69.04 -22.6 64.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.532 1.133 . . . . 0.0 111.549 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -45.25 145.99 1.68 Allowed Pre-proline 0 C--N 1.369 1.418 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.783 3.802 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 3.2 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.479 ' CG2' HG22 ' A' ' 73' ' ' THR . 47.5 pt -130.51 157.29 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.197 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.34 -167.49 0.19 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 73.7 64.62 0.09 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.5 mt 64.71 148.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 79.9 m -118.6 137.51 53.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.345 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -131.21 152.66 50.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.69 100.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -129.08 -178.73 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.668 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -95.3 5.91 50.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.455 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.11 -10.64 55.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.31 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.767 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.1 t -56.45 -40.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.34 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.04 -32.59 72.2 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.767 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.61 ' HZ ' ' H ' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.479 HG22 ' CG2' ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -54.13 -48.99 70.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -78.03 -84.89 0.07 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 47.98 -162.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.512 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.531 ' O ' ' SG ' ' A' ' 136' ' ' CYS . 0.3 OUTLIER -52.26 162.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 122.679 0.392 . . . . 0.0 111.642 179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.531 ' SG ' ' O ' ' A' ' 135' ' ' ILE . 9.1 p 44.54 -114.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.393 1.058 . . . . 0.0 112.479 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.24 166.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 123.332 0.395 . . . . 0.0 110.361 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -55.34 -34.26 88.12 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.948 2.432 . . . . 0.0 112.066 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.56 -87.83 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.719 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 mttt 173.86 169.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.47 -58.36 1.77 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -41.42 81.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.563 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.686 ' O ' ' C ' ' A' ' 145' ' ' LEU . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.686 ' C ' ' O ' ' A' ' 144' ' ' LEU . 1.7 tt 20.81 68.31 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.0 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 -74.16 0.37 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -94.98 -3.74 47.94 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.4 m -62.18 -40.78 97.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -168.42 116.22 0.69 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 116.693 -3.754 . . . . 0.0 109.799 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.61 ' H ' ' HZ ' ' A' ' 71' ' ' PHE . . . -166.96 161.48 15.05 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.444 -0.903 . . . . 0.0 110.468 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -59.18 -39.14 81.63 Favored 'General case' 0 C--N 1.301 -1.505 2 O-C-N 129.642 4.339 . . . . 0.0 107.673 176.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.5 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 1.7 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.42 -33.56 76.24 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.64 -45.29 75.77 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.2 t -63.83 136.09 57.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -173.88 130.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -158.21 177.73 34.78 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -124.93 147.62 48.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 59.66 -179.48 0.09 Allowed 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.926 0.869 . . . . 0.0 109.183 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 66.08 56.02 0.87 Allowed 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.49 143.17 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.15 142.81 49.11 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -68.31 135.79 52.44 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 156.57 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.4 p -71.67 158.99 35.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 62.94 170.76 0.14 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.6 p -151.9 139.23 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.399 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 115.105 -2.638 . . . . 0.0 111.458 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -63.76 -40.98 98.01 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -163.06 176.53 9.99 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.079 1.352 . . . . 0.0 108.43 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -149.5 150.62 22.74 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.63 -65.84 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 47.4 m -133.36 136.1 45.14 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.434 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 97.37 136.86 9.3 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 116.737 -2.649 . . . . 0.0 110.419 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -108.47 -36.65 6.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.31 51.17 60.16 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.77 -49.63 76.95 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -153.18 157.17 39.9 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 63.71 17.41 10.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.0 t -60.23 -44.22 95.37 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 120.857 -1.152 . . . . 0.0 108.086 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.581 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 4.9 p -63.82 -29.62 70.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -66.14 -39.8 90.13 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.1 67.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 116.913 -1.915 . . . . 0.0 110.119 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.33 -72.55 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 127.605 2.362 . . . . 0.0 105.884 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.8 -33.12 74.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 125.949 2.031 . . . . 0.0 114.429 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . 0.432 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 0.1 OUTLIER -72.42 -50.16 28.41 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 116.141 -2.224 . . . . 0.0 110.655 -178.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.08 -40.31 90.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -69.83 -38.47 76.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.331 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.07 -45.73 90.79 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 116.947 -1.901 . . . . 0.0 108.839 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.58 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.422 ' O ' HD13 ' A' ' 277' ' ' ILE . 0.4 OUTLIER -71.47 -37.86 71.3 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 121.555 -0.716 . . . . 0.0 111.82 -179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 21.0 p -70.32 -44.95 67.21 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 276' ' ' GLY . 0.1 OUTLIER -61.53 -43.82 98.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.592 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.458 ' N ' ' CD2' ' A' ' 275' ' ' LEU . . . -66.04 -38.12 93.77 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 273' ' ' LYS . 23.1 mt -70.17 -40.11 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 117.389 0.595 . . . . 0.0 110.813 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.702 HG23 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.4 -50.6 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.666 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.702 ' N ' HG23 ' A' ' 278' ' ' ILE . 14.8 ptt? -63.32 -40.96 98.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.647 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.38 96.18 Favored Glycine 0 C--N 1.348 1.239 0 C-N-CA 121.606 -0.33 . . . . 0.0 112.492 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -69.05 -49.36 58.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.514 ' HD2' HD12 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.478 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.0 p -70.51 -46.7 63.18 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.3 mt -68.54 -23.07 64.47 Favored 'General case' 0 N--CA 1.432 -1.336 1 O-C-N 115.966 -4.209 . . . . 0.0 108.975 -176.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 1.066 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 1.3 p -156.87 115.52 3.32 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.257 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 1.066 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 3.0 m95 135.2 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.609 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.94 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.554 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 68.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.0 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.824 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.554 ' HB3' ' HD1' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.82 -39.5 89.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.751 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.89 99.27 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.907 ' O ' HG11 ' A' ' 317' ' ' VAL . 65.8 mt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.918 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.616 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.12 -37.08 29.69 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 325' ' ' ILE . 7.1 m-85 -68.21 -32.77 73.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.329 0.652 . . . . 0.0 111.872 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.5 m-20 -54.04 -48.45 94.0 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.639 -171.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.6 Cg_exo -61.14 -34.72 88.81 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 CA-C-N 121.258 1.485 . . . . 0.0 112.666 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.59 -44.34 70.98 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.6 mm -93.31 -63.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.211 0.604 . . . . 0.0 112.255 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -42.98 -34.39 0.98 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -177.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 79.1 p -88.61 35.93 0.78 Allowed 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 124.717 1.207 . . . . 0.0 113.009 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -67.37 -24.16 65.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.51 1.124 . . . . 0.0 111.597 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.62 145.99 1.37 Allowed Pre-proline 0 C--N 1.378 1.841 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.942 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 55.9 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.797 3.811 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' OG1' ' A' ' 56' ' ' THR . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.475 ' O ' HG22 ' A' ' 56' ' ' THR . 0.0 OUTLIER -156.61 133.31 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.102 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 161.94 -85.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' ILE . . . -94.95 168.01 11.05 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 57' ' ' ALA . 5.7 mt 40.84 51.38 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -75.97 43.06 0.26 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.254 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -74.17 57.4 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -45.58 100.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.671 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 75.8 mm-40 -77.98 83.02 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.619 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 20.7 ttm180 78.18 -4.13 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.548 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.32 -10.64 52.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.41 0.68 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.6 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.319 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 134' ' ' ALA . 2.6 t80 -72.13 105.95 4.16 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' A' ' 133' ' ' PHE . . . 63.53 117.24 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.519 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.72 -57.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 122.735 0.414 . . . . 0.0 111.715 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 137' ' ' SER . 14.6 p -76.14 -37.71 57.66 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 124.381 1.05 . . . . 0.0 112.523 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 136' ' ' CYS . 60.0 m -141.55 160.52 56.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.855 0.722 . . . . 0.0 109.838 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.33 -13.97 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.027 2.485 . . . . 0.0 112.472 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -47.07 140.66 4.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.71 49.33 12.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 111.15 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -144.77 -54.85 0.32 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.21 -41.42 70.25 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.563 -175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 131.72 41.84 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.034 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -153.17 155.02 35.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt 60.06 27.1 16.5 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.729 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 76.1 m 49.14 45.04 23.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.416 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -60.3 127.5 32.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.265 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.46 ' HA ' HD11 ' A' ' 153' ' ' ILE . . . 175.44 -31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.135 0.493 . . . . 0.0 110.202 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -63.82 -39.14 93.52 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 3.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.9 m170 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.498 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.37 -33.46 76.02 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.23 -45.11 77.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.8 m -64.5 140.96 58.92 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -176.95 122.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.639 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -70.64 153.75 51.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -114.97 126.74 55.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 110.637 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.13 144.47 51.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.902 0.858 . . . . 0.0 109.18 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -143.98 32.07 1.26 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.82 137.23 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 57.17 32.89 22.48 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -88.67 177.5 6.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.36 63.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.63 -171.98 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -111.07 110.58 21.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.24 157.33 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.38 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.28 137.02 35.83 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 115.06 -2.656 . . . . 0.0 111.429 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -137.32 124.21 21.35 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -117.18 13.34 14.67 Favored 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 125.051 1.34 . . . . 0.0 108.335 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.81 157.56 51.62 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -153.25 157.97 40.98 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 153.45 33.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.43 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.28 48.2 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 116.788 -2.625 . . . . 0.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -156.82 143.48 18.43 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 59.19 -129.04 48.79 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -149.65 159.65 44.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -143.34 -71.67 0.3 Allowed 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -150.23 -41.89 0.13 Allowed 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.2 t -57.87 -44.21 86.49 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 49.7 m -63.83 -29.6 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -66.15 -39.74 90.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.17 67.28 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 116.928 -1.909 . . . . 0.0 110.112 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.21 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 127.649 2.38 . . . . 0.0 105.9 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 15.2 p -63.83 -33.15 75.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 126.036 2.085 . . . . 0.0 114.396 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -72.4 -50.21 28.16 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 116.087 -2.245 . . . . 0.0 110.654 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -65.94 -40.37 91.3 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -69.82 -38.49 76.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.322 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.7 mmpm? -63.07 -45.74 90.73 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.984 -1.886 . . . . 0.0 108.825 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.61 85.6 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -44.04 97.68 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.55 -37.79 71.07 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.621 -0.674 . . . . 0.0 111.802 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 19.1 p -70.31 -44.99 67.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 275' ' ' LEU . 16.8 tp -61.48 -43.81 98.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.14 93.78 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 34.7 mt -70.2 -40.07 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.365 0.582 . . . . 0.0 110.801 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.657 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.43 -50.56 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.671 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.657 ' N ' HG23 ' A' ' 278' ' ' ILE . 16.5 ptm -63.4 -40.92 98.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.588 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.41 96.24 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.01 -49.37 58.33 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.61 ' CE1' ' HE3' ' A' ' 215' ' ' MET . 7.7 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.437 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.7 p -70.54 -46.64 63.2 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.5 tp -72.06 -20.57 61.65 Favored 'General case' 0 N--CA 1.432 -1.33 1 O-C-N 116.004 -4.185 . . . . 0.0 109.002 -174.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.97 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.64 107.72 2.84 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.186 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.97 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.17 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.647 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.67 -48.05 94.28 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.861 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.561 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 69.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.1 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 64.8 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.621 ' HA ' HG13 ' A' ' 314' ' ' ILE . 0.0 OUTLIER -60.6 -39.94 89.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.736 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -41.89 98.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.911 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 0.9 OUTLIER -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.864 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.11 -37.71 28.1 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -165.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.649 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.29 -32.71 73.06 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.359 0.664 . . . . 0.0 111.864 -170.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.469 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.2 m-20 -54.16 -48.34 94.55 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-O 118.48 -0.772 . . . . 0.0 112.606 -171.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.469 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.7 Cg_exo -61.18 -34.66 88.49 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 121.252 1.483 . . . . 0.0 112.707 -176.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.7 mt -69.64 -44.3 70.87 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.743 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.8 mm -95.58 -63.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.248 0.619 . . . . 0.0 112.25 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.468 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.3 OUTLIER -43.42 -33.32 1.04 Allowed 'General case' 0 C--N 1.353 0.736 0 N-CA-C 119.987 3.329 . . . . 0.0 119.987 -177.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.5 p -86.64 36.2 0.7 Allowed 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.762 1.225 . . . . 0.0 113.014 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.07 -24.38 67.68 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.574 1.15 . . . . 0.0 111.51 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.38 145.99 3.59 Favored Pre-proline 0 C--N 1.377 1.762 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.942 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.69 3.744 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 54' ' ' VAL . 35.9 pt -138.53 162.23 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.178 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m 66.84 30.8 7.67 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -112.11 -81.16 0.59 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -124.05 118.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 m -85.67 148.36 25.92 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.273 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.31 36.37 27.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.066 0.46 . . . . 0.0 109.798 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -72.84 -42.73 63.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.12 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -156.82 -157.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -80.84 26.64 0.4 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.669 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -66.02 -10.64 41.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.3 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.771 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 28.2 m -56.5 -40.26 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.307 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -60.96 -32.59 72.12 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.718 -0.793 . . . . 0.0 108.863 -178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.771 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -44.71 140.9 2.28 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 140.24 57.1 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.506 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.2 pt -148.96 22.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 122.76 0.424 . . . . 0.0 111.701 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -103.5 -67.37 0.89 Allowed 'General case' 0 C--N 1.332 -0.179 0 O-C-N 124.376 1.048 . . . . 0.0 112.539 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.1 m -74.73 153.79 87.24 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.5 -21.3 13.27 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.36 2.707 . . . . 0.0 112.628 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.96 -38.91 92.53 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.192 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.34 175.85 6.53 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.063 0.459 . . . . 0.0 111.58 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 72.86 -55.83 0.67 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -41.42 74.28 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.563 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.39 110.43 18.14 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.06 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.6 p -135.92 167.21 21.62 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 69.09 -84.87 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.797 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.88 -79.61 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 150' ' ' ALA . 72.5 mmtt 60.27 -161.86 0.27 Allowed 'General case' 0 C--N 1.407 3.107 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.816 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 149' ' ' LYS . . . 77.23 -53.25 0.55 Allowed 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.534 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.56 -39.14 92.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.8 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.458 ' HA ' ' CE2' ' A' ' 219' ' ' TYR . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.69 -32.26 73.72 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -68.32 -46.97 68.79 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 43.6 t -62.52 136.89 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -172.94 125.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.571 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.06 139.45 10.98 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 138.29 44.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.654 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -149.63 113.47 5.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.852 0.834 . . . . 0.0 109.174 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -159.64 164.83 33.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.06 28.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 57.23 31.59 20.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 245' ' ' VAL . 83.4 m-20 -140.23 137.41 34.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 244' ' ' ASN . 6.3 t 68.29 131.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.3 p -69.86 160.13 32.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -131.44 149.4 52.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.83 140.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -145.93 30.04 1.08 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 115.026 -2.669 . . . . 0.0 111.442 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -61.68 -42.64 99.2 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -166.42 157.59 12.97 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 125.021 1.329 . . . . 0.0 108.371 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.52 74.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 107.154 -2.379 . . . . 0.0 107.154 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 81.5 p -124.98 -29.47 3.34 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.467 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 68.83 26.08 74.82 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 116.705 -2.664 . . . . 0.0 110.454 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -157.39 144.03 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 70.54 29.54 69.71 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -96.43 19.51 12.01 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -115.51 -32.66 5.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -60.98 -43.85 98.21 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.0 t -57.75 -44.17 85.92 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 6.2 p -63.82 -29.66 70.83 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -66.12 -39.8 90.18 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -30.21 67.4 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 116.996 -1.881 . . . . 0.0 110.074 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.27 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 127.651 2.38 . . . . 0.0 105.918 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 13.9 p -63.88 -33.08 74.89 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.013 2.071 . . . . 0.0 114.425 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -50.21 28.14 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.629 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -69.87 -38.44 76.41 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.331 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -45.7 90.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 116.997 -1.881 . . . . 0.0 108.861 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.63 85.54 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.69 -44.07 97.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.411 ' O ' HD13 ' A' ' 277' ' ' ILE . 0.0 OUTLIER -71.47 -37.84 71.29 Favored 'General case' 0 CA--C 1.495 -1.173 0 O-C-N 121.578 -0.701 . . . . 0.0 111.836 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.5 p -70.29 -44.98 67.25 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.62 HD11 ' HB2' ' A' ' 219' ' ' TYR . 5.1 tt -61.41 -43.86 98.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.581 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.15 93.69 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 273' ' ' LYS . 29.9 mt -70.14 -40.12 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 117.396 0.598 . . . . 0.0 110.791 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.695 HG23 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.44 -50.54 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.402 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.706 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.695 ' N ' HG23 ' A' ' 278' ' ' ILE . 16.5 ptm -63.37 -40.95 98.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.364 -1.334 . . . . 0.0 111.653 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.53 96.45 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.216 -0.302 . . . . 0.0 112.44 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -68.95 -49.34 58.81 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 121.822 -0.811 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.529 ' HD2' HD12 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.75 -58.26 7.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.493 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.54 -46.74 62.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.34 -22.73 63.74 Favored 'General case' 0 N--CA 1.432 -1.351 1 O-C-N 115.983 -4.198 . . . . 0.0 109.007 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.976 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.9 OUTLIER -156.18 113.86 3.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.238 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.976 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.3 m95 135.71 -58.91 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.83 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.861 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . 0.552 ' HD1' ' HB3' ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.5 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.827 ' O ' HG22 ' A' ' 314' ' ' ILE . 0.1 OUTLIER -61.07 -39.19 88.95 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.684 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -41.89 99.61 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.433 -0.792 . . . . 0.0 109.183 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.907 ' O ' HG11 ' A' ' 317' ' ' VAL . 2.8 tt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.875 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.434 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.43 -35.62 36.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -166.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . 0.667 ' O ' HG12 ' A' ' 325' ' ' ILE . 11.5 m-85 -68.26 -32.75 73.16 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 123.345 0.658 . . . . 0.0 111.82 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.468 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.2 m-80 -54.09 -48.38 94.32 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.654 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.468 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 51.3 Cg_exo -61.19 -34.66 88.38 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.254 1.484 . . . . 0.0 112.715 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.65 -44.29 70.87 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.74 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . 0.667 HG12 ' O ' ' A' ' 321' ' ' PHE . 2.1 mm -94.8 -64.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.237 0.615 . . . . 0.0 112.309 -173.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 322' ' ' ASN . 0.2 OUTLIER -43.44 -30.88 0.6 Allowed 'General case' 0 C--N 1.352 0.699 0 N-CA-C 119.979 3.326 . . . . 0.0 119.979 -177.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 81.7 p -93.03 36.1 1.05 Allowed 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.024 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -67.94 -23.09 65.03 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 124.531 1.132 . . . . 0.0 111.607 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.87 145.99 1.46 Allowed Pre-proline 0 C--N 1.374 1.649 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 88.4 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.743 3.777 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.902 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.902 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 HD11 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.411 HG21 ' ND2' ' A' ' 51' ' ' ASN . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 52' ' ' VAL . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.867 ' O ' HG13 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' CD1' ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.624 ' O ' ' OG1' ' A' ' 56' ' ' THR . 1.6 mm -146.57 159.04 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.624 ' OG1' ' O ' ' A' ' 55' ' ' ILE . 7.2 p 72.14 151.31 0.11 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 70.89 95.83 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.9 mt 61.98 99.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 p -129.13 126.88 40.27 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.364 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mmtt 174.5 -161.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.53 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 4.5 t80 83.37 -6.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.504 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 60.1 mm-40 48.21 -154.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.523 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 63.8 mtp85 72.15 -55.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.569 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.31 -10.64 52.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 61.0 t -56.3 -40.45 66.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.328 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.561 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.76 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.718 ' O ' HG13 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD23 HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.64 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.566 ' O ' HG13 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.58 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.804 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.474 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.643 ' HD3' HG12 ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.621 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 94' ' ' ILE . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.405 HG21 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.843 ' O ' HG21 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.621 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.779 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.54 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.662 ' O ' HG23 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.443 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.662 HG23 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.639 ' N ' HG22 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.797 ' CG2' ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.749 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.804 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.876 HG21 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 ' HB ' ' OG ' ' A' ' 161' ' ' SER . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.952 HD13 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TRP . . . . . 0.58 ' HD1' ' CG2' ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD22 HD23 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.522 ' CZ ' ' HA ' ' A' ' 271' ' ' ALA . 11.0 mtp85 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -67.31 -45.15 77.35 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.04 63.36 4.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 118.264 -1.375 . . . . 0.0 110.598 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 70.7 mt -63.32 -65.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 122.76 0.424 . . . . 0.0 111.681 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 19.0 p -178.03 -28.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.391 1.057 . . . . 0.0 112.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.7 m -81.42 121.28 79.89 Favored Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 123.504 0.502 . . . . 0.0 110.288 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.53 -13.89 22.45 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.224 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -66.02 -29.68 70.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -100.75 10.96 40.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.62 -55.35 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.43 -41.42 72.91 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.7 tt -96.54 116.45 29.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 119.491 -0.883 . . . . 0.0 109.014 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.5 p -144.72 -55.8 0.34 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.9 -46.04 92.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.773 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 173.46 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 53.04 65.31 1.56 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 118.982 -2.324 . . . . 0.0 109.776 -170.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.21 -61.53 0.08 Allowed 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.493 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.76 -39.14 93.23 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 153' ' ' ILE . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.528 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.851 ' O ' HG21 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.68 ' O ' HG12 ' A' ' 160' ' ' VAL . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.658 ' HZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.851 HG21 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.68 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.749 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.797 ' HB3' ' CG2' ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.704 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.6 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.914 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.75 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.75 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.914 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.764 ' CB ' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.733 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.531 ' HG3' HD22 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.733 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASN . . . . . 0.531 HD22 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.677 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.843 HG21 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' CYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.497 ' CZ ' ' CG2' ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.764 ' HE2' ' CB ' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.668 HD22 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.723 ' HG2' ' CG2' ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.637 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . 0.668 ' HB2' HD22 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.637 ' CD1' ' HA ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.573 ' HA ' HG12 ' A' ' 205' ' ' ILE . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 206' ' ' VAL . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' SER . . . . . 0.44 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.79 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.591 ' N ' HG13 ' A' ' 205' ' ' ILE . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.416 ' N ' ' CG2' ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.517 ' CE2' HD23 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.79 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.938 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PRO . . . . . 0.938 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.656 HD12 ' HD2' ' A' ' 282' ' ' PHE . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.481 HD13 ' O ' ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.861 ' O ' HG13 ' A' ' 222' ' ' VAL . 75.6 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.861 HG13 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . 0.915 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.915 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -65.69 -33.12 75.14 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.98 -45.64 77.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -64.09 131.62 48.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -177.95 138.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.551 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 158.79 -92.88 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 55.08 40.21 31.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 0.0 110.635 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -83.54 -2.52 56.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.791 0.805 . . . . 0.0 109.182 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -62.26 -39.44 92.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.9 m -62.04 -27.38 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? 67.02 109.94 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 63.9 t30 62.8 85.95 0.12 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 18.1 m -59.48 -31.14 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t 60.87 -167.59 0.19 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -108.04 154.78 21.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 2.3 t 54.66 45.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.385 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -68.76 155.99 39.13 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 115.098 -2.641 . . . . 0.0 111.492 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 70.35 100.84 0.06 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -68.89 147.64 51.39 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 124.955 1.302 . . . . 0.0 108.344 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -85.1 -1.56 88.53 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -62.33 -39.26 92.5 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 98.8 m -61.34 -44.46 97.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.355 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.89 -178.53 44.83 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 116.771 -2.633 . . . . 0.0 110.473 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.62 145.45 51.5 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 129.93 163.25 11.05 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -126.24 134.86 51.08 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 260' ' ' ARG . 96.7 mtm-85 -137.05 153.25 50.66 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 259' ' ' ARG . 86.4 mtt180 73.46 -76.04 0.07 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 259' ' ' ARG . 48.1 t -57.43 -44.16 84.43 Favored 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 120.75 -1.219 . . . . 0.0 108.105 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.586 ' O ' ' HB2' ' A' ' 265' ' ' ALA . 0.9 OUTLIER -63.89 -29.63 70.79 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -66.1 -39.8 90.27 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -30.18 67.36 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 116.964 -1.894 . . . . 0.0 110.136 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 262' ' ' SER . . . -50.29 -72.54 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 127.644 2.378 . . . . 0.0 105.885 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.7 p -63.82 -33.22 75.18 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 126.009 2.068 . . . . 0.0 114.359 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -72.35 -50.21 28.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 116.127 -2.229 . . . . 0.0 110.629 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.02 -40.39 91.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.177 -0.327 . . . . 0.0 111.86 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -69.78 -38.48 76.72 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.338 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.69 90.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 116.964 -1.894 . . . . 0.0 108.864 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ALA . . . . . 0.522 ' HA ' ' CZ ' ' A' ' 131' ' ' ARG . . . -58.3 -46.6 85.81 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.76 -44.02 97.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.55 -37.8 71.06 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.589 -0.694 . . . . 0.0 111.816 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 88.0 m -70.3 -44.96 67.25 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.631 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.93 -38.21 93.99 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.679 HD12 ' N ' ' A' ' 277' ' ' ILE . 0.3 OUTLIER -70.19 -40.09 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 117.327 0.563 . . . . 0.0 110.805 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.54 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.673 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' MET . . . . . 0.623 ' N ' HG23 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.47 -40.84 98.17 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.634 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.57 -38.44 96.29 Favored Glycine 0 C--N 1.348 1.218 0 C-N-CA 121.614 -0.327 . . . . 0.0 112.479 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.3 p -68.99 -49.37 58.44 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 117.813 0.806 . . . . 0.0 108.856 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.656 ' HD2' HD12 ' A' ' 212' ' ' LEU . 5.5 m-85 -54.05 -57.96 9.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.468 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.8 p -70.53 -46.72 63.07 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.667 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 83.1 mt -72.27 -20.17 61.57 Favored 'General case' 0 N--CA 1.432 -1.347 1 O-C-N 115.92 -4.238 . . . . 0.0 108.97 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' CYS . . . . . 0.903 ' HB2' ' HA2' ' A' ' 315' ' ' GLY . 0.8 OUTLIER -154.99 107.97 2.79 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.321 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.952 ' NE1' HD13 ' A' ' 121' ' ' ILE . 0.0 OUTLIER 138.45 -59.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.015 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 291' ' ' ILE . 1.5 tm? -60.74 -48.05 94.15 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.861 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.645 ' O ' HG23 ' A' ' 292' ' ' VAL . 1.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ILE . . . . . 0.675 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 74.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' HIS . . . . . 0.484 ' HA ' HD12 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.723 ' CG2' ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.416 ' N ' ' CG1' ' A' ' 297' ' ' VAL . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ASN . . . . . 0.571 ' H ' HD21 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.57 ' N ' HD11 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ARG . . . . . 0.653 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.627 ' O ' HD13 ' A' ' 310' ' ' LEU . 6.5 mm-40 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 304' ' ' ARG . 5.3 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' TYR . . . . . 0.537 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.67 93.72 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.655 ' HA ' HG13 ' A' ' 314' ' ' ILE . 94.4 mt -61.25 -38.87 88.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.784 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -41.89 99.42 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' TRP . . . . . 0.445 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ILE . . . . . 0.925 ' O ' HG11 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.49 -40.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.903 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.21 -35.91 92.57 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.925 HG11 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.97 13.73 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -163.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -68.29 -32.7 73.04 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.343 0.657 . . . . 0.0 111.886 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ASN . . . . . 0.484 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 8.3 m-20 -54.11 -48.44 94.16 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.597 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 62.0 Cg_exo -61.14 -34.7 88.87 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 121.273 1.49 . . . . 0.0 112.707 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.58 -44.31 71.06 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.777 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 8.8 mm -97.94 -70.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 123.211 0.604 . . . . 0.0 112.266 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -18.79 -57.49 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 120.03 3.344 . . . . 0.0 120.03 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 13.1 m -98.73 55.52 1.06 Allowed 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 124.738 1.215 . . . . 0.0 113.031 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -68.37 -0.7 5.17 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.485 1.114 . . . . 0.0 111.516 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.73 145.99 0.49 Allowed Pre-proline 0 CA--C 1.5 -0.977 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 12.9 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' PHE . . . . . 0.467 ' O ' HD13 ' A' ' 340' ' ' LEU . 21.0 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 336' ' ' PHE . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.9 pp . . . . . 0 CA--C 1.497 -1.073 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.22 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.624 0.25 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -67.55 -10.64 53.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.727 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.62 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.727 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.651 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.407 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.487 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -41.42 56.65 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 124.597 1.186 . . . . 0.0 110.563 -171.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.188 0 CA-C-O 121.359 0.6 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.86 -39.14 93.08 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.1 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.4 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.98 -32.75 74.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.61 -45.2 76.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.08 135.97 56.86 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.609 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.5 mttt . . . . . 0 CA--C 1.495 -1.149 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 3.8 p -70.33 -43.92 69.29 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.21 -42.54 96.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.418 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -65.54 -38.13 94.4 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 33.3 mt -70.17 -40.09 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 117.398 0.599 . . . . 0.0 110.817 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.41 -50.59 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.707 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.7 ptm -63.33 -40.97 98.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.637 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.44 96.31 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.657 -0.306 . . . . 0.0 112.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.5 p -69.01 -49.38 58.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 117.84 0.82 . . . . 0.0 108.81 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.98 -58.09 8.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.5 p -70.51 -46.68 63.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.581 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.8 mt -72.04 -20.64 61.66 Favored 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 116.008 -4.182 . . . . 0.0 108.947 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.971 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -156.39 106.74 2.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.971 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.0 OUTLIER 139.13 -58.75 0.0 OUTLIER 'General case' 0 C--N 1.361 1.066 0 O-C-N 125.213 1.571 . . . . 0.0 111.769 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.2 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.2 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.642 HG12 HD22 ' A' ' 311' ' ' LEU . 95.4 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.67 93.73 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.642 HD22 HG12 ' A' ' 307' ' ' VAL . 6.4 mp -60.71 -39.87 90.14 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.705 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.95 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 4.7 mt -55.18 -44.34 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.672 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.41 -35.91 92.37 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.449 ' ND2' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.69 -38.45 27.75 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 325' ' ' ILE . 9.3 m-85 -68.32 -32.72 73.05 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.334 0.653 . . . . 0.0 111.868 -170.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.514 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.3 m-20 -54.08 -48.44 94.1 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.621 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 53.4 Cg_exo -61.16 -34.71 88.65 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 121.22 1.471 . . . . 0.0 112.691 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.8 mt -69.6 -44.24 71.14 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.28 -63.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 123.153 0.581 . . . . 0.0 112.272 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.84 -36.28 1.44 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 120.032 3.345 . . . . 0.0 120.032 -177.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 40.2 m -88.29 40.76 0.97 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 124.745 1.218 . . . . 0.0 113.033 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -71.53 -21.75 61.86 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.503 1.121 . . . . 0.0 111.617 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -43.19 145.99 0.91 Allowed Pre-proline 0 C--N 1.375 1.676 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.458 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 91.3 m -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.68 3.737 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 323' ' ' PRO . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 47.5 pt . . . . . 0 CA--C 1.497 -1.067 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.165 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.68 -10.64 57.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.726 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.621 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.698 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 CA--C 1.493 -1.228 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.721 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -41.42 67.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.563 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.739 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 121.293 0.568 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -60.7 -39.14 87.42 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 125.313 1.445 . . . . 0.0 107.673 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.261 2.5 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.2 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.884 ' CD1' HD11 ' A' ' 275' ' ' LEU . 0.9 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.9 -32.67 74.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.26 -45.34 76.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 237' ' ' GLU . 46.7 t -64.17 134.49 54.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 236' ' ' SER . 56.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.65 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 CA--C 1.495 -1.152 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.529 HG22 ' HE1' ' A' ' 326' ' ' TYR . 34.0 p -70.37 -45.02 66.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 219' ' ' TYR . 4.1 tt -61.6 -43.72 98.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 278' ' ' ILE . 0.2 OUTLIER -70.2 -40.06 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 117.407 0.604 . . . . 0.0 110.823 -177.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.863 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.45 -50.57 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.677 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.863 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.4 ptt? -63.34 -40.9 98.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.65 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.37 96.14 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 121.627 -0.32 . . . . 0.0 112.49 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.3 p -69.04 -49.45 57.45 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 117.822 0.811 . . . . 0.0 108.814 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 212' ' ' LEU . 6.2 m-85 -54.06 -57.91 9.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.477 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.1 p -70.54 -46.71 63.08 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.632 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.4 tp -72.26 -20.55 61.51 Favored 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 115.926 -4.234 . . . . 0.0 108.997 -174.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.993 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.38 107.93 2.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.309 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.993 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.04 -59.41 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.044 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.97 -48.05 93.71 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 72.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.41 HG12 HD22 ' A' ' 311' ' ' LEU . 54.1 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.854 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 307' ' ' VAL . 5.3 mp -60.52 -40.01 89.91 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.786 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.23 -41.89 98.81 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.917 ' O ' HG12 ' A' ' 317' ' ' VAL . 13.6 mm -55.87 -43.31 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.886 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.93 -35.91 92.7 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.467 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.917 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -89.7 -23.68 32.66 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.27 -32.68 73.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.308 0.643 . . . . 0.0 111.899 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.495 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 2.5 m120 -54.13 -48.33 94.55 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.647 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 50.2 Cg_exo -61.21 -34.68 88.21 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 121.254 1.483 . . . . 0.0 112.705 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.3 mt -69.6 -44.32 70.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.763 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 14.3 mm -98.41 -64.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 123.191 0.596 . . . . 0.0 112.3 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.529 ' HE1' HG22 ' A' ' 274' ' ' THR . 49.1 t80 -52.66 -62.09 1.87 Allowed 'General case' 0 C--N 1.353 0.721 0 N-CA-C 120.002 3.334 . . . . 0.0 120.002 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 73.3 m -57.6 81.72 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.748 1.219 . . . . 0.0 112.989 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 329' ' ' SER . 7.7 mmt180 -117.69 -20.97 8.7 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 124.502 1.121 . . . . 0.0 111.57 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 328' ' ' ARG . 47.7 t -44.31 145.99 1.27 Allowed Pre-proline 0 C--N 1.386 2.155 0 O-C-N 118.942 -2.349 . . . . 0.0 110.942 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.463 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.7 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 55' ' ' ILE . 3.1 tp . . . . . 0 CA--C 1.498 -1.046 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.145 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.804 0.335 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.17 -10.64 55.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.719 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 5.1 m -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.613 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.719 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.653 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.571 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.584 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.596 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.435 -1.202 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -41.42 69.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.563 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.206 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.64 -39.14 93.17 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 4.4 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.4 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.545 ' CE1' ' CD2' ' A' ' 282' ' ' PHE . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 79.9 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -29.38 68.48 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.56 -46.16 67.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 70.3 m -63.83 137.03 57.87 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.705 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 CA--C 1.494 -1.175 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 7.2 p -70.27 -45.01 67.25 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.654 HD23 ' CG ' ' A' ' 219' ' ' TYR . 2.0 tm? -61.51 -43.84 98.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.56 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.14 93.83 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 326' ' ' TYR . 1.0 OUTLIER -70.21 -40.09 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 117.376 0.588 . . . . 0.0 110.805 -177.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.853 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.55 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.729 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.853 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.36 -40.94 98.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.36 -1.336 . . . . 0.0 111.626 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.44 96.28 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.208 -0.308 . . . . 0.0 112.446 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.5 p -69.06 -49.36 58.16 Favored 'General case' 0 CA--C 1.493 -1.22 0 O-C-N 121.801 -0.823 . . . . 0.0 108.816 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.799 ' CD2' HD13 ' A' ' 212' ' ' LEU . 1.9 m-85 -54.13 -57.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.491 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.6 p -70.49 -46.69 63.25 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.613 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 9.5 tp -73.44 -19.87 60.86 Favored 'General case' 0 N--CA 1.433 -1.315 1 O-C-N 116.009 -4.182 . . . . 0.0 109.014 -174.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.918 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.63 105.76 2.65 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.119 -178.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.918 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.0 OUTLIER 139.72 -59.59 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.646 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.88 -48.05 93.89 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.861 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 5.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 16.8 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.872 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 314' ' ' ILE . 5.3 mp -60.9 -39.35 88.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.803 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.65 -41.89 99.3 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.92 ' O ' HG12 ' A' ' 317' ' ' VAL . 12.7 mm -56.13 -42.89 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.859 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -63.12 -35.91 92.73 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.474 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -72.94 -50.8 11.96 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.33 -32.72 73.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.827 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.517 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.9 m120 -54.15 -48.36 94.49 Favored Pre-proline 0 N--CA 1.436 -1.147 0 CA-C-O 118.484 -0.769 . . . . 0.0 112.629 -171.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 66.2 Cg_exo -61.18 -34.67 88.48 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 121.265 1.488 . . . . 0.0 112.702 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.59 -44.33 71.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.759 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.642 ' HB ' HD11 ' A' ' 277' ' ' ILE . 18.7 mm -97.69 -68.52 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 123.176 0.59 . . . . 0.0 112.255 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.68 ' CD1' HG21 ' A' ' 277' ' ' ILE . 1.3 t80 -30.71 -39.24 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 119.984 3.327 . . . . 0.0 119.984 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 50.8 0.79 Allowed 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 124.755 1.222 . . . . 0.0 113.015 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -70.43 -5.88 31.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.549 1.14 . . . . 0.0 111.541 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.94 145.99 0.51 Allowed Pre-proline 0 C--N 1.359 0.996 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.479 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.9 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.0 t -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.8 pt . . . . . 0 CA--C 1.497 -1.08 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.146 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.781 0.324 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.0 -10.64 55.21 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 114.031 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.725 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.7 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.624 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.725 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.708 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.441 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.492 -1.271 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -41.42 71.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.563 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 121.274 0.559 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.41 -39.14 92.31 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.26 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.4 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.88 -33.01 74.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.43 -45.42 76.1 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.18 135.91 56.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.562 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 44.2 mttt . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.6 p -70.24 -44.98 67.42 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.568 HD13 ' CB ' ' A' ' 219' ' ' TYR . 15.4 tp -61.45 -43.88 98.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.06 -38.1 93.72 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 40.3 mt -70.2 -40.12 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 117.384 0.592 . . . . 0.0 110.802 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.36 -50.62 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.661 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.8 ptt? -63.42 -40.87 98.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.66 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.44 96.32 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.498 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.02 -49.46 57.49 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.512 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.6 m-85 -54.15 -57.83 9.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.498 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.46 -46.73 63.23 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 81.5 mt -71.55 -21.42 61.89 Favored 'General case' 0 N--CA 1.432 -1.348 1 O-C-N 115.892 -4.255 . . . . 0.0 108.962 -175.255 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.927 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.37 106.79 2.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.249 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.927 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.3 OUTLIER 138.72 -58.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.537 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.82 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.861 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.699 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.9 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.786 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 304' ' ' ARG . 4.4 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.541 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 288' ' ' PRO . 0.0 OUTLIER -60.59 -39.96 90.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.691 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.34 -41.89 98.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.61 -40.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.802 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.36 -35.91 92.55 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.47 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.77 -38.33 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -165.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.61 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.3 -32.8 73.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 123.363 0.665 . . . . 0.0 111.811 -170.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.0 m-20 -54.1 -48.32 94.5 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-O 118.499 -0.762 . . . . 0.0 112.665 -171.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 54.7 Cg_exo -61.19 -34.7 88.39 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 121.246 1.481 . . . . 0.0 112.724 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.4 mt -69.56 -44.29 71.19 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.791 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 321' ' ' PHE . 3.1 mm -95.55 -63.56 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 123.202 0.601 . . . . 0.0 112.233 -173.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.65 -38.51 3.11 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -177.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 46.0 m -87.17 42.77 1.05 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.754 1.222 . . . . 0.0 113.04 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -73.26 -20.92 60.73 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 124.553 1.141 . . . . 0.0 111.555 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -42.86 145.99 0.82 Allowed Pre-proline 0 C--N 1.378 1.83 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.434 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 1.7 m -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.76 3.787 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.754 ' C ' ' O ' ' A' ' 54' ' ' VAL . 56.9 mt . . . . . 0 CA--C 1.497 -1.085 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.213 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.664 0.269 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -72.33 -10.64 60.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 64.0 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.289 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.492 -1.277 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -41.42 74.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.563 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.199 0 CA-C-O 121.231 0.539 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -61.96 -39.14 91.1 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.0 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.35 -33.36 75.78 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -67.31 -45.44 76.5 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 45.8 t -64.49 137.87 58.1 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.664 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.424 ' O ' HD12 ' A' ' 277' ' ' ILE . 14.4 mmtp . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.5 p -70.3 -45.0 67.17 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.661 HD13 ' CB ' ' A' ' 219' ' ' TYR . 14.0 tp -61.49 -43.81 98.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.606 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 326' ' ' TYR . 20.0 mt -70.26 -40.08 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 117.394 0.597 . . . . 0.0 110.789 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.41 -50.52 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.724 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.2 ptt? -63.37 -40.93 98.6 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 118.411 -1.316 . . . . 0.0 111.662 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.62 -38.4 96.2 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 121.604 -0.332 . . . . 0.0 112.461 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.529 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.6 p -69.02 -49.39 58.04 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 121.789 -0.83 . . . . 0.0 108.804 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.599 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.08 -57.96 9.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.8 p -70.54 -46.72 63.04 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.3 tp -69.68 -22.35 63.44 Favored 'General case' 0 N--CA 1.432 -1.35 1 O-C-N 115.949 -4.219 . . . . 0.0 109.025 -176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 1.021 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -155.59 117.59 4.09 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.958 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 1.021 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 2.4 m95 131.88 -59.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.008 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.81 -48.05 94.02 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.861 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 4.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 43.4 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.488 HG12 HD22 ' A' ' 311' ' ' LEU . 55.2 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 314' ' ' ILE . 6.1 mp -62.03 -37.42 84.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.793 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.93 -41.89 97.51 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 120.898 -1.126 . . . . 0.0 109.183 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 3.4 tp -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.946 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.61 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -79.03 -35.5 30.55 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -165.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 325' ' ' ILE . 5.4 m-85 -68.3 -32.74 73.1 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.339 0.656 . . . . 0.0 111.834 -171.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.2 m-20 -54.09 -48.36 94.38 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.628 -171.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.0 Cg_exo -61.2 -34.71 88.26 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.284 1.494 . . . . 0.0 112.695 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.59 -44.27 71.11 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.772 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.9 mm -90.73 -61.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 C-N-CA 123.236 0.614 . . . . 0.0 112.276 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.533 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -48.59 -22.1 0.7 Allowed 'General case' 0 C--N 1.353 0.746 0 N-CA-C 119.965 3.32 . . . . 0.0 119.965 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 67.5 m -83.05 19.53 1.4 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 124.752 1.221 . . . . 0.0 113.072 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 329' ' ' SER . 0.8 OUTLIER -57.59 -33.65 68.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 124.494 1.118 . . . . 0.0 111.55 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.58 145.99 3.89 Favored Pre-proline 0 C--N 1.378 1.819 0 C-N-CA 115.959 -2.297 . . . . 0.0 110.942 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.474 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.713 3.758 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.6 mm . . . . . 0 CA--C 1.498 -1.041 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.167 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' HB2' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.801 0.334 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.38 -10.64 56.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 56.9 t -56.24 -40.5 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.363 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.549 ' CG ' ' CE1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -41.42 64.75 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 125.793 1.933 . . . . 0.0 110.563 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.189 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -66.38 -39.14 88.91 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 0.7 OUTLIER -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.921 ' HB2' ' HG ' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.88 -32.24 73.85 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -68.76 -44.44 73.72 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 t -78.62 83.16 4.82 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.535 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 43.0 mttt . . . . . 0 CA--C 1.495 -1.169 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 24.5 p -70.27 -45.01 67.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.921 ' HG ' ' HB2' ' A' ' 219' ' ' TYR . 5.0 mp -61.56 -43.77 98.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.99 -38.19 93.89 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 326' ' ' TYR . 42.4 mt -70.15 -40.13 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.403 0.601 . . . . 0.0 110.78 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.864 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.34 -50.66 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.702 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.864 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.6 ptt? -63.35 -40.95 98.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.632 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.46 96.34 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 121.621 -0.323 . . . . 0.0 112.456 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.1 p -69.0 -49.39 58.25 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 117.846 0.823 . . . . 0.0 108.848 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.06 -57.92 9.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.549 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.2 p -70.53 -46.66 63.18 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 80.8 mt -71.04 -21.5 62.26 Favored 'General case' 0 N--CA 1.433 -1.31 1 O-C-N 115.965 -4.209 . . . . 0.0 109.003 -175.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.915 ' HB3' ' O ' ' A' ' 314' ' ' ILE . 0.8 OUTLIER -154.67 109.13 2.99 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.167 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.875 ' HE3' ' HA ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER 137.09 -59.1 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.683 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.58 -48.05 94.47 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.861 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.453 HG13 ' NE2' ' A' ' 299' ' ' GLN . 68.8 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.655 ' HG3' HD12 ' A' ' 302' ' ' LEU . 9.4 pm0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 299' ' ' GLN . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 1.8 mp0 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.819 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.96 -39.26 88.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.776 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.71 -41.89 99.37 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 8.4 mm -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.472 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.62 -37.06 31.59 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -165.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.3 m-85 -68.22 -32.76 73.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 122.097 -0.649 . . . . 0.0 111.902 -170.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.4 m-80 -54.06 -48.37 94.27 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.66 -171.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.8 Cg_exo -61.19 -34.66 88.42 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 121.22 1.471 . . . . 0.0 112.697 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.63 -44.32 70.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.746 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.51 -64.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 123.216 0.606 . . . . 0.0 112.27 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -44.53 -33.14 1.64 Allowed 'General case' 0 C--N 1.352 0.715 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -177.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 75.1 m -89.52 39.06 0.93 Allowed 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.719 1.208 . . . . 0.0 113.071 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -69.04 -22.6 64.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.532 1.133 . . . . 0.0 111.549 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -45.25 145.99 1.68 Allowed Pre-proline 0 C--N 1.369 1.418 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.783 3.802 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 3.2 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.758 HG21 HG23 ' A' ' 73' ' ' THR . 47.5 pt . . . . . 0 CA--C 1.496 -1.105 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.197 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.957 0.408 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.11 -10.64 55.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.31 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.1 t -56.45 -40.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.34 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.04 -32.59 72.2 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' HB2' HG13 ' A' ' 218' ' ' VAL . 2.7 t80 -54.13 -48.99 70.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.529 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -41.42 81.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.563 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.428 ' N ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.194 0 CA-C-O 121.267 0.556 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -59.18 -39.14 81.63 Favored 'General case' 0 C--N 1.301 -1.505 2 O-C-N 129.642 4.339 . . . . 0.0 107.673 176.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.5 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 1.7 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.42 -33.56 76.24 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.64 -45.29 75.77 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.2 t -63.83 136.09 57.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.543 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 21.0 p -70.32 -44.95 67.21 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 276' ' ' GLY . 0.1 OUTLIER -61.53 -43.82 98.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.592 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.914 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -66.04 -38.12 93.77 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 326' ' ' TYR . 23.1 mt -70.17 -40.11 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 117.389 0.595 . . . . 0.0 110.813 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.4 -50.6 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.666 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 14.8 ptt? -63.32 -40.96 98.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.647 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.38 96.18 Favored Glycine 0 C--N 1.348 1.239 0 C-N-CA 121.606 -0.33 . . . . 0.0 112.492 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -69.05 -49.36 58.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.478 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.0 p -70.51 -46.7 63.18 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.3 mt -68.54 -23.07 64.47 Favored 'General case' 0 N--CA 1.432 -1.336 1 O-C-N 115.966 -4.209 . . . . 0.0 108.975 -176.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 1.066 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 1.3 p -156.87 115.52 3.32 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.257 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 1.066 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 3.0 m95 135.2 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.609 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.94 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.711 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.0 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.83 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.82 -39.5 89.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.751 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.62 -41.89 99.27 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.883 ' O ' ' CB ' ' A' ' 285' ' ' CYS . 65.8 mt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.916 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.655 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.12 -37.08 29.69 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 325' ' ' ILE . 7.1 m-85 -68.21 -32.77 73.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.329 0.652 . . . . 0.0 111.872 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.528 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 1.0 OUTLIER -54.04 -48.45 94.0 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.639 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 52.6 Cg_exo -61.14 -34.72 88.81 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 CA-C-N 121.258 1.485 . . . . 0.0 112.666 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.59 -44.34 70.98 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.6 mm -93.31 -63.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.211 0.604 . . . . 0.0 112.255 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.627 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.98 -34.39 0.98 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -177.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 79.1 p -88.61 35.93 0.78 Allowed 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 124.717 1.207 . . . . 0.0 113.009 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -67.37 -24.16 65.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.51 1.124 . . . . 0.0 111.597 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.62 145.99 1.37 Allowed Pre-proline 0 C--N 1.378 1.841 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.942 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.467 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 55.9 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.797 3.811 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.07 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.102 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -67.32 -10.64 52.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.41 0.68 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.6 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.319 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.744 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.402 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 CA--C 1.492 -1.255 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.808 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 t80 . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.21 -41.42 70.25 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.563 -175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -63.82 -39.14 93.52 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 3.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.9 m170 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.37 -33.46 76.02 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.23 -45.11 77.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.8 m -64.5 140.96 58.92 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.639 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 19.1 p -70.31 -44.99 67.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 219' ' ' TYR . 16.8 tp -61.48 -43.81 98.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.14 93.78 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.551 HG21 ' HD1' ' A' ' 326' ' ' TYR . 34.7 mt -70.2 -40.07 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.365 0.582 . . . . 0.0 110.801 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.857 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.43 -50.56 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.671 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.857 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.4 -40.92 98.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.588 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.41 96.24 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.01 -49.37 58.33 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.437 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.7 p -70.54 -46.64 63.2 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.5 tp -72.06 -20.57 61.65 Favored 'General case' 0 N--CA 1.432 -1.33 1 O-C-N 116.004 -4.185 . . . . 0.0 109.002 -174.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.97 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.64 107.72 2.84 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.186 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.97 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.17 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.647 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.67 -48.05 94.28 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.861 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.703 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 291' ' ' ILE . 69.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.1 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 64.8 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.6 -39.94 89.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.736 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.32 -41.89 98.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 0.9 OUTLIER -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.844 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.11 -37.71 28.1 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -165.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.663 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.29 -32.71 73.06 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.359 0.664 . . . . 0.0 111.864 -170.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.2 m-20 -54.16 -48.34 94.55 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-O 118.48 -0.772 . . . . 0.0 112.606 -171.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.7 Cg_exo -61.18 -34.66 88.49 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 121.252 1.483 . . . . 0.0 112.707 -176.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.7 mt -69.64 -44.3 70.87 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.743 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.8 mm -95.58 -63.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.248 0.619 . . . . 0.0 112.25 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.551 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.42 -33.32 1.04 Allowed 'General case' 0 C--N 1.353 0.736 0 N-CA-C 119.987 3.329 . . . . 0.0 119.987 -177.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.5 p -86.64 36.2 0.7 Allowed 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.762 1.225 . . . . 0.0 113.014 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.07 -24.38 67.68 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.574 1.15 . . . . 0.0 111.51 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.38 145.99 3.59 Favored Pre-proline 0 C--N 1.377 1.762 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.942 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.69 3.744 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 73' ' ' THR . 35.9 pt . . . . . 0 CA--C 1.497 -1.071 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.178 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -66.02 -10.64 41.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.3 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.799 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 28.2 m -56.5 -40.26 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.307 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -60.96 -32.59 72.12 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.718 -0.793 . . . . 0.0 108.863 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.799 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.694 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.406 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.587 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -41.42 74.28 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.563 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.656 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.21 0 CA-C-O 121.357 0.598 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.56 -39.14 92.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.8 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.863 ' CD1' HD11 ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 220' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.69 -32.26 73.72 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -68.32 -46.97 68.79 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 43.6 t -62.52 136.89 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.571 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.5 p -70.29 -44.98 67.25 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.974 HD23 ' O ' ' A' ' 275' ' ' LEU . 5.1 tt -61.41 -43.86 98.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.581 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.15 93.69 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 326' ' ' TYR . 29.9 mt -70.14 -40.12 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 117.396 0.598 . . . . 0.0 110.791 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.44 -50.54 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.402 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.706 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.37 -40.95 98.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.364 -1.334 . . . . 0.0 111.653 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.53 96.45 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.216 -0.302 . . . . 0.0 112.44 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -68.95 -49.34 58.81 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 121.822 -0.811 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.75 -58.26 7.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.493 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.54 -46.74 62.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.34 -22.73 63.74 Favored 'General case' 0 N--CA 1.432 -1.351 1 O-C-N 115.983 -4.198 . . . . 0.0 109.007 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.976 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.9 OUTLIER -156.18 113.86 3.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.238 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.976 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.3 m95 135.71 -58.91 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.83 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.861 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' PHE . . . . . 0.658 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.5 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 314' ' ' ILE . 0.1 OUTLIER -61.07 -39.19 88.95 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.684 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.92 -41.89 99.61 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.433 -0.792 . . . . 0.0 109.183 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.882 ' O ' HG12 ' A' ' 317' ' ' VAL . 2.8 tt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.877 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.463 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.43 -35.62 36.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -166.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 325' ' ' ILE . 11.5 m-85 -68.26 -32.75 73.16 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 123.345 0.658 . . . . 0.0 111.82 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.511 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.2 m-80 -54.09 -48.38 94.32 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.654 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 51.3 Cg_exo -61.19 -34.66 88.38 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.254 1.484 . . . . 0.0 112.715 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.65 -44.29 70.87 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.74 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 321' ' ' PHE . 2.1 mm -94.8 -64.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.237 0.615 . . . . 0.0 112.309 -173.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.61 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -43.44 -30.88 0.6 Allowed 'General case' 0 C--N 1.352 0.699 0 N-CA-C 119.979 3.326 . . . . 0.0 119.979 -177.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 81.7 p -93.03 36.1 1.05 Allowed 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.024 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -67.94 -23.09 65.03 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 124.531 1.132 . . . . 0.0 111.607 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.87 145.99 1.46 Allowed Pre-proline 0 C--N 1.374 1.649 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.461 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.3 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 88.4 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.743 3.777 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.588 HG12 HG13 ' A' ' 54' ' ' VAL . 1.6 mm . . . . . 0 CA--C 1.497 -1.075 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.188 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.722 0.296 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -67.31 -10.64 52.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 61.0 t -56.3 -40.45 66.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.328 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.931 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.819 HD11 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG13 ' A' ' 218' ' ' VAL . 1.9 t80 -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 CA--C 1.493 -1.235 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.679 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.43 -41.42 72.91 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 121.348 0.594 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.76 -39.14 93.23 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.6 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.6 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -65.69 -33.12 75.14 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.98 -45.64 77.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -64.09 131.62 48.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.551 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 88.0 m -70.3 -44.96 67.25 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 219' ' ' TYR . 6.6 tt -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.631 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.93 -38.21 93.99 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.576 ' N ' HD13 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -70.19 -40.09 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 117.327 0.563 . . . . 0.0 110.805 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.858 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.54 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.673 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' MET . . . . . 0.858 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.47 -40.84 98.17 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.634 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.57 -38.44 96.29 Favored Glycine 0 C--N 1.348 1.218 0 C-N-CA 121.614 -0.327 . . . . 0.0 112.479 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.3 p -68.99 -49.37 58.44 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 117.813 0.806 . . . . 0.0 108.856 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 212' ' ' LEU . 5.5 m-85 -54.05 -57.96 9.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.468 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.8 p -70.53 -46.72 63.07 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.667 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 83.1 mt -72.27 -20.17 61.57 Favored 'General case' 0 N--CA 1.432 -1.347 1 O-C-N 115.92 -4.238 . . . . 0.0 108.97 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 285' ' ' CYS . . . . . 0.891 ' HB2' ' HA2' ' A' ' 315' ' ' GLY . 0.8 OUTLIER -154.99 107.97 2.79 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.321 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.931 ' CZ2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 138.45 -59.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.015 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.74 -48.05 94.15 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.861 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.759 ' HB2' HD22 ' A' ' 311' ' ' LEU . 1.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 291' ' ' ILE . 74.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 6.5 mm-40 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 304' ' ' ARG . 5.3 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' TYR . . . . . 0.539 ' N ' HG23 ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.67 93.72 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 288' ' ' PRO . 94.4 mt -61.25 -38.87 88.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.784 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.75 -41.89 99.42 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ILE . . . . . 0.906 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.49 -40.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.196 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.891 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.21 -35.91 92.57 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' TYR . . . . . 0.473 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.97 13.73 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -163.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -68.29 -32.7 73.04 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.343 0.657 . . . . 0.0 111.886 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ASN . . . . . 0.559 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 8.3 m-20 -54.11 -48.44 94.16 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.597 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 62.0 Cg_exo -61.14 -34.7 88.87 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 121.273 1.49 . . . . 0.0 112.707 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.58 -44.31 71.06 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.777 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 277' ' ' ILE . 8.8 mm -97.94 -70.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 123.211 0.604 . . . . 0.0 112.266 -173.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' TYR . . . . . 0.441 ' CD1' HG21 ' A' ' 277' ' ' ILE . 2.0 t80 -18.79 -57.49 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 120.03 3.344 . . . . 0.0 120.03 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 13.1 m -98.73 55.52 1.06 Allowed 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 124.738 1.215 . . . . 0.0 113.031 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -68.37 -0.7 5.17 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.485 1.114 . . . . 0.0 111.516 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.73 145.99 0.49 Allowed Pre-proline 0 CA--C 1.5 -0.977 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 64' ' ' LEU . 5.7 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 12.9 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 21.0 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.9 pp -153.67 161.6 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.22 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -141.98 -46.95 0.35 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.38 148.79 4.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 58' ' ' ILE . 2.9 tt -61.57 109.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -173.56 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.374 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.76 138.14 58.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.098 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -121.1 92.49 3.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.423 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 95.1 mt-10 -139.44 38.04 2.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 22.0 ttt85 77.85 -13.65 0.93 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.424 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -67.55 -10.64 53.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.727 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.62 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.727 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.651 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.407 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.654 ' O ' HD12 ' A' ' 135' ' ' ILE . 5.0 m-85 -53.33 -13.59 0.58 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 132' ' ' TYR . . . -75.45 48.65 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.537 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 133' ' ' PHE . 1.3 mp -58.68 -14.31 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 122.696 0.398 . . . . 0.0 111.698 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.1 m 76.39 -132.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 124.396 1.06 . . . . 0.0 112.478 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 138' ' ' PRO . 0.8 OUTLIER 72.5 160.37 0.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 123.691 0.619 . . . . 0.0 109.962 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 137' ' ' SER . 19.1 Cg_endo -61.97 -31.54 84.26 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.868 2.379 . . . . 0.0 112.296 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.417 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 54.9 p90 -144.74 136.66 25.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 139' ' ' PHE . 1.5 mmtm 167.16 -47.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -71.19 -48.42 51.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -41.42 56.65 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 124.597 1.186 . . . . 0.0 110.563 -171.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt 59.04 42.61 18.86 Favored 'General case' 0 CA--C 1.493 -1.235 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.027 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.22 173.53 0.11 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.82 -39.95 95.87 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.829 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.5 m -149.08 -78.2 0.15 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.667 ' O ' HG12 ' A' ' 152' ' ' VAL . 99.4 mttt -145.24 149.9 35.73 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 117.817 -3.052 . . . . 0.0 109.731 -169.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -70.87 -27.84 64.12 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.459 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.86 -39.14 93.08 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.1 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.4 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.98 -32.75 74.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.61 -45.2 76.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.08 135.97 56.86 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -171.46 115.44 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.609 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -59.87 145.36 45.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -84.1 129.61 34.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.644 0.259 . . . . 0.0 110.877 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 88.7 t80 59.81 87.35 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.156 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -67.51 154.37 41.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 243' ' ' GLN . 22.2 m -57.75 -33.66 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.426 ' N ' HG23 ' A' ' 242' ' ' VAL . 0.7 OUTLIER 170.62 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 179.73 160.7 0.83 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.49 152.37 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 63.7 m -136.5 144.11 44.14 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -156.94 149.63 23.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.16 -29.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.365 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -152.32 -39.1 0.11 Allowed 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 115.123 -2.631 . . . . 0.0 111.491 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 64.21 41.91 5.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 52.3 -169.27 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 124.977 1.311 . . . . 0.0 108.417 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -105.06 -32.48 4.04 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 107.084 -2.406 . . . . 0.0 107.084 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -62.72 -39.56 94.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.3 158.23 0.13 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.438 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 177.7 -173.51 46.13 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 116.727 -2.654 . . . . 0.0 110.451 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 76.56 -69.93 0.15 Allowed 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.71 166.85 38.22 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -108.91 -28.06 9.35 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 61.25 -179.46 0.11 Allowed 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -83.84 -9.75 58.54 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.9 t -57.63 -44.16 85.34 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 5.1 p -63.92 -29.56 70.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -66.11 -39.84 90.25 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.13 67.24 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 116.98 -1.888 . . . . 0.0 110.072 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.33 -72.55 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 127.59 2.356 . . . . 0.0 105.883 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.7 p -63.86 -33.11 74.96 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 125.986 2.054 . . . . 0.0 114.366 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . 0.302 0.0 OUTLIER -72.37 -50.2 28.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 116.164 -2.214 . . . . 0.0 110.672 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.01 -40.32 91.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -69.87 -38.52 76.42 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 7.6 mmtm -63.03 -45.76 90.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 116.945 -1.902 . . . . 0.0 108.865 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.59 85.73 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.71 -44.03 97.71 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -71.51 -37.84 71.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.567 -0.708 . . . . 0.0 111.844 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 3.8 p -70.33 -43.92 69.29 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.21 -42.54 96.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.418 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -65.54 -38.13 94.4 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 33.3 mt -70.17 -40.09 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 117.398 0.599 . . . . 0.0 110.817 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.41 -50.59 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.707 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.7 ptm -63.33 -40.97 98.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.637 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.44 96.31 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.657 -0.306 . . . . 0.0 112.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.5 p -69.01 -49.38 58.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 117.84 0.82 . . . . 0.0 108.81 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.98 -58.09 8.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.5 p -70.51 -46.68 63.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.581 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.8 mt -72.04 -20.64 61.66 Favored 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 116.008 -4.182 . . . . 0.0 108.947 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.971 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -156.39 106.74 2.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.971 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.0 OUTLIER 139.13 -58.75 0.0 OUTLIER 'General case' 0 C--N 1.361 1.066 0 O-C-N 125.213 1.571 . . . . 0.0 111.769 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.2 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.2 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.642 HG12 HD22 ' A' ' 311' ' ' LEU . 95.4 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.67 93.73 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.642 HD22 HG12 ' A' ' 307' ' ' VAL . 6.4 mp -60.71 -39.87 90.14 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.705 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.95 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 4.7 mt -55.18 -44.34 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.672 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.41 -35.91 92.37 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.449 ' ND2' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.69 -38.45 27.75 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 325' ' ' ILE . 9.3 m-85 -68.32 -32.72 73.05 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.334 0.653 . . . . 0.0 111.868 -170.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.514 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.3 m-20 -54.08 -48.44 94.1 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.621 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 53.4 Cg_exo -61.16 -34.71 88.65 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 121.22 1.471 . . . . 0.0 112.691 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.8 mt -69.6 -44.24 71.14 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.28 -63.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 123.153 0.581 . . . . 0.0 112.272 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.84 -36.28 1.44 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 120.032 3.345 . . . . 0.0 120.032 -177.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 40.2 m -88.29 40.76 0.97 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 124.745 1.218 . . . . 0.0 113.033 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -71.53 -21.75 61.86 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.503 1.121 . . . . 0.0 111.617 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -43.19 145.99 0.91 Allowed Pre-proline 0 C--N 1.375 1.676 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.458 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 91.3 m -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.68 3.737 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 323' ' ' PRO . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 47.5 pt -81.68 164.33 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.165 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m 45.15 85.56 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' ' 58' ' ' ILE . . . -86.77 -68.63 0.73 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 62' ' ' GLU . 1.6 mp -132.8 -28.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.3 m 58.0 17.1 4.15 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.417 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.99 -44.31 2.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.009 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -169.64 133.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.674 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.497 ' HB3' HD13 ' A' ' 58' ' ' ILE . 22.4 pt-20 -174.95 170.34 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -103.3 -0.05 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.743 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.68 -10.64 57.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.726 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.621 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.698 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.72 -20.77 15.67 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.65 85.78 0.65 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.573 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 135' ' ' ILE . 9.0 tt -91.98 22.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 122.747 0.419 . . . . 0.0 111.712 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.3 p 37.97 60.07 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 124.484 1.115 . . . . 0.0 112.538 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 t -157.71 136.83 8.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.26 -9.66 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.95 2.433 . . . . 0.0 112.042 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.87 -11.16 59.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.426 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -117.08 -50.25 2.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.255 0.55 . . . . 0.0 111.913 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -62.12 -53.84 49.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -41.42 67.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.563 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 145' ' ' LEU . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER 80.22 126.6 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.995 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 p -63.75 96.26 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.697 ' HG2' HD11 ' A' ' 153' ' ' ILE . 30.3 mmtp 49.02 -162.56 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.8 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.5 -52.35 65.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 48.5 mmtm -157.37 11.34 0.21 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.73 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.739 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . 72.53 -27.56 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.414 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.585 ' H ' ' C ' ' A' ' 149' ' ' LYS . 61.2 mtt180 -60.7 -39.14 87.42 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 125.313 1.445 . . . . 0.0 107.673 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.261 2.5 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.2 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.884 ' CD1' HD11 ' A' ' 275' ' ' LEU . 0.9 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.9 -32.67 74.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.26 -45.34 76.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 237' ' ' GLU . 46.7 t -64.17 134.49 54.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 236' ' ' SER . 56.9 tt0 178.81 135.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.65 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -87.02 -176.7 49.14 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -109.16 17.36 21.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.31 . . . . 0.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.47 -39.42 93.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.866 0.841 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -156.88 164.43 38.07 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.4 t -121.18 126.62 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -125.4 117.17 23.13 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -111.04 17.67 20.2 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.5 t 63.02 91.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.4 t -60.25 -45.15 94.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -178.54 -40.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.58 148.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.44 -39.54 93.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 115.118 -2.633 . . . . 0.0 111.443 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 74.36 59.28 0.08 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 53.2 t0 51.95 48.35 22.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 124.971 1.308 . . . . 0.0 108.39 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -66.64 147.64 49.88 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -139.52 134.09 31.75 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 12.4 t -148.54 151.59 35.37 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.362 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.18 4.79 83.01 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 116.775 -2.631 . . . . 0.0 110.425 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.34 -46.48 89.77 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.3 145.41 45.97 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 165.76 -56.34 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 260' ' ' ARG . 83.2 mtt85 -132.1 153.53 50.38 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 259' ' ' ARG . 27.2 ttp85 79.06 -65.87 0.2 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.7 t -57.49 -44.15 84.73 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 9.7 t -63.86 -29.61 70.78 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -66.11 -39.8 90.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -30.12 67.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.116 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.32 -72.57 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 127.603 2.361 . . . . 0.0 105.89 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.8 -33.16 75.05 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.987 2.054 . . . . 0.0 114.37 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -72.35 -50.23 28.34 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 116.107 -2.237 . . . . 0.0 110.631 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -65.99 -40.38 91.12 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -69.81 -38.45 76.6 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.321 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -45.73 90.71 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.86 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.6 85.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.76 -44.09 97.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -71.45 -37.8 71.37 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 121.566 -0.709 . . . . 0.0 111.866 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.529 HG22 ' HE1' ' A' ' 326' ' ' TYR . 34.0 p -70.37 -45.02 66.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 219' ' ' TYR . 4.1 tt -61.6 -43.72 98.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 278' ' ' ILE . 0.2 OUTLIER -70.2 -40.06 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 117.407 0.604 . . . . 0.0 110.823 -177.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.863 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.45 -50.57 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.677 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.863 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.4 ptt? -63.34 -40.9 98.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.65 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.37 96.14 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 121.627 -0.32 . . . . 0.0 112.49 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.3 p -69.04 -49.45 57.45 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 117.822 0.811 . . . . 0.0 108.814 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 212' ' ' LEU . 6.2 m-85 -54.06 -57.91 9.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.477 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.1 p -70.54 -46.71 63.08 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.632 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.4 tp -72.26 -20.55 61.51 Favored 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 115.926 -4.234 . . . . 0.0 108.997 -174.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.993 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.38 107.93 2.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.309 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.993 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.04 -59.41 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.044 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.97 -48.05 93.71 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 72.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.41 HG12 HD22 ' A' ' 311' ' ' LEU . 54.1 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.854 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 307' ' ' VAL . 5.3 mp -60.52 -40.01 89.91 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.786 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.23 -41.89 98.81 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.917 ' O ' HG12 ' A' ' 317' ' ' VAL . 13.6 mm -55.87 -43.31 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.886 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.93 -35.91 92.7 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.467 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.917 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -89.7 -23.68 32.66 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.27 -32.68 73.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.308 0.643 . . . . 0.0 111.899 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.495 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 2.5 m120 -54.13 -48.33 94.55 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.647 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 50.2 Cg_exo -61.21 -34.68 88.21 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 121.254 1.483 . . . . 0.0 112.705 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.3 mt -69.6 -44.32 70.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.763 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 14.3 mm -98.41 -64.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 123.191 0.596 . . . . 0.0 112.3 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.529 ' HE1' HG22 ' A' ' 274' ' ' THR . 49.1 t80 -52.66 -62.09 1.87 Allowed 'General case' 0 C--N 1.353 0.721 0 N-CA-C 120.002 3.334 . . . . 0.0 120.002 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 73.3 m -57.6 81.72 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.748 1.219 . . . . 0.0 112.989 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 329' ' ' SER . 7.7 mmt180 -117.69 -20.97 8.7 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 124.502 1.121 . . . . 0.0 111.57 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 328' ' ' ARG . 47.7 t -44.31 145.99 1.27 Allowed Pre-proline 0 C--N 1.386 2.155 0 O-C-N 118.942 -2.349 . . . . 0.0 110.942 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.463 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.7 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.668 HG23 ' O ' ' A' ' 55' ' ' ILE . 3.1 tp -103.3 43.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.145 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.8 m -71.33 76.64 0.74 Allowed 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.855 ' HB1' ' SG ' ' A' ' 59' ' ' CYS . . . 50.04 84.74 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.13 -26.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.855 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -45.75 -28.48 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.283 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -104.17 166.47 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 58.12 83.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 17.5 mp0 -61.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.57 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 5.9 tpt180 77.22 -50.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.444 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.17 -10.64 55.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.719 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 5.1 m -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.613 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.719 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.653 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.571 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.596 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER -24.4 -72.37 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -171.13 100.48 0.21 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 118.291 -1.364 . . . . 0.0 110.549 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.57 -40.18 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 122.661 0.384 . . . . 0.0 111.662 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 29.2 p -121.24 156.75 31.79 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.458 1.098 . . . . 0.0 112.513 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.3 m 45.93 71.39 1.57 Allowed Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 124.375 1.047 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.34 48.72 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.922 2.415 . . . . 0.0 112.741 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.22 -49.84 76.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.217 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -76.61 -28.29 56.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.037 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -47.62 -53.72 13.94 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -41.42 69.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.563 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 tt -53.48 107.19 0.22 Allowed 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.036 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.1 m -170.33 -48.51 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -107.71 164.74 11.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 69.0 m 57.95 66.39 1.13 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.703 ' O ' HG12 ' A' ' 152' ' ' VAL . 59.2 mtmt -56.67 158.44 4.59 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.744 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -59.12 -26.61 64.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.488 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.64 -39.14 93.17 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 4.4 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.4 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.545 ' CE1' ' CD2' ' A' ' 282' ' ' PHE . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 79.9 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -29.38 68.48 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.56 -46.16 67.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 70.3 m -63.83 137.03 57.87 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -176.33 132.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.705 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -152.27 153.1 24.69 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -135.56 123.25 22.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.54 94.5 0.08 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -151.82 30.82 0.57 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.45 157.16 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 172.15 -54.42 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -158.26 172.98 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.06 137.22 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.1 t -153.84 45.73 0.61 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 54.23 46.6 24.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.47 122.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.54 151.76 25.22 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 115.029 -2.668 . . . . 0.0 111.446 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -100.28 117.15 33.91 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.4 -40.15 95.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.067 1.347 . . . . 0.0 108.433 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -98.97 126.87 9.07 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -127.03 -36.71 2.15 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 90.0 m -133.38 137.07 45.67 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.439 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.36 56.79 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 116.702 -2.666 . . . . 0.0 110.394 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -65.08 162.98 15.75 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 59.15 -130.7 51.16 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -68.65 154.62 41.58 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -142.79 95.84 2.84 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.11 18.71 0.87 Allowed 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.7 m -58.85 -44.15 90.93 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 4.6 p -63.86 -29.63 70.8 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -66.14 -39.82 90.12 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -30.14 67.29 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 116.958 -1.897 . . . . 0.0 110.116 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.31 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.625 2.37 . . . . 0.0 105.856 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -33.14 75.03 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.985 2.053 . . . . 0.0 114.4 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -72.35 -50.19 28.57 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 116.126 -2.229 . . . . 0.0 110.679 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.0 -40.39 91.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -69.85 -38.4 76.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 118.804 -1.159 . . . . 0.0 109.361 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -63.15 -45.7 90.67 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 116.921 -1.911 . . . . 0.0 108.828 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.61 85.64 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.75 -44.07 97.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.42 -37.9 71.44 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.555 -0.715 . . . . 0.0 111.851 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 7.2 p -70.27 -45.01 67.25 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.654 HD23 ' CG ' ' A' ' 219' ' ' TYR . 2.0 tm? -61.51 -43.84 98.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.56 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.14 93.83 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 326' ' ' TYR . 1.0 OUTLIER -70.21 -40.09 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 117.376 0.588 . . . . 0.0 110.805 -177.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.853 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.55 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.729 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.853 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.36 -40.94 98.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.36 -1.336 . . . . 0.0 111.626 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.44 96.28 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.208 -0.308 . . . . 0.0 112.446 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.5 p -69.06 -49.36 58.16 Favored 'General case' 0 CA--C 1.493 -1.22 0 O-C-N 121.801 -0.823 . . . . 0.0 108.816 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.799 ' CD2' HD13 ' A' ' 212' ' ' LEU . 1.9 m-85 -54.13 -57.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.491 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.6 p -70.49 -46.69 63.25 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.613 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 9.5 tp -73.44 -19.87 60.86 Favored 'General case' 0 N--CA 1.433 -1.315 1 O-C-N 116.009 -4.182 . . . . 0.0 109.014 -174.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.918 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.63 105.76 2.65 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.119 -178.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.918 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.0 OUTLIER 139.72 -59.59 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.646 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.88 -48.05 93.89 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.861 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 5.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 16.8 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.872 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 314' ' ' ILE . 5.3 mp -60.9 -39.35 88.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.803 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.65 -41.89 99.3 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.92 ' O ' HG12 ' A' ' 317' ' ' VAL . 12.7 mm -56.13 -42.89 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.859 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -63.12 -35.91 92.73 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.474 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -72.94 -50.8 11.96 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.33 -32.72 73.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.827 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.517 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.9 m120 -54.15 -48.36 94.49 Favored Pre-proline 0 N--CA 1.436 -1.147 0 CA-C-O 118.484 -0.769 . . . . 0.0 112.629 -171.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 66.2 Cg_exo -61.18 -34.67 88.48 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 121.265 1.488 . . . . 0.0 112.702 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.59 -44.33 71.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.759 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.642 ' HB ' HD11 ' A' ' 277' ' ' ILE . 18.7 mm -97.69 -68.52 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 123.176 0.59 . . . . 0.0 112.255 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.68 ' CD1' HG21 ' A' ' 277' ' ' ILE . 1.3 t80 -30.71 -39.24 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 119.984 3.327 . . . . 0.0 119.984 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 50.8 0.79 Allowed 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 124.755 1.222 . . . . 0.0 113.015 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -70.43 -5.88 31.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.549 1.14 . . . . 0.0 111.541 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.94 145.99 0.51 Allowed Pre-proline 0 C--N 1.359 0.996 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.479 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.9 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.0 t -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.8 pt -75.49 105.89 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.146 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 56' ' ' THR . 5.7 t -45.8 140.64 3.41 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.21 -60.79 1.6 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 tt -63.27 -28.9 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.6 m 57.87 51.44 9.09 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.77 -26.41 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -86.69 126.92 34.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.632 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 7.8 tt0 -93.63 -149.41 0.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 86.1 mtt180 73.24 -47.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.0 -10.64 55.21 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 114.031 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.725 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.7 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.624 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.725 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.708 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.441 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -43.56 102.56 0.03 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.662 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . . . -63.11 156.66 24.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.539 -176.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.23 -19.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 122.701 0.4 . . . . 0.0 111.631 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.512 ' O ' ' C ' ' A' ' 137' ' ' SER . 7.9 p -88.33 -150.72 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 124.387 1.055 . . . . 0.0 112.484 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -30.96 -61.43 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 137' ' ' SER . 17.5 Cg_endo -57.69 144.34 93.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.826 2.35 . . . . 0.0 112.191 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' HD1' ' HB3' ' A' ' 134' ' ' ALA . 99.1 m-85 58.28 -118.98 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.617 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 172.12 -33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.519 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 74.78 -54.23 0.67 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -41.42 71.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.563 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.01 146.27 14.89 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.7 -163.08 1.06 Allowed 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -58.81 -44.61 90.87 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.836 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 51.3 t -102.06 -104.17 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm 53.0 45.15 29.43 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 119.999 -1.688 . . . . 0.0 109.781 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -161.77 -57.67 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.462 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.41 -39.14 92.31 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.26 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.4 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.88 -33.01 74.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.43 -45.42 76.1 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.18 135.91 56.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -179.62 140.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.562 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 143.89 59.08 0.02 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -151.55 146.83 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 110.574 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 52.05 34.53 14.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.977 0.894 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -102.66 24.12 11.0 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.71 89.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -125.7 65.06 1.18 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 56.56 38.33 29.53 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.34 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.8 t -154.86 148.63 25.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 56.03 51.58 11.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 26.8 m -59.82 -30.22 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.328 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -81.26 136.03 35.77 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 115.126 -2.63 . . . . 0.0 111.536 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -120.49 -44.99 2.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 162.16 -48.02 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.991 1.316 . . . . 0.0 108.353 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.27 -162.4 35.71 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 107.081 -2.408 . . . . 0.0 107.081 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 54.93 40.48 32.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 95.4 m -113.53 127.94 56.26 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.432 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.47 72.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 116.647 -2.692 . . . . 0.0 110.457 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -98.44 118.13 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -129.22 34.83 2.73 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 73.63 -66.62 0.3 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -163.53 157.54 19.74 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -173.08 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.2 t -58.22 -44.18 88.08 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 5.8 p -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -66.1 -39.8 90.26 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 116.957 -1.897 . . . . 0.0 110.103 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.3 -72.52 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 127.592 2.357 . . . . 0.0 105.92 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 1.4 p -63.84 -33.15 75.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.982 2.051 . . . . 0.0 114.385 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.404 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 8.1 mttt -72.34 -50.23 28.36 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 116.111 -2.236 . . . . 0.0 110.634 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.02 -40.36 91.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -69.8 -38.46 76.64 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.34 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.476 ' HD3' HG23 ' A' ' 274' ' ' THR . 10.9 tppt? -63.14 -45.74 90.49 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 116.975 -1.89 . . . . 0.0 108.792 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.19 -46.64 85.43 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.76 -44.04 97.67 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -71.5 -37.88 71.21 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.549 -0.719 . . . . 0.0 111.788 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.476 HG23 ' HD3' ' A' ' 270' ' ' LYS . 25.6 p -70.24 -44.98 67.42 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.568 HD13 ' CB ' ' A' ' 219' ' ' TYR . 15.4 tp -61.45 -43.88 98.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.06 -38.1 93.72 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 40.3 mt -70.2 -40.12 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 117.384 0.592 . . . . 0.0 110.802 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.36 -50.62 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.661 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.8 ptt? -63.42 -40.87 98.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.66 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.44 96.32 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.498 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.02 -49.46 57.49 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.512 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.6 m-85 -54.15 -57.83 9.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.498 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.46 -46.73 63.23 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 81.5 mt -71.55 -21.42 61.89 Favored 'General case' 0 N--CA 1.432 -1.348 1 O-C-N 115.892 -4.255 . . . . 0.0 108.962 -175.255 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.927 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.37 106.79 2.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.249 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.927 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.3 OUTLIER 138.72 -58.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.537 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.82 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.861 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.699 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.9 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.786 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 304' ' ' ARG . 4.4 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.541 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 288' ' ' PRO . 0.0 OUTLIER -60.59 -39.96 90.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.691 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.34 -41.89 98.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.61 -40.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.802 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.36 -35.91 92.55 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.47 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.77 -38.33 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -165.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.61 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.3 -32.8 73.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 123.363 0.665 . . . . 0.0 111.811 -170.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.0 m-20 -54.1 -48.32 94.5 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-O 118.499 -0.762 . . . . 0.0 112.665 -171.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 54.7 Cg_exo -61.19 -34.7 88.39 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 121.246 1.481 . . . . 0.0 112.724 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.4 mt -69.56 -44.29 71.19 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.791 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 321' ' ' PHE . 3.1 mm -95.55 -63.56 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 123.202 0.601 . . . . 0.0 112.233 -173.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.65 -38.51 3.11 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -177.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 46.0 m -87.17 42.77 1.05 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.754 1.222 . . . . 0.0 113.04 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -73.26 -20.92 60.73 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 124.553 1.141 . . . . 0.0 111.555 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -42.86 145.99 0.82 Allowed Pre-proline 0 C--N 1.378 1.83 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.434 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 1.7 m -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.76 3.787 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.754 ' C ' ' O ' ' A' ' 54' ' ' VAL . 56.9 mt 5.77 -95.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.213 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.663 ' N ' HG22 ' A' ' 55' ' ' ILE . 88.5 m 64.9 -70.49 0.09 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 55' ' ' ILE . . . 45.2 -155.45 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.467 ' HA ' HE22 ' A' ' 65' ' ' GLN . 24.7 pt -87.2 25.41 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.9 t -82.1 -69.44 0.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.242 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -130.78 -177.31 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 61.33 92.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -64.66 -19.33 65.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.384 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -67.91 -46.58 71.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.659 ' CB ' HG21 ' A' ' 56' ' ' THR . 6.9 mp -72.33 -10.64 60.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.467 HE22 ' HA ' ' A' ' 58' ' ' ILE . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 64.0 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.289 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.52 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -39.59 -32.74 0.14 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 133' ' ' PHE . . . 67.21 151.34 0.07 Allowed 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.542 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.56 23.95 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 122.711 0.404 . . . . 0.0 111.72 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.8 m -38.64 145.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.396 1.06 . . . . 0.0 112.533 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -52.44 -56.34 23.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 137' ' ' SER . 50.8 Cg_exo -29.99 -67.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.775 2.983 . . . . 0.0 113.142 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 52.2 p90 -179.45 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 139' ' ' PHE . 25.6 ttpt 78.94 52.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -177.44 -55.84 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -41.42 74.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.563 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.51 130.66 35.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.062 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.3 p -116.18 31.05 6.96 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp 63.21 30.53 15.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.743 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 44.8 t -129.16 -38.42 1.61 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.9 86.43 5.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 116.38 -3.95 . . . . 0.0 109.778 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -158.57 -59.71 0.07 Allowed 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.539 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -61.96 -39.14 91.1 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.0 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.35 -33.36 75.78 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -67.31 -45.44 76.5 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 45.8 t -64.49 137.87 58.1 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -169.27 116.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.664 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.79 -178.77 50.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -129.09 127.97 42.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 110.699 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -130.19 148.08 51.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.88 0.848 . . . . 0.0 109.202 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -100.27 111.74 24.03 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.55 29.3 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -61.23 -41.2 96.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -103.01 130.93 50.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.81 123.8 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.8 m -100.43 -33.03 10.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -130.44 149.6 52.04 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.51 122.77 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.333 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.05 153.01 37.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 115.156 -2.618 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -106.04 123.26 47.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -161.8 -179.5 7.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.004 1.322 . . . . 0.0 108.371 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.95 -59.54 2.4 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 107.133 -2.387 . . . . 0.0 107.133 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -62.26 -39.89 94.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 62.3 p -135.9 157.5 46.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.44 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 70.3 23.89 77.06 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 116.714 -2.66 . . . . 0.0 110.426 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -68.13 147.52 52.19 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -41.71 99.69 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.49 149.09 24.74 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -102.17 21.05 15.56 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.34 -38.84 92.73 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.9 t -57.87 -44.21 86.48 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 61.6 m -63.83 -29.63 70.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -66.22 -39.71 89.79 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.17 67.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 116.914 -1.914 . . . . 0.0 110.069 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.23 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 127.624 2.37 . . . . 0.0 105.885 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.79 -33.22 75.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 126.005 2.066 . . . . 0.0 114.357 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 7.5 pttt -72.3 -50.28 28.22 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 116.172 -2.211 . . . . 0.0 110.641 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.98 -40.39 91.16 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -69.83 -38.46 76.53 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.312 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -63.13 -45.72 90.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.977 -1.889 . . . . 0.0 108.813 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.53 85.81 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.81 -44.06 97.62 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.424 ' O ' HD12 ' A' ' 277' ' ' ILE . 14.4 mmtp -71.49 -37.84 71.25 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 121.586 -0.696 . . . . 0.0 111.831 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.5 p -70.3 -45.0 67.17 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.661 HD13 ' CB ' ' A' ' 219' ' ' TYR . 14.0 tp -61.49 -43.81 98.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.606 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 326' ' ' TYR . 20.0 mt -70.26 -40.08 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 117.394 0.597 . . . . 0.0 110.789 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.41 -50.52 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.724 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.2 ptt? -63.37 -40.93 98.6 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 118.411 -1.316 . . . . 0.0 111.662 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.62 -38.4 96.2 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 121.604 -0.332 . . . . 0.0 112.461 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.529 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.6 p -69.02 -49.39 58.04 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 121.789 -0.83 . . . . 0.0 108.804 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.599 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.08 -57.96 9.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.8 p -70.54 -46.72 63.04 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.3 tp -69.68 -22.35 63.44 Favored 'General case' 0 N--CA 1.432 -1.35 1 O-C-N 115.949 -4.219 . . . . 0.0 109.025 -176.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 1.021 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -155.59 117.59 4.09 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.958 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 1.021 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 2.4 m95 131.88 -59.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.008 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.81 -48.05 94.02 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.861 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 4.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 43.4 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.488 HG12 HD22 ' A' ' 311' ' ' LEU . 55.2 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 314' ' ' ILE . 6.1 mp -62.03 -37.42 84.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.793 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -63.93 -41.89 97.51 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 120.898 -1.126 . . . . 0.0 109.183 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 3.4 tp -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.946 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.61 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -79.03 -35.5 30.55 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -165.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 325' ' ' ILE . 5.4 m-85 -68.3 -32.74 73.1 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.339 0.656 . . . . 0.0 111.834 -171.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.2 m-20 -54.09 -48.36 94.38 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.628 -171.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.0 Cg_exo -61.2 -34.71 88.26 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.284 1.494 . . . . 0.0 112.695 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.59 -44.27 71.11 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.772 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.9 mm -90.73 -61.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 C-N-CA 123.236 0.614 . . . . 0.0 112.276 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.533 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -48.59 -22.1 0.7 Allowed 'General case' 0 C--N 1.353 0.746 0 N-CA-C 119.965 3.32 . . . . 0.0 119.965 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 67.5 m -83.05 19.53 1.4 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 124.752 1.221 . . . . 0.0 113.072 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 329' ' ' SER . 0.8 OUTLIER -57.59 -33.65 68.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 124.494 1.118 . . . . 0.0 111.55 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.58 145.99 3.89 Favored Pre-proline 0 C--N 1.378 1.819 0 C-N-CA 115.959 -2.297 . . . . 0.0 110.942 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.474 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.713 3.758 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.6 mm -158.8 133.03 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.167 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 HG22 ' A' ' 52' ' ' VAL . 30.8 p -115.49 -34.47 4.9 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.81 161.21 1.21 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 58' ' ' ILE . 9.3 tp -66.6 131.47 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.0 m -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.358 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -75.84 96.87 3.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.602 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -139.38 157.54 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.583 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -131.66 56.76 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.566 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' HB2' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -158.72 -70.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.568 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.38 -10.64 56.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 56.9 t -56.24 -40.5 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.363 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.804 ' O ' ' C ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -27.38 130.85 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.804 ' C ' ' O ' ' A' ' 133' ' ' PHE . . . -11.08 104.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.549 -176.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 136' ' ' CYS . 0.7 OUTLIER -97.15 101.65 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 122.69 0.396 . . . . 0.0 111.621 -177.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 135' ' ' ILE . 5.3 p 156.32 -169.83 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.507 1.13 . . . . 0.0 112.442 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.35 164.88 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.81 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.821 2.347 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -150.79 124.37 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.527 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 52.51 27.48 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.582 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.549 ' CG ' ' CE1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -112.72 -51.85 2.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -41.42 64.75 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 125.793 1.933 . . . . 0.0 110.563 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.43 107.31 9.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.067 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 90.8 m -132.79 133.25 43.17 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt 61.98 -166.72 0.21 Allowed 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.776 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 16.2 p -65.94 156.38 33.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.51 0.671 . . . . 0.0 111.738 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.692 ' O ' HG12 ' A' ' 152' ' ' VAL . 87.6 tttt -178.94 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -67.97 -36.74 80.58 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.512 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -66.38 -39.14 88.91 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 0.7 OUTLIER -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.921 ' HB2' ' HG ' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.88 -32.24 73.85 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -68.76 -44.44 73.72 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 t -78.62 83.16 4.82 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -148.48 91.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 176.65 -169.07 41.4 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -91.38 126.59 36.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.575 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -78.16 146.02 35.31 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.892 0.853 . . . . 0.0 109.191 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -66.61 158.48 29.8 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.53 -54.38 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -172.12 -167.46 0.48 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.33 41.46 13.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.76 -54.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.2 p -70.6 160.91 31.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.99 -74.95 0.43 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 71.4 t -120.99 -57.08 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -81.3 145.61 30.81 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 115.126 -2.629 . . . . 0.0 111.475 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -130.17 144.73 51.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.68 -40.24 94.29 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.035 1.334 . . . . 0.0 108.411 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 174.19 179.06 44.57 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -96.69 -32.08 12.36 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 58.5 p -136.54 160.25 39.33 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.44 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 146.24 35.71 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 116.792 -2.623 . . . . 0.0 110.489 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -64.19 -40.01 95.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.31 148.56 21.97 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -157.37 162.23 39.05 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 54.36 37.76 28.18 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -102.75 -34.43 9.03 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.7 t -57.68 -44.16 85.57 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 12.2 t -63.85 -29.63 70.8 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -66.12 -39.81 90.18 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.14 67.25 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 116.899 -1.92 . . . . 0.0 110.133 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.25 -72.52 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.608 2.363 . . . . 0.0 105.927 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.85 -33.2 75.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 125.973 2.046 . . . . 0.0 114.365 -179.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 9.4 mttt -72.34 -50.19 28.66 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 116.135 -2.226 . . . . 0.0 110.671 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -69.91 -38.42 76.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.302 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.526 ' HE3' HG23 ' A' ' 274' ' ' THR . 0.0 OUTLIER -63.11 -45.72 90.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 116.924 -1.911 . . . . 0.0 108.853 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.64 85.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.79 -44.05 97.64 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -71.44 -37.86 71.38 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 121.582 -0.699 . . . . 0.0 111.825 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.526 HG23 ' HE3' ' A' ' 270' ' ' LYS . 24.5 p -70.27 -45.01 67.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.921 ' HG ' ' HB2' ' A' ' 219' ' ' TYR . 5.0 mp -61.56 -43.77 98.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.99 -38.19 93.89 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 326' ' ' TYR . 42.4 mt -70.15 -40.13 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.403 0.601 . . . . 0.0 110.78 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.864 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.34 -50.66 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.702 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.864 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.6 ptt? -63.35 -40.95 98.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.632 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.46 96.34 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 121.621 -0.323 . . . . 0.0 112.456 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.1 p -69.0 -49.39 58.25 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 117.846 0.823 . . . . 0.0 108.848 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.06 -57.92 9.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.549 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.2 p -70.53 -46.66 63.18 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 80.8 mt -71.04 -21.5 62.26 Favored 'General case' 0 N--CA 1.433 -1.31 1 O-C-N 115.965 -4.209 . . . . 0.0 109.003 -175.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.915 ' HB3' ' O ' ' A' ' 314' ' ' ILE . 0.8 OUTLIER -154.67 109.13 2.99 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.167 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.875 ' HE3' ' HA ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER 137.09 -59.1 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.683 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.58 -48.05 94.47 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.861 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.453 HG13 ' NE2' ' A' ' 299' ' ' GLN . 68.8 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.655 ' HG3' HD12 ' A' ' 302' ' ' LEU . 9.4 pm0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 299' ' ' GLN . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 1.8 mp0 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.819 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.96 -39.26 88.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.776 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.71 -41.89 99.37 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 8.4 mm -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.472 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.62 -37.06 31.59 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -165.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.3 m-85 -68.22 -32.76 73.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 122.097 -0.649 . . . . 0.0 111.902 -170.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.4 m-80 -54.06 -48.37 94.27 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.66 -171.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.8 Cg_exo -61.19 -34.66 88.42 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 121.22 1.471 . . . . 0.0 112.697 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.63 -44.32 70.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.746 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.51 -64.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 123.216 0.606 . . . . 0.0 112.27 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -44.53 -33.14 1.64 Allowed 'General case' 0 C--N 1.352 0.715 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -177.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 75.1 m -89.52 39.06 0.93 Allowed 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.719 1.208 . . . . 0.0 113.071 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -69.04 -22.6 64.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.532 1.133 . . . . 0.0 111.549 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -45.25 145.99 1.68 Allowed Pre-proline 0 C--N 1.369 1.418 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.783 3.802 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 3.2 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.758 HG21 HG23 ' A' ' 73' ' ' THR . 47.5 pt -130.51 157.29 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.197 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.545 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 68.34 -167.49 0.19 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 56' ' ' THR . . . 73.7 64.62 0.09 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 59' ' ' CYS . 59.5 mt 64.71 148.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.436 ' N ' HG22 ' A' ' 58' ' ' ILE . 79.9 m -118.6 137.51 53.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.345 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -131.21 152.66 50.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.69 100.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -129.08 -178.73 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.668 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -95.3 5.91 50.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.455 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -68.11 -10.64 55.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.31 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.1 t -56.45 -40.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.34 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.04 -32.59 72.2 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.623 ' HZ ' ' H ' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' HB2' HG13 ' A' ' 218' ' ' VAL . 2.7 t80 -54.13 -48.99 70.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -78.03 -84.89 0.07 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 47.98 -162.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.512 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 136' ' ' CYS . 0.3 OUTLIER -52.26 162.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 122.679 0.392 . . . . 0.0 111.642 179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.619 ' H ' HG22 ' A' ' 135' ' ' ILE . 9.1 p 44.54 -114.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.393 1.058 . . . . 0.0 112.479 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.24 166.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 123.332 0.395 . . . . 0.0 110.361 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -55.34 -34.26 88.12 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.948 2.432 . . . . 0.0 112.066 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.56 -87.83 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.719 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 mttt 173.86 169.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.47 -58.36 1.77 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -41.42 81.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.563 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.69 HD23 ' SG ' ' A' ' 148' ' ' CYS . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.686 ' C ' ' O ' ' A' ' 144' ' ' LEU . 1.7 tt 20.81 68.31 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.0 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 -74.16 0.37 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -94.98 -3.74 47.94 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' A' ' 144' ' ' LEU . 90.4 m -62.18 -40.78 97.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -168.42 116.22 0.69 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 116.693 -3.754 . . . . 0.0 109.799 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.623 ' H ' ' HZ ' ' A' ' 71' ' ' PHE . . . -166.96 161.48 15.05 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.444 -0.903 . . . . 0.0 110.468 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -59.18 -39.14 81.63 Favored 'General case' 0 C--N 1.301 -1.505 2 O-C-N 129.642 4.339 . . . . 0.0 107.673 176.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.5 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 1.7 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.42 HD12 HG22 ' A' ' 254' ' ' THR . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.496 HG21 ' HA2' ' A' ' 255' ' ' GLY . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.42 -33.56 76.24 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.64 -45.29 75.77 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.2 t -63.83 136.09 57.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -173.88 130.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -158.21 177.73 34.78 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -124.93 147.62 48.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 59.66 -179.48 0.09 Allowed 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.926 0.869 . . . . 0.0 109.183 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 66.08 56.02 0.87 Allowed 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.49 143.17 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.15 142.81 49.11 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -68.31 135.79 52.44 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 156.57 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.4 p -71.67 158.99 35.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 62.94 170.76 0.14 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 248' ' ' VAL . 8.6 p -151.9 139.23 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.399 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 115.105 -2.638 . . . . 0.0 111.458 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -63.76 -40.98 98.01 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -163.06 176.53 9.99 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.079 1.352 . . . . 0.0 108.43 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -149.5 150.62 22.74 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.63 -65.84 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.42 HG22 HD12 ' A' ' 230' ' ' LEU . 47.4 m -133.36 136.1 45.14 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.434 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLY . . . . . 0.496 ' HA2' HG21 ' A' ' 233' ' ' ILE . . . 97.37 136.86 9.3 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 116.737 -2.649 . . . . 0.0 110.419 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -108.47 -36.65 6.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.31 51.17 60.16 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -58.77 -49.63 76.95 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -153.18 157.17 39.9 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 63.71 17.41 10.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.0 t -60.23 -44.22 95.37 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 120.857 -1.152 . . . . 0.0 108.086 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 4.9 p -63.82 -29.62 70.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -66.14 -39.8 90.13 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.1 67.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 116.913 -1.915 . . . . 0.0 110.119 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.33 -72.55 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 127.605 2.362 . . . . 0.0 105.884 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.8 -33.12 74.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 125.949 2.031 . . . . 0.0 114.429 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 267' ' ' LYS . . . . . 0.552 ' HE2' HD12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -72.42 -50.16 28.41 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 116.141 -2.224 . . . . 0.0 110.655 -178.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.08 -40.31 90.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -69.83 -38.47 76.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.331 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.07 -45.73 90.79 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 116.947 -1.901 . . . . 0.0 108.839 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.58 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.86 71.3 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 121.555 -0.716 . . . . 0.0 111.82 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 21.0 p -70.32 -44.95 67.21 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 276' ' ' GLY . 0.1 OUTLIER -61.53 -43.82 98.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.592 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.914 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -66.04 -38.12 93.77 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 326' ' ' TYR . 23.1 mt -70.17 -40.11 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 117.389 0.595 . . . . 0.0 110.813 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.4 -50.6 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.666 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 14.8 ptt? -63.32 -40.96 98.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.647 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.38 96.18 Favored Glycine 0 C--N 1.348 1.239 0 C-N-CA 121.606 -0.33 . . . . 0.0 112.492 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -69.05 -49.36 58.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.478 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.0 p -70.51 -46.7 63.18 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.3 mt -68.54 -23.07 64.47 Favored 'General case' 0 N--CA 1.432 -1.336 1 O-C-N 115.966 -4.209 . . . . 0.0 108.975 -176.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 1.066 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 1.3 p -156.87 115.52 3.32 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.257 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 1.066 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 3.0 m95 135.2 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.609 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.94 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.711 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.0 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.83 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.82 -39.5 89.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.751 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.62 -41.89 99.27 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.883 ' O ' ' CB ' ' A' ' 285' ' ' CYS . 65.8 mt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.916 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.655 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.12 -37.08 29.69 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 325' ' ' ILE . 7.1 m-85 -68.21 -32.77 73.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.329 0.652 . . . . 0.0 111.872 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.528 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 1.0 OUTLIER -54.04 -48.45 94.0 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.639 -171.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 52.6 Cg_exo -61.14 -34.72 88.81 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 CA-C-N 121.258 1.485 . . . . 0.0 112.666 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.59 -44.34 70.98 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.6 mm -93.31 -63.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.211 0.604 . . . . 0.0 112.255 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.627 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.98 -34.39 0.98 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -177.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 79.1 p -88.61 35.93 0.78 Allowed 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 124.717 1.207 . . . . 0.0 113.009 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -67.37 -24.16 65.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.51 1.124 . . . . 0.0 111.597 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.62 145.99 1.37 Allowed Pre-proline 0 C--N 1.378 1.841 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.942 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.467 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 55.9 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.797 3.811 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' OG1' ' A' ' 56' ' ' THR . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -156.61 133.31 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.102 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 161.94 -85.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' ILE . . . -94.95 168.01 11.05 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 57' ' ' ALA . 5.7 mt 40.84 51.38 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -75.97 43.06 0.26 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.254 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -74.17 57.4 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -45.58 100.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.671 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 75.8 mm-40 -77.98 83.02 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.619 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 20.7 ttm180 78.18 -4.13 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.548 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -67.32 -10.64 52.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.41 0.68 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.6 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.319 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.744 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.402 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 2.6 t80 -72.13 105.95 4.16 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 133' ' ' PHE . . . 63.53 117.24 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.519 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 135' ' ' ILE . 0.1 OUTLIER -142.72 -57.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 122.735 0.414 . . . . 0.0 111.715 -178.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 137' ' ' SER . 14.6 p -76.14 -37.71 57.66 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 124.381 1.05 . . . . 0.0 112.523 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 136' ' ' CYS . 60.0 m -141.55 160.52 56.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.855 0.722 . . . . 0.0 109.838 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.33 -13.97 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.027 2.485 . . . . 0.0 112.472 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -47.07 140.66 4.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.71 49.33 12.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 111.15 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -144.77 -54.85 0.32 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.21 -41.42 70.25 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.563 -175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 131.72 41.84 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.034 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -153.17 155.02 35.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt 60.06 27.1 16.5 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.729 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 76.1 m 49.14 45.04 23.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.416 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 150' ' ' ALA . 41.6 ttmt -60.3 127.5 32.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.265 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . 175.44 -31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.135 0.493 . . . . 0.0 110.202 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -63.82 -39.14 93.52 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 3.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.9 m170 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.37 -33.46 76.02 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.23 -45.11 77.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.8 m -64.5 140.96 58.92 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -176.95 122.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.639 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -70.64 153.75 51.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -114.97 126.74 55.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 110.637 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.13 144.47 51.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.902 0.858 . . . . 0.0 109.18 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -143.98 32.07 1.26 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.82 137.23 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 57.17 32.89 22.48 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -88.67 177.5 6.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.36 63.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.63 -171.98 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -111.07 110.58 21.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.24 157.33 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.38 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.28 137.02 35.83 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 115.06 -2.656 . . . . 0.0 111.429 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -137.32 124.21 21.35 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -117.18 13.34 14.67 Favored 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 125.051 1.34 . . . . 0.0 108.335 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.81 157.56 51.62 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -153.25 157.97 40.98 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 153.45 33.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.43 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.28 48.2 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 116.788 -2.625 . . . . 0.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -156.82 143.48 18.43 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 59.19 -129.04 48.79 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -149.65 159.65 44.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -143.34 -71.67 0.3 Allowed 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -150.23 -41.89 0.13 Allowed 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.2 t -57.87 -44.21 86.49 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 49.7 m -63.83 -29.6 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -66.15 -39.74 90.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.17 67.28 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 116.928 -1.909 . . . . 0.0 110.112 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.21 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 127.649 2.38 . . . . 0.0 105.9 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 15.2 p -63.83 -33.15 75.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 126.036 2.085 . . . . 0.0 114.396 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -72.4 -50.21 28.16 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 116.087 -2.245 . . . . 0.0 110.654 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -65.94 -40.37 91.3 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -69.82 -38.49 76.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.322 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.7 mmpm? -63.07 -45.74 90.73 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.984 -1.886 . . . . 0.0 108.825 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.61 85.6 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -44.04 97.68 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.55 -37.79 71.07 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.621 -0.674 . . . . 0.0 111.802 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 19.1 p -70.31 -44.99 67.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 219' ' ' TYR . 16.8 tp -61.48 -43.81 98.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.14 93.78 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.551 HG21 ' HD1' ' A' ' 326' ' ' TYR . 34.7 mt -70.2 -40.07 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.365 0.582 . . . . 0.0 110.801 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.857 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.43 -50.56 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.671 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.857 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.4 -40.92 98.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.588 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.41 96.24 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.01 -49.37 58.33 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.437 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.7 p -70.54 -46.64 63.2 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.5 tp -72.06 -20.57 61.65 Favored 'General case' 0 N--CA 1.432 -1.33 1 O-C-N 116.004 -4.185 . . . . 0.0 109.002 -174.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.97 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.64 107.72 2.84 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.186 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.97 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.17 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.647 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.67 -48.05 94.28 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.861 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.703 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 291' ' ' ILE . 69.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.1 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 64.8 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.6 -39.94 89.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.736 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.32 -41.89 98.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 0.9 OUTLIER -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.844 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.11 -37.71 28.1 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -165.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.663 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.29 -32.71 73.06 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.359 0.664 . . . . 0.0 111.864 -170.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.2 m-20 -54.16 -48.34 94.55 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-O 118.48 -0.772 . . . . 0.0 112.606 -171.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.7 Cg_exo -61.18 -34.66 88.49 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 121.252 1.483 . . . . 0.0 112.707 -176.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.7 mt -69.64 -44.3 70.87 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.743 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.8 mm -95.58 -63.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.248 0.619 . . . . 0.0 112.25 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.551 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.42 -33.32 1.04 Allowed 'General case' 0 C--N 1.353 0.736 0 N-CA-C 119.987 3.329 . . . . 0.0 119.987 -177.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.5 p -86.64 36.2 0.7 Allowed 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.762 1.225 . . . . 0.0 113.014 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.07 -24.38 67.68 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.574 1.15 . . . . 0.0 111.51 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.38 145.99 3.59 Favored Pre-proline 0 C--N 1.377 1.762 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.942 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.69 3.744 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 73' ' ' THR . 35.9 pt -138.53 162.23 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.178 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m 66.84 30.8 7.67 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.56 ' C ' HD12 ' A' ' 58' ' ' ILE . . . -112.11 -81.16 0.59 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.56 HD12 ' C ' ' A' ' 57' ' ' ALA . 3.1 mp -124.05 118.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 m -85.67 148.36 25.92 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.273 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.31 36.37 27.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.066 0.46 . . . . 0.0 109.798 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 58' ' ' ILE . 15.1 t80 -72.84 -42.73 63.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.12 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -156.82 -157.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -80.84 26.64 0.4 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.669 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -66.02 -10.64 41.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.3 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.799 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 28.2 m -56.5 -40.26 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.307 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -60.96 -32.59 72.12 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.718 -0.793 . . . . 0.0 108.863 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.799 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.694 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.406 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -44.71 140.9 2.28 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 140.24 57.1 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.506 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.2 pt -148.96 22.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 122.76 0.424 . . . . 0.0 111.701 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -103.5 -67.37 0.89 Allowed 'General case' 0 C--N 1.332 -0.179 0 O-C-N 124.376 1.048 . . . . 0.0 112.539 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.1 m -74.73 153.79 87.24 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.5 -21.3 13.27 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.36 2.707 . . . . 0.0 112.628 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.96 -38.91 92.53 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.192 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.34 175.85 6.53 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.063 0.459 . . . . 0.0 111.58 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 72.86 -55.83 0.67 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -41.42 74.28 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.563 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.39 110.43 18.14 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.06 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.6 p -135.92 167.21 21.62 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 69.09 -84.87 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.797 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.88 -79.61 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 72.5 mmtt 60.27 -161.86 0.27 Allowed 'General case' 0 C--N 1.407 3.107 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.816 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 149' ' ' LYS . . . 77.23 -53.25 0.55 Allowed 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.534 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.56 -39.14 92.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.8 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.863 ' CD1' HD11 ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.69 -32.26 73.72 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -68.32 -46.97 68.79 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 43.6 t -62.52 136.89 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -172.94 125.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.571 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.06 139.45 10.98 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 138.29 44.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.654 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -149.63 113.47 5.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.852 0.834 . . . . 0.0 109.174 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -159.64 164.83 33.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.06 28.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 57.23 31.59 20.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 245' ' ' VAL . 83.4 m-20 -140.23 137.41 34.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 244' ' ' ASN . 6.3 t 68.29 131.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.3 p -69.86 160.13 32.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -131.44 149.4 52.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 248' ' ' VAL . 10.0 p -138.83 140.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -145.93 30.04 1.08 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 115.026 -2.669 . . . . 0.0 111.442 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -61.68 -42.64 99.2 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -166.42 157.59 12.97 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 125.021 1.329 . . . . 0.0 108.371 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.52 74.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 107.154 -2.379 . . . . 0.0 107.154 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 81.5 p -124.98 -29.47 3.34 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.467 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 68.83 26.08 74.82 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 116.705 -2.664 . . . . 0.0 110.454 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -157.39 144.03 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 70.54 29.54 69.71 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -96.43 19.51 12.01 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -115.51 -32.66 5.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -60.98 -43.85 98.21 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.0 t -57.75 -44.17 85.92 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 6.2 p -63.82 -29.66 70.83 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -66.12 -39.8 90.18 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -30.21 67.4 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 116.996 -1.881 . . . . 0.0 110.074 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.27 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 127.651 2.38 . . . . 0.0 105.918 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 13.9 p -63.88 -33.08 74.89 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.013 2.071 . . . . 0.0 114.425 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -50.21 28.14 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.629 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -69.87 -38.44 76.41 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.331 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.728 ' HE2' HG23 ' A' ' 274' ' ' THR . 0.0 OUTLIER -63.08 -45.7 90.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 116.997 -1.881 . . . . 0.0 108.861 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.63 85.54 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.69 -44.07 97.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -37.84 71.29 Favored 'General case' 0 CA--C 1.495 -1.173 0 O-C-N 121.578 -0.701 . . . . 0.0 111.836 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.728 HG23 ' HE2' ' A' ' 270' ' ' LYS . 25.5 p -70.29 -44.98 67.25 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.974 HD23 ' O ' ' A' ' 275' ' ' LEU . 5.1 tt -61.41 -43.86 98.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.581 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.15 93.69 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 326' ' ' TYR . 29.9 mt -70.14 -40.12 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 117.396 0.598 . . . . 0.0 110.791 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.44 -50.54 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.402 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.706 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.37 -40.95 98.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.364 -1.334 . . . . 0.0 111.653 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.53 96.45 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.216 -0.302 . . . . 0.0 112.44 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -68.95 -49.34 58.81 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 121.822 -0.811 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.75 -58.26 7.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.493 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.54 -46.74 62.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.34 -22.73 63.74 Favored 'General case' 0 N--CA 1.432 -1.351 1 O-C-N 115.983 -4.198 . . . . 0.0 109.007 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.976 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.9 OUTLIER -156.18 113.86 3.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.238 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.976 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.3 m95 135.71 -58.91 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.83 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.861 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PHE . . . . . 0.658 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.5 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 314' ' ' ILE . 0.1 OUTLIER -61.07 -39.19 88.95 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.684 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.92 -41.89 99.61 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.433 -0.792 . . . . 0.0 109.183 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.882 ' O ' HG12 ' A' ' 317' ' ' VAL . 2.8 tt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.877 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.463 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.43 -35.62 36.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -166.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 325' ' ' ILE . 11.5 m-85 -68.26 -32.75 73.16 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 123.345 0.658 . . . . 0.0 111.82 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.511 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.2 m-80 -54.09 -48.38 94.32 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.654 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 51.3 Cg_exo -61.19 -34.66 88.38 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.254 1.484 . . . . 0.0 112.715 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.65 -44.29 70.87 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.74 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 321' ' ' PHE . 2.1 mm -94.8 -64.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.237 0.615 . . . . 0.0 112.309 -173.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.61 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -43.44 -30.88 0.6 Allowed 'General case' 0 C--N 1.352 0.699 0 N-CA-C 119.979 3.326 . . . . 0.0 119.979 -177.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 81.7 p -93.03 36.1 1.05 Allowed 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.024 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -67.94 -23.09 65.03 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 124.531 1.132 . . . . 0.0 111.607 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.87 145.99 1.46 Allowed Pre-proline 0 C--N 1.374 1.649 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.461 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.3 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 88.4 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 61' ' ' PHE . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.743 3.777 . . . . 0.0 109.262 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 23.1 m120 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.721 HG22 ' N ' ' A' ' 56' ' ' THR . 1.6 mm -146.57 159.04 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.721 ' N ' HG22 ' A' ' 55' ' ' ILE . 7.2 p 72.14 151.31 0.11 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 56' ' ' THR . . . 70.89 95.83 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.9 mt 61.98 99.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 p -129.13 126.88 40.27 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.364 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mmtt 174.5 -161.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.53 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 4.5 t80 83.37 -6.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.504 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 60.1 mm-40 48.21 -154.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.523 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 63.8 mtp85 72.15 -55.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.569 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 64' ' ' LEU . 6.9 mp -67.31 -10.64 52.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 61.0 t -56.3 -40.45 66.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.328 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.748 ' HB2' ' ND2' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.931 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.819 HD11 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 271' ' ' ALA . 11.0 mtp85 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG13 ' A' ' 218' ' ' VAL . 1.9 t80 -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -67.31 -45.15 77.35 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.04 63.36 4.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 118.264 -1.375 . . . . 0.0 110.598 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.424 HG21 ' OE2' ' A' ' 225' ' ' GLU . 70.7 mt -63.32 -65.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 122.76 0.424 . . . . 0.0 111.681 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 19.0 p -178.03 -28.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.391 1.057 . . . . 0.0 112.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.7 m -81.42 121.28 79.89 Favored Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 123.504 0.502 . . . . 0.0 110.288 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.53 -13.89 22.45 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.224 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -66.02 -29.68 70.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -100.75 10.96 40.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.62 -55.35 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.43 -41.42 72.91 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 145' ' ' LEU . 7.7 tt -96.54 116.45 29.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 119.491 -0.883 . . . . 0.0 109.014 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.5 p -144.72 -55.8 0.34 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.9 -46.04 92.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.773 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' CYS . . . . . 0.407 ' O ' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER 173.46 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 53.04 65.31 1.56 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 118.982 -2.324 . . . . 0.0 109.776 -170.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -158.21 -61.53 0.08 Allowed 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.493 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.76 -39.14 93.23 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.6 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.591 ' O ' HG13 ' A' ' 182' ' ' ILE . 55.7 t-80 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.65 ' H ' HD13 ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.6 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' OE2' HG21 ' A' ' 135' ' ' ILE . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -65.69 -33.12 75.14 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.98 -45.64 77.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -64.09 131.62 48.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -177.95 138.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.551 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 158.79 -92.88 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ARG . . . . . 0.428 ' O ' HG22 ' A' ' 242' ' ' VAL . 99.8 mtt180 55.08 40.21 31.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 0.0 110.635 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -83.54 -2.52 56.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.791 0.805 . . . . 0.0 109.182 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -62.26 -39.44 92.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 239' ' ' ARG . 18.9 m -62.04 -27.38 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? 67.02 109.94 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 63.9 t30 62.8 85.95 0.12 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 18.1 m -59.48 -31.14 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t 60.87 -167.59 0.19 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -108.04 154.78 21.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 2.3 t 54.66 45.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.385 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -68.76 155.99 39.13 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 115.098 -2.641 . . . . 0.0 111.492 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 70.35 100.84 0.06 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -68.89 147.64 51.39 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 124.955 1.302 . . . . 0.0 108.344 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -85.1 -1.56 88.53 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -62.33 -39.26 92.5 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 98.8 m -61.34 -44.46 97.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.355 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.89 -178.53 44.83 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 116.771 -2.633 . . . . 0.0 110.473 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.62 145.45 51.5 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 129.93 163.25 11.05 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -126.24 134.86 51.08 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 260' ' ' ARG . 96.7 mtm-85 -137.05 153.25 50.66 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 259' ' ' ARG . 86.4 mtt180 73.46 -76.04 0.07 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 259' ' ' ARG . 48.1 t -57.43 -44.16 84.43 Favored 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 120.75 -1.219 . . . . 0.0 108.105 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 0.9 OUTLIER -63.89 -29.63 70.79 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -66.1 -39.8 90.27 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -30.18 67.36 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 116.964 -1.894 . . . . 0.0 110.136 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.29 -72.54 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 127.644 2.378 . . . . 0.0 105.885 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.7 p -63.82 -33.22 75.18 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 126.009 2.068 . . . . 0.0 114.359 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -72.35 -50.21 28.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 116.127 -2.229 . . . . 0.0 110.629 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.02 -40.39 91.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.177 -0.327 . . . . 0.0 111.86 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -69.78 -38.48 76.72 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.338 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.69 90.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 116.964 -1.894 . . . . 0.0 108.864 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ALA . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 131' ' ' ARG . . . -58.3 -46.6 85.81 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.76 -44.02 97.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.55 -37.8 71.06 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.589 -0.694 . . . . 0.0 111.816 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 88.0 m -70.3 -44.96 67.25 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 219' ' ' TYR . 6.6 tt -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.631 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.93 -38.21 93.99 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.576 ' N ' HD13 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -70.19 -40.09 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 117.327 0.563 . . . . 0.0 110.805 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.858 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.54 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.673 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' MET . . . . . 0.858 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.47 -40.84 98.17 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.634 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.57 -38.44 96.29 Favored Glycine 0 C--N 1.348 1.218 0 C-N-CA 121.614 -0.327 . . . . 0.0 112.479 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.3 p -68.99 -49.37 58.44 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 117.813 0.806 . . . . 0.0 108.856 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 212' ' ' LEU . 5.5 m-85 -54.05 -57.96 9.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.468 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.8 p -70.53 -46.72 63.07 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.667 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 83.1 mt -72.27 -20.17 61.57 Favored 'General case' 0 N--CA 1.432 -1.347 1 O-C-N 115.92 -4.238 . . . . 0.0 108.97 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 285' ' ' CYS . . . . . 0.891 ' HB2' ' HA2' ' A' ' 315' ' ' GLY . 0.8 OUTLIER -154.99 107.97 2.79 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.321 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.931 ' CZ2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 138.45 -59.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.015 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.74 -48.05 94.15 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.861 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.759 ' HB2' HD22 ' A' ' 311' ' ' LEU . 1.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 291' ' ' ILE . 74.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 1.2 t-80 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 6.5 mm-40 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 304' ' ' ARG . 5.3 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' TYR . . . . . 0.539 ' N ' HG23 ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.67 93.72 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 288' ' ' PRO . 94.4 mt -61.25 -38.87 88.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.784 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -62.75 -41.89 99.42 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ILE . . . . . 0.906 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.49 -40.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.196 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.891 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.21 -35.91 92.57 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' TYR . . . . . 0.473 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.97 13.73 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -163.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -68.29 -32.7 73.04 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.343 0.657 . . . . 0.0 111.886 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ASN . . . . . 0.559 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 8.3 m-20 -54.11 -48.44 94.16 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.597 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 62.0 Cg_exo -61.14 -34.7 88.87 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 121.273 1.49 . . . . 0.0 112.707 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.58 -44.31 71.06 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.777 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 277' ' ' ILE . 8.8 mm -97.94 -70.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 123.211 0.604 . . . . 0.0 112.266 -173.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' TYR . . . . . 0.441 ' CD1' HG21 ' A' ' 277' ' ' ILE . 2.0 t80 -18.79 -57.49 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 120.03 3.344 . . . . 0.0 120.03 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 13.1 m -98.73 55.52 1.06 Allowed 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 124.738 1.215 . . . . 0.0 113.031 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -68.37 -0.7 5.17 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.485 1.114 . . . . 0.0 111.516 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.73 145.99 0.49 Allowed Pre-proline 0 CA--C 1.5 -0.977 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 64' ' ' LEU . 5.7 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 12.9 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 21.0 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.9 pp . . . . . 0 CA--C 1.497 -1.073 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.22 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.0 ttt85 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.624 0.25 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -67.55 -10.64 53.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.727 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.62 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.727 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.651 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.407 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 . . . . . 0 N--CA 1.434 -1.23 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.487 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.7 t80 . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -41.42 56.65 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 124.597 1.186 . . . . 0.0 110.563 -171.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.188 0 CA-C-O 121.359 0.6 . . . . 0.0 110.459 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.86 -39.14 93.08 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.1 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.4 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.98 -32.75 74.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.61 -45.2 76.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.08 135.97 56.86 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.609 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.5 mttt . . . . . 0 CA--C 1.495 -1.149 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 3.8 p -70.33 -43.92 69.29 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.21 -42.54 96.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.418 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -65.54 -38.13 94.4 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 33.3 mt -70.17 -40.09 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 117.398 0.599 . . . . 0.0 110.817 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.41 -50.59 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.707 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.7 ptm -63.33 -40.97 98.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.637 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.44 96.31 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.657 -0.306 . . . . 0.0 112.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.5 p -69.01 -49.38 58.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 117.84 0.82 . . . . 0.0 108.81 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.98 -58.09 8.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.5 p -70.51 -46.68 63.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.581 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.8 mt -72.04 -20.64 61.66 Favored 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 116.008 -4.182 . . . . 0.0 108.947 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.971 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -156.39 106.74 2.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.971 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.0 OUTLIER 139.13 -58.75 0.0 OUTLIER 'General case' 0 C--N 1.361 1.066 0 O-C-N 125.213 1.571 . . . . 0.0 111.769 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.2 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.2 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.642 HG12 HD22 ' A' ' 311' ' ' LEU . 95.4 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.67 93.73 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.642 HD22 HG12 ' A' ' 307' ' ' VAL . 6.4 mp -60.71 -39.87 90.14 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.705 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.95 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 4.7 mt -55.18 -44.34 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.672 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.41 -35.91 92.37 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.449 ' ND2' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.69 -38.45 27.75 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 325' ' ' ILE . 9.3 m-85 -68.32 -32.72 73.05 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.334 0.653 . . . . 0.0 111.868 -170.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.514 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.3 m-20 -54.08 -48.44 94.1 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.621 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 53.4 Cg_exo -61.16 -34.71 88.65 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 121.22 1.471 . . . . 0.0 112.691 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.8 mt -69.6 -44.24 71.14 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.28 -63.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 123.153 0.581 . . . . 0.0 112.272 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.84 -36.28 1.44 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 120.032 3.345 . . . . 0.0 120.032 -177.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 40.2 m -88.29 40.76 0.97 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 124.745 1.218 . . . . 0.0 113.033 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -71.53 -21.75 61.86 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.503 1.121 . . . . 0.0 111.617 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -43.19 145.99 0.91 Allowed Pre-proline 0 C--N 1.375 1.676 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.458 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 91.3 m -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.68 3.737 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 323' ' ' PRO . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 47.5 pt . . . . . 0 CA--C 1.497 -1.067 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.165 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.68 -10.64 57.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.726 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.621 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.698 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 CA--C 1.493 -1.228 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.721 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -41.42 67.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.563 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.739 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.201 0 CA-C-O 121.293 0.568 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -60.7 -39.14 87.42 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 125.313 1.445 . . . . 0.0 107.673 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.261 2.5 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.2 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.884 ' CD1' HD11 ' A' ' 275' ' ' LEU . 0.9 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.9 -32.67 74.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.26 -45.34 76.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 237' ' ' GLU . 46.7 t -64.17 134.49 54.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 236' ' ' SER . 56.9 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.65 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 CA--C 1.495 -1.152 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.529 HG22 ' HE1' ' A' ' 326' ' ' TYR . 34.0 p -70.37 -45.02 66.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 219' ' ' TYR . 4.1 tt -61.6 -43.72 98.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 278' ' ' ILE . 0.2 OUTLIER -70.2 -40.06 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 117.407 0.604 . . . . 0.0 110.823 -177.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.863 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.45 -50.57 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.677 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.863 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.4 ptt? -63.34 -40.9 98.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.65 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.37 96.14 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 121.627 -0.32 . . . . 0.0 112.49 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.3 p -69.04 -49.45 57.45 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 117.822 0.811 . . . . 0.0 108.814 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 212' ' ' LEU . 6.2 m-85 -54.06 -57.91 9.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.477 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.1 p -70.54 -46.71 63.08 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.632 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.4 tp -72.26 -20.55 61.51 Favored 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 115.926 -4.234 . . . . 0.0 108.997 -174.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.993 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.38 107.93 2.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.309 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.993 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.04 -59.41 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.044 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.97 -48.05 93.71 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 72.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.41 HG12 HD22 ' A' ' 311' ' ' LEU . 54.1 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.854 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 307' ' ' VAL . 5.3 mp -60.52 -40.01 89.91 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.786 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -41.89 98.81 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.917 ' O ' HG12 ' A' ' 317' ' ' VAL . 13.6 mm -55.87 -43.31 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.886 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.93 -35.91 92.7 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.467 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.917 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -89.7 -23.68 32.66 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.27 -32.68 73.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.308 0.643 . . . . 0.0 111.899 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.495 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 2.5 m120 -54.13 -48.33 94.55 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.647 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 50.2 Cg_exo -61.21 -34.68 88.21 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 121.254 1.483 . . . . 0.0 112.705 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.3 mt -69.6 -44.32 70.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.763 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 14.3 mm -98.41 -64.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 123.191 0.596 . . . . 0.0 112.3 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.529 ' HE1' HG22 ' A' ' 274' ' ' THR . 49.1 t80 -52.66 -62.09 1.87 Allowed 'General case' 0 C--N 1.353 0.721 0 N-CA-C 120.002 3.334 . . . . 0.0 120.002 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 73.3 m -57.6 81.72 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.748 1.219 . . . . 0.0 112.989 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 329' ' ' SER . 7.7 mmt180 -117.69 -20.97 8.7 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 124.502 1.121 . . . . 0.0 111.57 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 328' ' ' ARG . 47.7 t -44.31 145.99 1.27 Allowed Pre-proline 0 C--N 1.386 2.155 0 O-C-N 118.942 -2.349 . . . . 0.0 110.942 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.463 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.7 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.668 ' O ' HG23 ' A' ' 55' ' ' ILE . 3.1 tp . . . . . 0 CA--C 1.498 -1.046 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.145 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.804 0.335 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.17 -10.64 55.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.719 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 5.1 m -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.613 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.719 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.653 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.571 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.584 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.596 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.0 t80 . . . . . 0 N--CA 1.435 -1.202 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -41.42 69.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.563 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.206 0 CA-C-O 121.293 0.568 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.64 -39.14 93.17 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 4.4 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.4 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.545 ' CE1' ' CD2' ' A' ' 282' ' ' PHE . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 79.9 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -29.38 68.48 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.56 -46.16 67.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 70.3 m -63.83 137.03 57.87 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.705 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 24.5 mttt . . . . . 0 CA--C 1.494 -1.175 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 7.2 p -70.27 -45.01 67.25 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.654 HD23 ' CG ' ' A' ' 219' ' ' TYR . 2.0 tm? -61.51 -43.84 98.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.56 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.14 93.83 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 326' ' ' TYR . 1.0 OUTLIER -70.21 -40.09 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 117.376 0.588 . . . . 0.0 110.805 -177.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.853 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.55 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.729 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.853 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.36 -40.94 98.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.36 -1.336 . . . . 0.0 111.626 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.44 96.28 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.208 -0.308 . . . . 0.0 112.446 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.5 p -69.06 -49.36 58.16 Favored 'General case' 0 CA--C 1.493 -1.22 0 O-C-N 121.801 -0.823 . . . . 0.0 108.816 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.799 ' CD2' HD13 ' A' ' 212' ' ' LEU . 1.9 m-85 -54.13 -57.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.491 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.6 p -70.49 -46.69 63.25 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.613 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 9.5 tp -73.44 -19.87 60.86 Favored 'General case' 0 N--CA 1.433 -1.315 1 O-C-N 116.009 -4.182 . . . . 0.0 109.014 -174.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.918 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.63 105.76 2.65 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.119 -178.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.918 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.0 OUTLIER 139.72 -59.59 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.646 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.88 -48.05 93.89 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.861 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 5.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 16.8 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.872 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 314' ' ' ILE . 5.3 mp -60.9 -39.35 88.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.803 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -41.89 99.3 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.92 ' O ' HG12 ' A' ' 317' ' ' VAL . 12.7 mm -56.13 -42.89 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.859 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -63.12 -35.91 92.73 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.474 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -72.94 -50.8 11.96 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.33 -32.72 73.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.827 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.517 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.9 m120 -54.15 -48.36 94.49 Favored Pre-proline 0 N--CA 1.436 -1.147 0 CA-C-O 118.484 -0.769 . . . . 0.0 112.629 -171.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 66.2 Cg_exo -61.18 -34.67 88.48 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 121.265 1.488 . . . . 0.0 112.702 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.59 -44.33 71.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.759 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.642 ' HB ' HD11 ' A' ' 277' ' ' ILE . 18.7 mm -97.69 -68.52 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 123.176 0.59 . . . . 0.0 112.255 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.68 ' CD1' HG21 ' A' ' 277' ' ' ILE . 1.3 t80 -30.71 -39.24 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 119.984 3.327 . . . . 0.0 119.984 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 50.8 0.79 Allowed 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 124.755 1.222 . . . . 0.0 113.015 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -70.43 -5.88 31.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.549 1.14 . . . . 0.0 111.541 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.94 145.99 0.51 Allowed Pre-proline 0 C--N 1.359 0.996 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.479 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.9 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.0 t -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.8 pt . . . . . 0 CA--C 1.497 -1.08 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.146 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.781 0.324 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.0 -10.64 55.21 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 114.031 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.725 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.7 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.624 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.725 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.708 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.441 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.492 -1.271 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 . . . . . 0 N--CA 1.437 -1.098 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -41.42 71.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.563 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 121.274 0.559 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.41 -39.14 92.31 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.26 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.4 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.88 -33.01 74.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.43 -45.42 76.1 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.18 135.91 56.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.562 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 44.2 mttt . . . . . 0 CA--C 1.496 -1.131 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.6 p -70.24 -44.98 67.42 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.568 HD13 ' CB ' ' A' ' 219' ' ' TYR . 15.4 tp -61.45 -43.88 98.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.06 -38.1 93.72 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 40.3 mt -70.2 -40.12 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 117.384 0.592 . . . . 0.0 110.802 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.36 -50.62 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.661 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.8 ptt? -63.42 -40.87 98.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.66 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.44 96.32 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.498 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.02 -49.46 57.49 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.512 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.6 m-85 -54.15 -57.83 9.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.498 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.46 -46.73 63.23 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 81.5 mt -71.55 -21.42 61.89 Favored 'General case' 0 N--CA 1.432 -1.348 1 O-C-N 115.892 -4.255 . . . . 0.0 108.962 -175.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.927 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.37 106.79 2.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.249 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.927 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.3 OUTLIER 138.72 -58.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.537 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.82 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.861 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.699 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.9 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.786 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 304' ' ' ARG . 4.4 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.541 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 288' ' ' PRO . 0.0 OUTLIER -60.59 -39.96 90.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.691 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -41.89 98.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.61 -40.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.802 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.36 -35.91 92.55 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.47 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.77 -38.33 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -165.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.61 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.3 -32.8 73.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 123.363 0.665 . . . . 0.0 111.811 -170.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.0 m-20 -54.1 -48.32 94.5 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-O 118.499 -0.762 . . . . 0.0 112.665 -171.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 54.7 Cg_exo -61.19 -34.7 88.39 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 121.246 1.481 . . . . 0.0 112.724 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.4 mt -69.56 -44.29 71.19 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.791 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 321' ' ' PHE . 3.1 mm -95.55 -63.56 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 123.202 0.601 . . . . 0.0 112.233 -173.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.65 -38.51 3.11 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -177.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 46.0 m -87.17 42.77 1.05 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.754 1.222 . . . . 0.0 113.04 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -73.26 -20.92 60.73 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 124.553 1.141 . . . . 0.0 111.555 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -42.86 145.99 0.82 Allowed Pre-proline 0 C--N 1.378 1.83 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.434 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 1.7 m -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.76 3.787 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.754 ' C ' ' O ' ' A' ' 54' ' ' VAL . 56.9 mt . . . . . 0 CA--C 1.497 -1.085 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.213 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.664 0.269 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -72.33 -10.64 60.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 64.0 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.289 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.402 ' C ' ' O ' ' A' ' 132' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.492 -1.277 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -41.42 74.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.563 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.199 0 CA-C-O 121.231 0.539 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -61.96 -39.14 91.1 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.0 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.35 -33.36 75.78 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -67.31 -45.44 76.5 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 45.8 t -64.49 137.87 58.1 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.664 -179.712 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.424 ' O ' HD12 ' A' ' 277' ' ' ILE . 14.4 mmtp . . . . . 0 CA--C 1.495 -1.15 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.5 p -70.3 -45.0 67.17 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.661 HD13 ' CB ' ' A' ' 219' ' ' TYR . 14.0 tp -61.49 -43.81 98.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.606 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 326' ' ' TYR . 20.0 mt -70.26 -40.08 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 117.394 0.597 . . . . 0.0 110.789 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.41 -50.52 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.724 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.2 ptt? -63.37 -40.93 98.6 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 118.411 -1.316 . . . . 0.0 111.662 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.62 -38.4 96.2 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 121.604 -0.332 . . . . 0.0 112.461 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.529 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.6 p -69.02 -49.39 58.04 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 121.789 -0.83 . . . . 0.0 108.804 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.599 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.08 -57.96 9.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.8 p -70.54 -46.72 63.04 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.3 tp -69.68 -22.35 63.44 Favored 'General case' 0 N--CA 1.432 -1.35 1 O-C-N 115.949 -4.219 . . . . 0.0 109.025 -176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 1.021 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -155.59 117.59 4.09 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.958 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 1.021 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 2.4 m95 131.88 -59.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.008 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.81 -48.05 94.02 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.861 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 4.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 43.4 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.488 HG12 HD22 ' A' ' 311' ' ' LEU . 55.2 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 314' ' ' ILE . 6.1 mp -62.03 -37.42 84.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.793 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -41.89 97.51 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 120.898 -1.126 . . . . 0.0 109.183 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 3.4 tp -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.946 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.61 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -79.03 -35.5 30.55 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -165.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 325' ' ' ILE . 5.4 m-85 -68.3 -32.74 73.1 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.339 0.656 . . . . 0.0 111.834 -171.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.2 m-20 -54.09 -48.36 94.38 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.628 -171.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.0 Cg_exo -61.2 -34.71 88.26 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.284 1.494 . . . . 0.0 112.695 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.59 -44.27 71.11 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.772 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.9 mm -90.73 -61.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 C-N-CA 123.236 0.614 . . . . 0.0 112.276 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.533 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -48.59 -22.1 0.7 Allowed 'General case' 0 C--N 1.353 0.746 0 N-CA-C 119.965 3.32 . . . . 0.0 119.965 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 67.5 m -83.05 19.53 1.4 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 124.752 1.221 . . . . 0.0 113.072 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 329' ' ' SER . 0.8 OUTLIER -57.59 -33.65 68.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 124.494 1.118 . . . . 0.0 111.55 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.58 145.99 3.89 Favored Pre-proline 0 C--N 1.378 1.819 0 C-N-CA 115.959 -2.297 . . . . 0.0 110.942 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.474 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.713 3.758 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.6 mm . . . . . 0 CA--C 1.498 -1.041 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.167 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' HB2' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.801 0.334 . . . . 0.0 110.568 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.38 -10.64 56.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 56.9 t -56.24 -40.5 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.363 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.655 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.283 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.549 ' CG ' ' CE1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.435 -1.199 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -41.42 64.75 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 125.793 1.933 . . . . 0.0 110.563 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.189 0 CA-C-O 121.374 0.607 . . . . 0.0 110.512 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -66.38 -39.14 88.91 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 0.7 OUTLIER -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.921 ' HB2' ' HG ' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.88 -32.24 73.85 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -68.76 -44.44 73.72 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 t -78.62 83.16 4.82 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.535 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 43.0 mttt . . . . . 0 CA--C 1.495 -1.169 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 24.5 p -70.27 -45.01 67.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.921 ' HG ' ' HB2' ' A' ' 219' ' ' TYR . 5.0 mp -61.56 -43.77 98.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.99 -38.19 93.89 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 326' ' ' TYR . 42.4 mt -70.15 -40.13 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.403 0.601 . . . . 0.0 110.78 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.864 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.34 -50.66 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.702 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.864 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.6 ptt? -63.35 -40.95 98.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.632 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.46 96.34 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 121.621 -0.323 . . . . 0.0 112.456 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.1 p -69.0 -49.39 58.25 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 117.846 0.823 . . . . 0.0 108.848 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.06 -57.92 9.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.549 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.2 p -70.53 -46.66 63.18 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 80.8 mt -71.04 -21.5 62.26 Favored 'General case' 0 N--CA 1.433 -1.31 1 O-C-N 115.965 -4.209 . . . . 0.0 109.003 -175.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.915 ' HB3' ' O ' ' A' ' 314' ' ' ILE . 0.8 OUTLIER -154.67 109.13 2.99 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.167 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.875 ' HA ' ' HE3' ' A' ' 286' ' ' TRP . 0.0 OUTLIER 137.09 -59.1 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.683 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.58 -48.05 94.47 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.861 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.453 HG13 ' NE2' ' A' ' 299' ' ' GLN . 68.8 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.655 ' HG3' HD12 ' A' ' 302' ' ' LEU . 9.4 pm0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 299' ' ' GLN . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 1.8 mp0 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.819 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.96 -39.26 88.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.776 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -41.89 99.37 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 8.4 mm -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.472 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.62 -37.06 31.59 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -165.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.3 m-85 -68.22 -32.76 73.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 122.097 -0.649 . . . . 0.0 111.902 -170.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.4 m-80 -54.06 -48.37 94.27 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.66 -171.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.8 Cg_exo -61.19 -34.66 88.42 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 121.22 1.471 . . . . 0.0 112.697 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.63 -44.32 70.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.746 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.51 -64.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 123.216 0.606 . . . . 0.0 112.27 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -44.53 -33.14 1.64 Allowed 'General case' 0 C--N 1.352 0.715 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -177.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 75.1 m -89.52 39.06 0.93 Allowed 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.719 1.208 . . . . 0.0 113.071 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -69.04 -22.6 64.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.532 1.133 . . . . 0.0 111.549 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -45.25 145.99 1.68 Allowed Pre-proline 0 C--N 1.369 1.418 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.783 3.802 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 3.2 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.758 HG21 HG23 ' A' ' 73' ' ' THR . 47.5 pt . . . . . 0 CA--C 1.496 -1.105 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.197 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.957 0.408 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.11 -10.64 55.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.31 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.1 t -56.45 -40.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.34 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.04 -32.59 72.2 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.413 ' HB2' HG13 ' A' ' 218' ' ' VAL . 2.7 t80 -54.13 -48.99 70.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 . . . . . 0 CA--C 1.491 -1.32 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.1 t80 . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -41.42 81.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.563 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.428 ' N ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.194 0 CA-C-O 121.267 0.556 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -59.18 -39.14 81.63 Favored 'General case' 0 C--N 1.301 -1.505 2 O-C-N 129.642 4.339 . . . . 0.0 107.673 176.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.5 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 1.7 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.42 -33.56 76.24 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.64 -45.29 75.77 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.2 t -63.83 136.09 57.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.543 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 21.0 p -70.32 -44.95 67.21 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 276' ' ' GLY . 0.1 OUTLIER -61.53 -43.82 98.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.592 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.914 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -66.04 -38.12 93.77 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 326' ' ' TYR . 23.1 mt -70.17 -40.11 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 117.389 0.595 . . . . 0.0 110.813 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.4 -50.6 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.666 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 14.8 ptt? -63.32 -40.96 98.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.647 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.38 96.18 Favored Glycine 0 C--N 1.348 1.239 0 C-N-CA 121.606 -0.33 . . . . 0.0 112.492 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -69.05 -49.36 58.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.478 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.0 p -70.51 -46.7 63.18 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.3 mt -68.54 -23.07 64.47 Favored 'General case' 0 N--CA 1.432 -1.336 1 O-C-N 115.966 -4.209 . . . . 0.0 108.975 -176.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 1.066 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 1.3 p -156.87 115.52 3.32 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.257 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 1.066 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 3.0 m95 135.2 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.609 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.94 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.711 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.0 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.83 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.82 -39.5 89.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.751 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.89 99.27 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.883 ' O ' ' CB ' ' A' ' 285' ' ' CYS . 65.8 mt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.916 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.655 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.12 -37.08 29.69 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 325' ' ' ILE . 7.1 m-85 -68.21 -32.77 73.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.329 0.652 . . . . 0.0 111.872 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.528 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 3.5 m-20 -54.04 -48.45 94.0 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.639 -171.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 52.6 Cg_exo -61.14 -34.72 88.81 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 CA-C-N 121.258 1.485 . . . . 0.0 112.666 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.59 -44.34 70.98 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.6 mm -93.31 -63.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.211 0.604 . . . . 0.0 112.255 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.627 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.98 -34.39 0.98 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -177.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 79.1 p -88.61 35.93 0.78 Allowed 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 124.717 1.207 . . . . 0.0 113.009 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -67.37 -24.16 65.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.51 1.124 . . . . 0.0 111.597 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.62 145.99 1.37 Allowed Pre-proline 0 C--N 1.378 1.841 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.942 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.467 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 55.9 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.797 3.811 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.07 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.102 177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -67.32 -10.64 52.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.41 0.68 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.6 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.319 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.744 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.402 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 t80 . . . . . 0 CA--C 1.492 -1.255 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.808 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 t80 . . . . . 0 N--CA 1.435 -1.175 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.21 -41.42 70.25 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.563 -175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -63.82 -39.14 93.52 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 3.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.9 m170 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.37 -33.46 76.02 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.23 -45.11 77.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.8 m -64.5 140.96 58.92 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.639 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 CA--C 1.495 -1.137 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 19.1 p -70.31 -44.99 67.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 219' ' ' TYR . 16.8 tp -61.48 -43.81 98.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.14 93.78 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.551 HG21 ' HD1' ' A' ' 326' ' ' TYR . 34.7 mt -70.2 -40.07 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.365 0.582 . . . . 0.0 110.801 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.857 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.43 -50.56 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.671 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.857 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.4 -40.92 98.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.588 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.41 96.24 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.01 -49.37 58.33 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.437 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.7 p -70.54 -46.64 63.2 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.5 tp -72.06 -20.57 61.65 Favored 'General case' 0 N--CA 1.432 -1.33 1 O-C-N 116.004 -4.185 . . . . 0.0 109.002 -174.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.97 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.64 107.72 2.84 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.186 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.97 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.17 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.647 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.67 -48.05 94.28 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.861 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.703 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 291' ' ' ILE . 69.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.1 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 64.8 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.6 -39.94 89.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.736 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -41.89 98.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 0.9 OUTLIER -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.844 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.11 -37.71 28.1 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -165.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.663 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.29 -32.71 73.06 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.359 0.664 . . . . 0.0 111.864 -170.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.2 m-20 -54.16 -48.34 94.55 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-O 118.48 -0.772 . . . . 0.0 112.606 -171.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.7 Cg_exo -61.18 -34.66 88.49 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 121.252 1.483 . . . . 0.0 112.707 -176.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.7 mt -69.64 -44.3 70.87 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.743 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.8 mm -95.58 -63.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.248 0.619 . . . . 0.0 112.25 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.551 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.42 -33.32 1.04 Allowed 'General case' 0 C--N 1.353 0.736 0 N-CA-C 119.987 3.329 . . . . 0.0 119.987 -177.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.5 p -86.64 36.2 0.7 Allowed 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.762 1.225 . . . . 0.0 113.014 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.07 -24.38 67.68 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.574 1.15 . . . . 0.0 111.51 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.38 145.99 3.59 Favored Pre-proline 0 C--N 1.377 1.762 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.942 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.69 3.744 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 73' ' ' THR . 35.9 pt . . . . . 0 CA--C 1.497 -1.071 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.178 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -66.02 -10.64 41.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.3 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.799 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 28.2 m -56.5 -40.26 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.307 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -60.96 -32.59 72.12 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.718 -0.793 . . . . 0.0 108.863 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.799 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.694 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.406 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 CA--C 1.493 -1.247 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.587 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -41.42 74.28 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.563 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.656 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.494 -1.21 0 CA-C-O 121.357 0.598 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.56 -39.14 92.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.8 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.863 ' CD1' HD11 ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.69 -32.26 73.72 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -68.32 -46.97 68.79 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 43.6 t -62.52 136.89 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.571 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.495 -1.173 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 25.5 p -70.29 -44.98 67.25 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.974 ' O ' HD23 ' A' ' 275' ' ' LEU . 5.1 tt -61.41 -43.86 98.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.581 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.15 93.69 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 326' ' ' TYR . 29.9 mt -70.14 -40.12 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 117.396 0.598 . . . . 0.0 110.791 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.44 -50.54 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.402 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.706 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.37 -40.95 98.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.364 -1.334 . . . . 0.0 111.653 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.53 96.45 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.216 -0.302 . . . . 0.0 112.44 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -68.95 -49.34 58.81 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 121.822 -0.811 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.75 -58.26 7.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.493 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.54 -46.74 62.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.34 -22.73 63.74 Favored 'General case' 0 N--CA 1.432 -1.351 1 O-C-N 115.983 -4.198 . . . . 0.0 109.007 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.976 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.9 OUTLIER -156.18 113.86 3.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.238 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.976 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.3 m95 135.71 -58.91 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.83 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.861 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . 0.658 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.5 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 314' ' ' ILE . 0.1 OUTLIER -61.07 -39.19 88.95 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.684 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -41.89 99.61 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.433 -0.792 . . . . 0.0 109.183 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.882 ' O ' HG12 ' A' ' 317' ' ' VAL . 2.8 tt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.877 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.463 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.43 -35.62 36.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -166.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 325' ' ' ILE . 11.5 m-85 -68.26 -32.75 73.16 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 123.345 0.658 . . . . 0.0 111.82 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.511 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.2 m-80 -54.09 -48.38 94.32 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.654 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 51.3 Cg_exo -61.19 -34.66 88.38 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.254 1.484 . . . . 0.0 112.715 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.65 -44.29 70.87 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.74 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 321' ' ' PHE . 2.1 mm -94.8 -64.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.237 0.615 . . . . 0.0 112.309 -173.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.61 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -43.44 -30.88 0.6 Allowed 'General case' 0 C--N 1.352 0.699 0 N-CA-C 119.979 3.326 . . . . 0.0 119.979 -177.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 81.7 p -93.03 36.1 1.05 Allowed 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.024 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -67.94 -23.09 65.03 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 124.531 1.132 . . . . 0.0 111.607 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.87 145.99 1.46 Allowed Pre-proline 0 C--N 1.374 1.649 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.461 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.3 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 88.4 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.743 3.777 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.588 HG12 HG13 ' A' ' 54' ' ' VAL . 1.6 mm . . . . . 0 CA--C 1.497 -1.075 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.188 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.722 0.296 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -67.31 -10.64 52.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 61.0 t -56.3 -40.45 66.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.328 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.931 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.819 HD11 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG13 ' A' ' 218' ' ' VAL . 1.9 t80 -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 CA--C 1.493 -1.235 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.679 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.4 t80 . . . . . 0 N--CA 1.437 -1.12 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.43 -41.42 72.91 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . . . . . . 0 CA--C 1.493 -1.221 0 CA-C-O 121.348 0.594 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.76 -39.14 93.23 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.6 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.6 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -65.69 -33.12 75.14 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.98 -45.64 77.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -64.09 131.62 48.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.551 -179.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 CA--C 1.496 -1.129 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 88.0 m -70.3 -44.96 67.25 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 219' ' ' TYR . 6.6 tt -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.631 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.93 -38.21 93.99 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 277' ' ' ILE . 0.3 OUTLIER -70.19 -40.09 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 117.327 0.563 . . . . 0.0 110.805 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.858 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.54 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.673 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' MET . . . . . 0.858 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.47 -40.84 98.17 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.634 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.57 -38.44 96.29 Favored Glycine 0 C--N 1.348 1.218 0 C-N-CA 121.614 -0.327 . . . . 0.0 112.479 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.3 p -68.99 -49.37 58.44 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 117.813 0.806 . . . . 0.0 108.856 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 212' ' ' LEU . 5.5 m-85 -54.05 -57.96 9.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.468 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.8 p -70.53 -46.72 63.07 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.667 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 83.1 mt -72.27 -20.17 61.57 Favored 'General case' 0 N--CA 1.432 -1.347 1 O-C-N 115.92 -4.238 . . . . 0.0 108.97 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' CYS . . . . . 0.891 ' HB2' ' HA2' ' A' ' 315' ' ' GLY . 0.8 OUTLIER -154.99 107.97 2.79 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.321 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.931 ' CZ2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 138.45 -59.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.015 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.74 -48.05 94.15 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.861 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.759 ' HB2' HD22 ' A' ' 311' ' ' LEU . 1.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 291' ' ' ILE . 74.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 6.5 mm-40 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 304' ' ' ARG . 5.3 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' TYR . . . . . 0.539 ' N ' HG23 ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.67 93.72 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 288' ' ' PRO . 94.4 mt -61.25 -38.87 88.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.784 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -41.89 99.42 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ILE . . . . . 0.906 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.49 -40.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.891 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.21 -35.91 92.57 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' TYR . . . . . 0.473 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.97 13.73 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -163.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -68.29 -32.7 73.04 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.343 0.657 . . . . 0.0 111.886 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ASN . . . . . 0.559 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 8.3 m-20 -54.11 -48.44 94.16 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.597 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 62.0 Cg_exo -61.14 -34.7 88.87 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 121.273 1.49 . . . . 0.0 112.707 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.58 -44.31 71.06 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.777 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 277' ' ' ILE . 8.8 mm -97.94 -70.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 123.211 0.604 . . . . 0.0 112.266 -173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' TYR . . . . . 0.441 ' CD1' HG21 ' A' ' 277' ' ' ILE . 2.0 t80 -18.79 -57.49 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 120.03 3.344 . . . . 0.0 120.03 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 13.1 m -98.73 55.52 1.06 Allowed 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 124.738 1.215 . . . . 0.0 113.031 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -68.37 -0.7 5.17 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.485 1.114 . . . . 0.0 111.516 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.73 145.99 0.49 Allowed Pre-proline 0 CA--C 1.5 -0.977 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 64' ' ' LEU . 5.7 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 12.9 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 21.0 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.9 pp -153.67 161.6 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.22 178.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.7 m -141.98 -46.95 0.35 Allowed 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.38 148.79 4.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 58' ' ' ILE . 2.9 tt -61.57 109.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.3 p -173.56 -41.26 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.374 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.76 138.14 58.36 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.098 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -121.1 92.49 3.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.423 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 95.1 mt-10 -139.44 38.04 2.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 22.0 ttt85 77.85 -13.65 0.93 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.424 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -67.55 -10.64 53.72 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.727 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.62 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.727 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.651 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.407 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.654 ' O ' HD12 ' A' ' 135' ' ' ILE . 5.0 m-85 -53.33 -13.59 0.58 Allowed 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.41 ' N ' ' C ' ' A' ' 132' ' ' TYR . . . -75.45 48.65 0.44 Allowed 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.28 -1.368 . . . . 0.0 110.537 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 133' ' ' PHE . 1.3 mp -58.68 -14.31 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 122.696 0.398 . . . . 0.0 111.698 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 4.1 m 76.39 -132.38 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 O-C-N 124.396 1.06 . . . . 0.0 112.478 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 138' ' ' PRO . 0.8 OUTLIER 72.5 160.37 0.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 123.691 0.619 . . . . 0.0 109.962 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 137' ' ' SER . 19.1 Cg_endo -61.97 -31.54 84.26 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.868 2.379 . . . . 0.0 112.296 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.417 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 54.9 p90 -144.74 136.66 25.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.417 ' CB ' ' O ' ' A' ' 139' ' ' PHE . 1.5 mmtm 167.16 -47.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -71.19 -48.42 51.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.35 -41.42 56.65 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 124.597 1.186 . . . . 0.0 110.563 -171.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 75.2 mt 59.04 42.61 18.86 Favored 'General case' 0 CA--C 1.493 -1.235 0 C-N-CA 119.514 -0.875 . . . . 0.0 109.027 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.22 173.53 0.11 Allowed 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -62.82 -39.95 95.87 Favored 'General case' 0 N--CA 1.433 -1.303 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.829 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 90.5 m -149.08 -78.2 0.15 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.667 ' O ' HG12 ' A' ' 152' ' ' VAL . 99.4 mttt -145.24 149.9 35.73 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 117.817 -3.052 . . . . 0.0 109.731 -169.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -70.87 -27.84 64.12 Favored 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.459 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.86 -39.14 93.08 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.1 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.4 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.98 -32.75 74.42 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.61 -45.2 76.13 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.08 135.97 56.86 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -171.46 115.44 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.609 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -59.87 145.36 45.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.0 ttp-105 -84.1 129.61 34.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.644 0.259 . . . . 0.0 110.877 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 88.7 t80 59.81 87.35 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 121.853 0.835 . . . . 0.0 109.156 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -67.51 154.37 41.57 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.426 HG23 ' N ' ' A' ' 243' ' ' GLN . 22.2 m -57.75 -33.66 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.426 ' N ' HG23 ' A' ' 242' ' ' VAL . 0.7 OUTLIER 170.62 -72.92 0.0 OUTLIER 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 179.73 160.7 0.83 Allowed 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.49 152.37 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 63.7 m -136.5 144.11 44.14 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -156.94 149.63 23.51 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.16 -29.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.365 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -152.32 -39.1 0.11 Allowed 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 115.123 -2.631 . . . . 0.0 111.491 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 64.21 41.91 5.81 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 52.3 -169.27 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 124.977 1.311 . . . . 0.0 108.417 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -105.06 -32.48 4.04 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 107.084 -2.406 . . . . 0.0 107.084 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -62.72 -39.56 94.45 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.3 158.23 0.13 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 118.836 -1.146 . . . . 0.0 108.438 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 177.7 -173.51 46.13 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 116.727 -2.654 . . . . 0.0 110.451 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 70.6 t60 76.56 -69.93 0.15 Allowed 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -164.71 166.85 38.22 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -108.91 -28.06 9.35 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 61.25 -179.46 0.11 Allowed 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -83.84 -9.75 58.54 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.9 t -57.63 -44.16 85.34 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 5.1 p -63.92 -29.56 70.72 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -66.11 -39.84 90.25 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.13 67.24 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 116.98 -1.888 . . . . 0.0 110.072 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.33 -72.55 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.644 0 C-N-CA 127.59 2.356 . . . . 0.0 105.883 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.7 p -63.86 -33.11 74.96 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 125.986 2.054 . . . . 0.0 114.366 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . 0.302 0.0 OUTLIER -72.37 -50.2 28.43 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 116.164 -2.214 . . . . 0.0 110.672 -178.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -66.01 -40.32 91.02 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -69.87 -38.52 76.42 Favored 'General case' 0 CA--C 1.49 -1.331 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 7.6 mmtm -63.03 -45.76 90.79 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 116.945 -1.902 . . . . 0.0 108.865 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.27 -46.59 85.73 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.71 -44.03 97.71 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -71.51 -37.84 71.2 Favored 'General case' 0 CA--C 1.495 -1.149 0 O-C-N 121.567 -0.708 . . . . 0.0 111.844 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 3.8 p -70.33 -43.92 69.29 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.21 -42.54 96.57 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.418 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -65.54 -38.13 94.4 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 33.3 mt -70.17 -40.09 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 117.398 0.599 . . . . 0.0 110.817 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.41 -50.59 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.707 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.7 ptm -63.33 -40.97 98.78 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 118.397 -1.321 . . . . 0.0 111.637 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.54 -38.44 96.31 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.657 -0.306 . . . . 0.0 112.477 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 6.5 p -69.01 -49.38 58.26 Favored 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 117.84 0.82 . . . . 0.0 108.81 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.551 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.98 -58.09 8.59 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.5 p -70.51 -46.68 63.18 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.581 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.8 mt -72.04 -20.64 61.66 Favored 'General case' 0 N--CA 1.433 -1.296 1 O-C-N 116.008 -4.182 . . . . 0.0 108.947 -175.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.971 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -156.39 106.74 2.37 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 119.406 -0.918 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.971 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.0 OUTLIER 139.13 -58.75 0.0 OUTLIER 'General case' 0 C--N 1.361 1.066 0 O-C-N 125.213 1.571 . . . . 0.0 111.769 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.95 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.2 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 8.2 mmt85 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.2 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.642 HG12 HD22 ' A' ' 311' ' ' LEU . 95.4 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.67 93.73 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.642 HD22 HG12 ' A' ' 307' ' ' VAL . 6.4 mp -60.71 -39.87 90.14 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.705 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.95 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 4.7 mt -55.18 -44.34 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.376 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.672 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.41 -35.91 92.37 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.468 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.924 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.449 ' ND2' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.69 -38.45 27.75 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.679 ' O ' HG12 ' A' ' 325' ' ' ILE . 9.3 m-85 -68.32 -32.72 73.05 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.334 0.653 . . . . 0.0 111.868 -170.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.514 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.3 m-20 -54.08 -48.44 94.1 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.621 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.514 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 53.4 Cg_exo -61.16 -34.71 88.65 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-N 121.22 1.471 . . . . 0.0 112.691 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.8 mt -69.6 -44.24 71.14 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.28 -63.92 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 C-N-CA 123.153 0.581 . . . . 0.0 112.272 -174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.84 -36.28 1.44 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 120.032 3.345 . . . . 0.0 120.032 -177.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 40.2 m -88.29 40.76 0.97 Allowed 'General case' 0 CA--C 1.495 -1.167 0 C-N-CA 124.745 1.218 . . . . 0.0 113.033 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -71.53 -21.75 61.86 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 124.503 1.121 . . . . 0.0 111.617 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -43.19 145.99 0.91 Allowed Pre-proline 0 C--N 1.375 1.676 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.458 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 91.3 m -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.68 3.737 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 323' ' ' PRO . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 47.5 pt -81.68 164.33 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.067 0 C-N-CA 119.575 -0.85 . . . . 0.0 110.165 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.5 m 45.15 85.56 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.285 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' ' 58' ' ' ILE . . . -86.77 -68.63 0.73 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 62' ' ' GLU . 1.6 mp -132.8 -28.28 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 85.3 m 58.0 17.1 4.15 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.326 -0.55 . . . . 0.0 112.417 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.99 -44.31 2.06 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.009 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -169.64 133.49 1.29 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.674 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.497 ' HB3' HD13 ' A' ' 58' ' ' ILE . 22.4 pt-20 -174.95 170.34 3.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.583 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -103.3 -0.05 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.743 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.68 -10.64 57.48 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.726 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.9 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.621 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.726 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.698 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.3 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.72 -20.77 15.67 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.65 85.78 0.65 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 118.261 -1.376 . . . . 0.0 110.573 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 135' ' ' ILE . 9.0 tt -91.98 22.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 C-N-CA 122.747 0.419 . . . . 0.0 111.712 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 6.3 p 37.97 60.07 1.26 Allowed 'General case' 0 CA--C 1.52 -0.191 0 O-C-N 124.484 1.115 . . . . 0.0 112.538 -176.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.8 t -157.71 136.83 8.15 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -82.26 -9.66 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.95 2.433 . . . . 0.0 112.042 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.87 -11.16 59.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.426 -178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -117.08 -50.25 2.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.255 0.55 . . . . 0.0 111.913 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -62.12 -53.84 49.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -41.42 67.92 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.563 -175.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 145' ' ' LEU . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.506 ' CB ' ' O ' ' A' ' 144' ' ' LEU . 0.2 OUTLIER 80.22 126.6 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.553 -0.859 . . . . 0.0 108.995 -177.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.8 p -63.75 96.26 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.697 ' HG2' HD11 ' A' ' 153' ' ' ILE . 30.3 mmtp 49.02 -162.56 0.04 OUTLIER 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.8 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.5 -52.35 65.58 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 48.5 mmtm -157.37 11.34 0.21 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.73 -171.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.739 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . 72.53 -27.56 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.414 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.585 ' H ' ' C ' ' A' ' 149' ' ' LYS . 61.2 mtt180 -60.7 -39.14 87.42 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 125.313 1.445 . . . . 0.0 107.673 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.261 2.5 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.2 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 42.2 ttp85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.884 ' CD1' HD11 ' A' ' 275' ' ' LEU . 0.9 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.9 -32.67 74.31 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.26 -45.34 76.96 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 237' ' ' GLU . 46.7 t -64.17 134.49 54.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 236' ' ' SER . 56.9 tt0 178.81 135.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.65 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -87.02 -176.7 49.14 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -109.16 17.36 21.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.752 0.31 . . . . 0.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.47 -39.42 93.78 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.866 0.841 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 35.4 p80 -156.88 164.43 38.07 Favored 'General case' 0 CA--C 1.488 -1.428 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 90.4 t -121.18 126.62 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -125.4 117.17 23.13 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -111.04 17.67 20.2 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.5 t 63.02 91.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 48.4 t -60.25 -45.15 94.27 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -178.54 -40.26 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.8 p -149.58 148.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.381 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.44 -39.54 93.65 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 115.118 -2.633 . . . . 0.0 111.443 -178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 74.36 59.28 0.08 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 53.2 t0 51.95 48.35 22.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 124.971 1.308 . . . . 0.0 108.39 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -66.64 147.64 49.88 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 107.135 -2.386 . . . . 0.0 107.135 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -139.52 134.09 31.75 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 12.4 t -148.54 151.59 35.37 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 118.812 -1.155 . . . . 0.0 108.362 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -90.18 4.79 83.01 Favored Glycine 0 N--CA 1.428 -1.849 0 C-N-CA 116.775 -2.631 . . . . 0.0 110.425 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -60.34 -46.48 89.77 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -67.3 145.41 45.97 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 165.76 -56.34 0.0 OUTLIER 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.548 ' O ' ' CB ' ' A' ' 260' ' ' ARG . 83.2 mtt85 -132.1 153.53 50.38 Favored 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.548 ' CB ' ' O ' ' A' ' 259' ' ' ARG . 27.2 ttp85 79.06 -65.87 0.2 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.7 t -57.49 -44.15 84.73 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 9.7 t -63.86 -29.61 70.78 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -66.11 -39.8 90.21 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -30.12 67.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 116.923 -1.911 . . . . 0.0 110.116 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.32 -72.57 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 127.603 2.361 . . . . 0.0 105.89 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.8 -33.16 75.05 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.987 2.054 . . . . 0.0 114.37 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -72.35 -50.23 28.34 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 116.107 -2.237 . . . . 0.0 110.631 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -65.99 -40.38 91.12 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -69.81 -38.45 76.6 Favored 'General case' 0 CA--C 1.49 -1.344 0 C-N-CA 118.79 -1.164 . . . . 0.0 109.321 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -45.73 90.71 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.86 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.6 85.49 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.76 -44.09 97.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -71.45 -37.8 71.37 Favored 'General case' 0 CA--C 1.495 -1.152 0 O-C-N 121.566 -0.709 . . . . 0.0 111.866 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.529 HG22 ' HE1' ' A' ' 326' ' ' TYR . 34.0 p -70.37 -45.02 66.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.884 HD11 ' CD1' ' A' ' 219' ' ' TYR . 4.1 tt -61.6 -43.72 98.33 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.594 HG22 ' N ' ' A' ' 278' ' ' ILE . 0.2 OUTLIER -70.2 -40.06 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 117.407 0.604 . . . . 0.0 110.823 -177.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.863 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.45 -50.57 50.16 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.677 -177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.863 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.4 ptt? -63.34 -40.9 98.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.374 -1.33 . . . . 0.0 111.65 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.64 -38.37 96.14 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 121.627 -0.32 . . . . 0.0 112.49 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 5.3 p -69.04 -49.45 57.45 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 117.822 0.811 . . . . 0.0 108.814 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.612 ' CD2' HD13 ' A' ' 212' ' ' LEU . 6.2 m-85 -54.06 -57.91 9.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.477 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.1 p -70.54 -46.71 63.08 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.632 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.4 tp -72.26 -20.55 61.51 Favored 'General case' 0 N--CA 1.432 -1.346 1 O-C-N 115.926 -4.234 . . . . 0.0 108.997 -174.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.993 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.38 107.93 2.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.309 -178.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.993 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.04 -59.41 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.044 178.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.97 -48.05 93.71 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.684 -0.807 . . . . 0.0 111.861 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 291' ' ' ILE . 72.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.41 HG12 HD22 ' A' ' 311' ' ' LEU . 54.1 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.854 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 307' ' ' VAL . 5.3 mp -60.52 -40.01 89.91 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.786 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.23 -41.89 98.81 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.917 ' O ' HG12 ' A' ' 317' ' ' VAL . 13.6 mm -55.87 -43.31 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.886 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -62.93 -35.91 92.7 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.467 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.917 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -89.7 -23.68 32.66 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -68.27 -32.68 73.02 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.308 0.643 . . . . 0.0 111.899 -172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.495 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 2.5 m120 -54.13 -48.33 94.55 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 118.532 -0.747 . . . . 0.0 112.647 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.495 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 50.2 Cg_exo -61.21 -34.68 88.21 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 CA-C-N 121.254 1.483 . . . . 0.0 112.705 -177.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.3 mt -69.6 -44.32 70.96 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.763 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . . . . . . . . . 14.3 mm -98.41 -64.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 C-N-CA 123.191 0.596 . . . . 0.0 112.3 -174.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.529 ' HE1' HG22 ' A' ' 274' ' ' THR . 49.1 t80 -52.66 -62.09 1.87 Allowed 'General case' 0 C--N 1.353 0.721 0 N-CA-C 120.002 3.334 . . . . 0.0 120.002 -174.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 73.3 m -57.6 81.72 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.748 1.219 . . . . 0.0 112.989 -175.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.469 ' O ' ' C ' ' A' ' 329' ' ' SER . 7.7 mmt180 -117.69 -20.97 8.7 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 124.502 1.121 . . . . 0.0 111.57 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.469 ' C ' ' O ' ' A' ' 328' ' ' ARG . 47.7 t -44.31 145.99 1.27 Allowed Pre-proline 0 C--N 1.386 2.155 0 O-C-N 118.942 -2.349 . . . . 0.0 110.942 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.463 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.7 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.668 ' O ' HG23 ' A' ' 55' ' ' ILE . 3.1 tp -103.3 43.68 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.145 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.8 m -71.33 76.64 0.74 Allowed 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.855 ' HB1' ' SG ' ' A' ' 59' ' ' CYS . . . 50.04 84.74 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.2 tt -56.13 -26.81 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.855 ' SG ' ' HB1' ' A' ' 57' ' ' ALA . 0.9 OUTLIER -45.75 -28.48 1.05 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.382 -0.527 . . . . 0.0 112.283 -179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -104.17 166.47 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.573 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 58.12 83.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.555 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 17.5 mp0 -61.5 -158.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.57 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 5.9 tpt180 77.22 -50.64 0.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.444 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.17 -10.64 55.79 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.719 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 5.1 m -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.613 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.719 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.596 HG23 HD13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.653 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.571 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.596 ' O ' ' HB2' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.584 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.596 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER -24.4 -72.37 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -171.13 100.48 0.21 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 118.291 -1.364 . . . . 0.0 110.549 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.57 -40.18 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 C-N-CA 122.661 0.384 . . . . 0.0 111.662 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 29.2 p -121.24 156.75 31.79 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.458 1.098 . . . . 0.0 112.513 -177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.3 m 45.93 71.39 1.57 Allowed Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 124.375 1.047 . . . . 0.0 109.424 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.34 48.72 1.57 Allowed 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.922 2.415 . . . . 0.0 112.741 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.22 -49.84 76.03 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.217 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -76.61 -28.29 56.08 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.037 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -47.62 -53.72 13.94 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -41.42 69.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.563 -175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.7 tt -53.48 107.19 0.22 Allowed 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.036 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 53.1 m -170.33 -48.51 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -107.71 164.74 11.98 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 120.476 -0.49 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 69.0 m 57.95 66.39 1.13 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.703 ' O ' HG12 ' A' ' 152' ' ' VAL . 59.2 mtmt -56.67 158.44 4.59 Favored 'General case' 0 C--N 1.369 1.434 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.744 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -59.12 -26.61 64.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.488 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -64.64 -39.14 93.17 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -175.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 4.4 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 2.4 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.545 ' CE1' ' CD2' ' A' ' 282' ' ' PHE . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 79.9 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.86 -29.38 68.48 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -69.56 -46.16 67.06 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 70.3 m -63.83 137.03 57.87 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -176.33 132.82 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.705 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -152.27 153.1 24.69 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -135.56 123.25 22.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.781 0.324 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -174.54 94.5 0.08 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.936 0.874 . . . . 0.0 109.162 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -151.82 30.82 0.57 Allowed 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.45 157.16 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 172.15 -54.42 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -158.26 172.98 17.38 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.06 137.22 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 39.1 t -153.84 45.73 0.61 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 54.23 46.6 24.91 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.47 122.77 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.54 151.76 25.22 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 115.029 -2.668 . . . . 0.0 111.446 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -100.28 117.15 33.91 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -62.4 -40.15 95.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.067 1.347 . . . . 0.0 108.433 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -98.97 126.87 9.07 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 107.089 -2.404 . . . . 0.0 107.089 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -127.03 -36.71 2.15 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 90.0 m -133.38 137.07 45.67 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.439 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 85.45 20.36 56.79 Favored Glycine 0 N--CA 1.429 -1.82 0 C-N-CA 116.702 -2.666 . . . . 0.0 110.394 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -65.08 162.98 15.75 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 59.15 -130.7 51.16 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -68.65 154.62 41.58 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -142.79 95.84 2.84 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -150.11 18.71 0.87 Allowed 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 73.7 m -58.85 -44.15 90.93 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 4.6 p -63.86 -29.63 70.8 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -66.14 -39.82 90.12 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -30.14 67.29 Favored 'General case' 0 CA--C 1.491 -1.309 0 C-N-CA 116.958 -1.897 . . . . 0.0 110.116 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.31 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 127.625 2.37 . . . . 0.0 105.856 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -33.14 75.03 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.985 2.053 . . . . 0.0 114.4 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -72.35 -50.19 28.57 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 116.126 -2.229 . . . . 0.0 110.679 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.0 -40.39 91.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -69.85 -38.4 76.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 C-N-CA 118.804 -1.159 . . . . 0.0 109.361 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -63.15 -45.7 90.67 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 116.921 -1.911 . . . . 0.0 108.828 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.61 85.64 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.75 -44.07 97.63 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.42 -37.9 71.44 Favored 'General case' 0 CA--C 1.494 -1.175 0 O-C-N 121.555 -0.715 . . . . 0.0 111.851 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 7.2 p -70.27 -45.01 67.25 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.654 HD23 ' CG ' ' A' ' 219' ' ' TYR . 2.0 tm? -61.51 -43.84 98.14 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.56 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.0 -38.14 93.83 Favored Glycine 0 N--CA 1.433 -1.543 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.68 HG21 ' CD1' ' A' ' 326' ' ' TYR . 1.0 OUTLIER -70.21 -40.09 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-N 117.376 0.588 . . . . 0.0 110.805 -177.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.853 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.55 50.57 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.729 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.853 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.36 -40.94 98.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.36 -1.336 . . . . 0.0 111.626 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.44 96.28 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 122.208 -0.308 . . . . 0.0 112.446 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.5 p -69.06 -49.36 58.16 Favored 'General case' 0 CA--C 1.493 -1.22 0 O-C-N 121.801 -0.823 . . . . 0.0 108.816 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.799 ' CD2' HD13 ' A' ' 212' ' ' LEU . 1.9 m-85 -54.13 -57.92 9.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.491 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.6 p -70.49 -46.69 63.25 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.613 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 9.5 tp -73.44 -19.87 60.86 Favored 'General case' 0 N--CA 1.433 -1.315 1 O-C-N 116.009 -4.182 . . . . 0.0 109.014 -174.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.918 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.63 105.76 2.65 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.119 -178.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.918 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.0 OUTLIER 139.72 -59.59 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.646 179.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.88 -48.05 93.89 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.861 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 5.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 291' ' ' ILE . 71.1 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 16.8 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.872 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 314' ' ' ILE . 5.3 mp -60.9 -39.35 88.98 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.803 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.65 -41.89 99.3 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.92 ' O ' HG12 ' A' ' 317' ' ' VAL . 12.7 mm -56.13 -42.89 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.859 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -63.12 -35.91 92.73 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.474 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.92 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.44 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -72.94 -50.8 11.96 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -164.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -68.33 -32.72 73.04 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 123.337 0.655 . . . . 0.0 111.827 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.517 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.9 m120 -54.15 -48.36 94.49 Favored Pre-proline 0 N--CA 1.436 -1.147 0 CA-C-O 118.484 -0.769 . . . . 0.0 112.629 -171.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 66.2 Cg_exo -61.18 -34.67 88.48 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 CA-C-N 121.265 1.488 . . . . 0.0 112.702 -177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 32.2 mt -69.59 -44.33 71.01 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.759 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.642 ' HB ' HD11 ' A' ' 277' ' ' ILE . 18.7 mm -97.69 -68.52 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 123.176 0.59 . . . . 0.0 112.255 -174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.68 ' CD1' HG21 ' A' ' 277' ' ' ILE . 1.3 t80 -30.71 -39.24 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 119.984 3.327 . . . . 0.0 119.984 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.17 50.8 0.79 Allowed 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 124.755 1.222 . . . . 0.0 113.015 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -70.43 -5.88 31.68 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 124.549 1.14 . . . . 0.0 111.541 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.94 145.99 0.51 Allowed Pre-proline 0 C--N 1.359 0.996 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.479 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.9 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 2.0 t -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 1.8 pt -75.49 105.89 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.146 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 56' ' ' THR . 5.7 t -45.8 140.64 3.41 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -106.21 -60.79 1.6 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 21.0 tt -63.27 -28.9 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 24.6 m 57.87 51.44 9.09 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.352 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -116.77 -26.41 6.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.501 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -86.69 126.92 34.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.632 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 7.8 tt0 -93.63 -149.41 0.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.604 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 86.1 mtt180 73.24 -47.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.611 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.0 -10.64 55.21 Favored 'General case' 0 N--CA 1.441 -0.9 0 O-C-N 120.033 -1.667 . . . . 0.0 114.031 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 143.28 0.35 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.725 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 2.7 p -60.53 -39.59 81.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.141 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.481 -174.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.624 ' N ' HG13 ' A' ' 67' ' ' VAL . 11.7 t -61.44 -32.59 72.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.725 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.708 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.441 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -43.56 102.56 0.03 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.662 ' HB3' ' HD1' ' A' ' 139' ' ' PHE . . . -63.11 156.66 24.37 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.539 -176.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 1.8 pp -123.23 -19.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 C-N-CA 122.701 0.4 . . . . 0.0 111.631 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.512 ' O ' ' C ' ' A' ' 137' ' ' SER . 7.9 p -88.33 -150.72 0.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 O-C-N 124.387 1.055 . . . . 0.0 112.484 -177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -30.96 -61.43 0.26 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.51 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 137' ' ' SER . 17.5 Cg_endo -57.69 144.34 93.19 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.826 2.35 . . . . 0.0 112.191 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.662 ' HD1' ' HB3' ' A' ' 134' ' ' ALA . 99.1 m-85 58.28 -118.98 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.617 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 mttt 172.12 -33.56 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.519 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.6 t80 74.78 -54.23 0.67 Allowed 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -41.42 71.03 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.659 -0.816 . . . . 0.0 110.563 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.01 146.27 14.89 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.7 -163.08 1.06 Allowed 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -58.81 -44.61 90.87 Favored 'General case' 0 N--CA 1.433 -1.277 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.836 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 51.3 t -102.06 -104.17 0.27 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm 53.0 45.15 29.43 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 119.999 -1.688 . . . . 0.0 109.781 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.568 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -161.77 -57.67 0.05 OUTLIER 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.462 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.41 -39.14 92.31 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 167' ' ' LEU 0.26 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.3 tmm_? -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.4 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -65.88 -33.01 74.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.43 -45.42 76.1 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.0 t -64.18 135.91 56.74 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -179.62 140.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.562 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 143.89 59.08 0.02 OUTLIER Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -151.55 146.83 26.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 110.574 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 52.05 34.53 14.18 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.977 0.894 . . . . 0.0 109.191 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -102.66 24.12 11.0 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.71 89.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -125.7 65.06 1.18 Allowed 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 56.56 38.33 29.53 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.34 140.85 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 47.8 t -154.86 148.63 25.51 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 56.03 51.58 11.78 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 26.8 m -59.82 -30.22 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.328 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -81.26 136.03 35.77 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 115.126 -2.63 . . . . 0.0 111.536 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -120.49 -44.99 2.44 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 162.16 -48.02 0.0 OUTLIER 'General case' 0 N--CA 1.432 -1.339 0 C-N-CA 124.991 1.316 . . . . 0.0 108.353 -178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 165.27 -162.4 35.71 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 107.081 -2.408 . . . . 0.0 107.081 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 54.93 40.48 32.02 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 95.4 m -113.53 127.94 56.26 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.432 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.47 72.16 Favored Glycine 0 N--CA 1.428 -1.897 0 C-N-CA 116.647 -2.692 . . . . 0.0 110.457 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -98.44 118.13 34.41 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -129.22 34.83 2.73 Favored Glycine 0 N--CA 1.431 -1.667 0 N-CA-C 107.713 -2.155 . . . . 0.0 107.713 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 73.63 -66.62 0.3 Allowed 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.6 ptt180 -163.53 157.54 19.74 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -173.08 -80.37 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.2 t -58.22 -44.18 88.08 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 5.8 p -63.88 -29.63 70.79 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -66.1 -39.8 90.26 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -30.15 67.28 Favored 'General case' 0 CA--C 1.492 -1.287 0 C-N-CA 116.957 -1.897 . . . . 0.0 110.103 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.3 -72.52 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 127.592 2.357 . . . . 0.0 105.92 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . 0.404 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 1.4 p -63.84 -33.15 75.05 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 125.982 2.051 . . . . 0.0 114.385 -179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.404 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 8.1 mttt -72.34 -50.23 28.36 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 116.111 -2.236 . . . . 0.0 110.634 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.02 -40.36 91.0 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -69.8 -38.46 76.64 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.797 -1.161 . . . . 0.0 109.34 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.476 ' HD3' HG23 ' A' ' 274' ' ' THR . 10.9 tppt? -63.14 -45.74 90.49 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 116.975 -1.89 . . . . 0.0 108.792 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.19 -46.64 85.43 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.1 tp -61.76 -44.04 97.67 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -71.5 -37.88 71.21 Favored 'General case' 0 CA--C 1.496 -1.131 0 O-C-N 121.549 -0.719 . . . . 0.0 111.788 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.476 HG23 ' HD3' ' A' ' 270' ' ' LYS . 25.6 p -70.24 -44.98 67.42 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.568 HD13 ' CB ' ' A' ' 219' ' ' TYR . 15.4 tp -61.45 -43.88 98.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.553 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.06 -38.1 93.72 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.553 HG21 ' HD1' ' A' ' 326' ' ' TYR . 40.3 mt -70.2 -40.12 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 117.384 0.592 . . . . 0.0 110.802 -177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.861 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.36 -50.62 50.17 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.661 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.861 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.8 ptt? -63.42 -40.87 98.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.66 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.44 96.32 Favored Glycine 0 C--N 1.349 1.265 0 C-N-CA 121.655 -0.307 . . . . 0.0 112.498 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.02 -49.46 57.49 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.512 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.6 m-85 -54.15 -57.83 9.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.498 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.46 -46.73 63.23 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 81.5 mt -71.55 -21.42 61.89 Favored 'General case' 0 N--CA 1.432 -1.348 1 O-C-N 115.892 -4.255 . . . . 0.0 108.962 -175.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.927 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.37 106.79 2.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.249 -178.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.927 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.3 OUTLIER 138.72 -58.59 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.537 179.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.82 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.818 -0.753 . . . . 0.0 111.861 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.699 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 291' ' ' ILE . 59.9 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.786 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.6 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 304' ' ' ARG . 4.4 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.541 ' N ' ' CG2' ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 288' ' ' PRO . 0.0 OUTLIER -60.59 -39.96 90.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.691 -179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -41.89 98.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.898 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.61 -40.53 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.802 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.36 -35.91 92.55 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.47 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.898 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.435 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.77 -38.33 27.77 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -165.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.61 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.3 -32.8 73.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 123.363 0.665 . . . . 0.0 111.811 -170.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.516 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.0 m-20 -54.1 -48.32 94.5 Favored Pre-proline 0 N--CA 1.436 -1.143 0 CA-C-O 118.499 -0.762 . . . . 0.0 112.665 -171.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.516 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 54.7 Cg_exo -61.19 -34.7 88.39 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 121.246 1.481 . . . . 0.0 112.724 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.4 mt -69.56 -44.29 71.19 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.791 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 321' ' ' PHE . 3.1 mm -95.55 -63.56 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 123.202 0.601 . . . . 0.0 112.233 -173.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.553 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.65 -38.51 3.11 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -177.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 46.0 m -87.17 42.77 1.05 Allowed 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 124.754 1.222 . . . . 0.0 113.04 -177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -73.26 -20.92 60.73 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 124.553 1.141 . . . . 0.0 111.555 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -42.86 145.99 0.82 Allowed Pre-proline 0 C--N 1.378 1.83 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.434 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.5 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 1.7 m -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.76 3.787 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.754 ' C ' ' O ' ' A' ' 54' ' ' VAL . 56.9 mt 5.77 -95.06 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.497 -1.085 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.213 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.663 ' N ' HG22 ' A' ' 55' ' ' ILE . 88.5 m 64.9 -70.49 0.09 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 55' ' ' ILE . . . 45.2 -155.45 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.467 ' HA ' HE22 ' A' ' 65' ' ' GLN . 24.7 pt -87.2 25.41 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 8.9 t -82.1 -69.44 0.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.242 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -130.78 -177.31 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.664 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 61.33 92.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.566 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -64.66 -19.33 65.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.384 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 75.8 mtp85 -67.91 -46.58 71.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.659 ' CB ' HG21 ' A' ' 56' ' ' THR . 6.9 mp -72.33 -10.64 60.05 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.467 HE22 ' HA ' ' A' ' 58' ' ' ILE . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 64.0 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.289 -177.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.415 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.52 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -39.59 -32.74 0.14 Allowed 'General case' 0 CA--C 1.492 -1.277 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 133' ' ' PHE . . . 67.21 151.34 0.07 Allowed 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 118.239 -1.384 . . . . 0.0 110.542 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 42.1 pt -132.56 23.95 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 C-N-CA 122.711 0.404 . . . . 0.0 111.72 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.8 m -38.64 145.62 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 O-C-N 124.396 1.06 . . . . 0.0 112.533 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.634 ' N ' ' HD2' ' A' ' 138' ' ' PRO . 0.7 OUTLIER -52.44 -56.34 23.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -177.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 137' ' ' SER . 50.8 Cg_exo -29.99 -67.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.775 2.983 . . . . 0.0 113.142 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 52.2 p90 -179.45 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.851 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 139' ' ' PHE . 25.6 ttpt 78.94 52.97 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.419 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -177.44 -55.84 0.01 OUTLIER 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.04 -41.42 74.26 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.563 -176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 9.1 mp -79.51 130.66 35.6 Favored 'General case' 0 CA--C 1.493 -1.233 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.062 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 75.3 p -116.18 31.05 6.96 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 63.9 mttp 63.21 30.53 15.86 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.743 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 44.8 t -129.16 -38.42 1.61 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -79.9 86.43 5.43 Favored 'General case' 0 N--CA 1.432 -1.356 0 O-C-N 116.38 -3.95 . . . . 0.0 109.778 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -158.57 -59.71 0.07 Allowed 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.539 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -61.96 -39.14 91.1 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.0 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.0 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.35 -33.36 75.78 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -67.31 -45.44 76.5 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 45.8 t -64.49 137.87 58.1 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -169.27 116.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.664 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -85.79 -178.77 50.19 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -129.09 127.97 42.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.863 0.363 . . . . 0.0 110.699 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -130.19 148.08 51.99 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 121.88 0.848 . . . . 0.0 109.202 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -100.27 111.74 24.03 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.55 29.3 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -61.23 -41.2 96.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -103.01 130.93 50.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 85.3 t -123.81 123.8 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 72.8 m -100.43 -33.03 10.52 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -130.44 149.6 52.04 Favored 'General case' 0 CA--C 1.489 -1.369 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 77.1 t -109.51 122.77 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.333 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -149.05 153.01 37.23 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 115.156 -2.618 . . . . 0.0 111.432 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -106.04 123.26 47.71 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -161.8 -179.5 7.26 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.004 1.322 . . . . 0.0 108.371 -178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 92.95 -59.54 2.4 Favored Glycine 0 N--CA 1.431 -1.656 0 N-CA-C 107.133 -2.387 . . . . 0.0 107.133 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -62.26 -39.89 94.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 62.3 p -135.9 157.5 46.7 Favored 'General case' 0 N--CA 1.429 -1.523 0 C-N-CA 118.787 -1.165 . . . . 0.0 108.44 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 70.3 23.89 77.06 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 116.714 -2.66 . . . . 0.0 110.426 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -68.13 147.52 52.19 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -62.02 -41.71 99.69 Favored Glycine 0 N--CA 1.431 -1.689 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -102.49 149.09 24.74 Favored 'General case' 0 CA--C 1.49 -1.352 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.7 mmt180 -102.17 21.05 15.56 Favored 'General case' 0 CA--C 1.486 -1.498 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.34 -38.84 92.73 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 105.805 -1.924 . . . . 0.0 105.805 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.9 t -57.87 -44.21 86.48 Favored 'General case' 0 CA--C 1.491 -1.309 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 61.6 m -63.83 -29.63 70.8 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -66.22 -39.71 89.79 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.17 67.28 Favored 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 116.914 -1.914 . . . . 0.0 110.069 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.23 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.633 0 C-N-CA 127.624 2.37 . . . . 0.0 105.885 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . 0.433 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.79 -33.22 75.18 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 126.005 2.066 . . . . 0.0 114.357 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.433 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 7.5 pttt -72.3 -50.28 28.22 Favored 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 116.172 -2.211 . . . . 0.0 110.641 -178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -65.98 -40.39 91.16 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -69.83 -38.46 76.53 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 118.833 -1.147 . . . . 0.0 109.312 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -63.13 -45.72 90.61 Favored 'General case' 0 N--CA 1.432 -1.365 0 C-N-CA 116.977 -1.889 . . . . 0.0 108.813 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.25 -46.53 85.81 Favored 'General case' 0 CA--C 1.5 -0.942 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.81 -44.06 97.62 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.424 ' O ' HD12 ' A' ' 277' ' ' ILE . 14.4 mmtp -71.49 -37.84 71.25 Favored 'General case' 0 CA--C 1.495 -1.15 0 O-C-N 121.586 -0.696 . . . . 0.0 111.831 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.5 p -70.3 -45.0 67.17 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.661 HD13 ' CB ' ' A' ' 219' ' ' TYR . 14.0 tp -61.49 -43.81 98.21 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.606 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.05 93.7 Favored Glycine 0 N--CA 1.432 -1.579 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' A' ' 326' ' ' TYR . 20.0 mt -70.26 -40.08 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 CA-C-N 117.394 0.597 . . . . 0.0 110.789 -177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.41 -50.52 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.421 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.724 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.2 ptt? -63.37 -40.93 98.6 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 118.411 -1.316 . . . . 0.0 111.662 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.62 -38.4 96.2 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 121.604 -0.332 . . . . 0.0 112.461 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.529 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.6 p -69.02 -49.39 58.04 Favored 'General case' 0 CA--C 1.494 -1.184 0 O-C-N 121.789 -0.83 . . . . 0.0 108.804 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.599 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.08 -57.96 9.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.494 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 62.8 p -70.54 -46.72 63.04 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.3 tp -69.68 -22.35 63.44 Favored 'General case' 0 N--CA 1.432 -1.35 1 O-C-N 115.949 -4.219 . . . . 0.0 109.025 -176.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 1.021 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -155.59 117.59 4.09 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.958 -178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 1.021 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 2.4 m95 131.88 -59.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.008 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.81 -48.05 94.02 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.861 -176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 4.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 43.4 mt-10 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.488 HG12 HD22 ' A' ' 311' ' ' LEU . 55.2 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.886 ' O ' HG22 ' A' ' 314' ' ' ILE . 6.1 mp -62.03 -37.42 84.87 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.793 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -41.89 97.51 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 120.898 -1.126 . . . . 0.0 109.183 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 3.4 tp -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.946 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.61 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -79.03 -35.5 30.55 Favored Glycine 0 N--CA 1.439 -1.152 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -165.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 325' ' ' ILE . 5.4 m-85 -68.3 -32.74 73.1 Favored 'General case' 0 CA--C 1.497 -1.065 0 C-N-CA 123.339 0.656 . . . . 0.0 111.834 -171.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 326' ' ' TYR . 3.2 m-20 -54.09 -48.36 94.38 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.628 -171.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.0 Cg_exo -61.2 -34.71 88.26 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.284 1.494 . . . . 0.0 112.695 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.8 mt -69.59 -44.27 71.11 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 120.269 -0.573 . . . . 0.0 109.772 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.9 mm -90.73 -61.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 C-N-CA 123.236 0.614 . . . . 0.0 112.276 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.533 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -48.59 -22.1 0.7 Allowed 'General case' 0 C--N 1.353 0.746 0 N-CA-C 119.965 3.32 . . . . 0.0 119.965 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 67.5 m -83.05 19.53 1.4 Allowed 'General case' 0 CA--C 1.494 -1.198 0 C-N-CA 124.752 1.221 . . . . 0.0 113.072 -177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 329' ' ' SER . 0.8 OUTLIER -57.59 -33.65 68.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 124.494 1.118 . . . . 0.0 111.55 -177.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.58 145.99 3.89 Favored Pre-proline 0 C--N 1.378 1.819 0 C-N-CA 115.959 -2.297 . . . . 0.0 110.942 -174.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.474 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.713 3.758 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.528 ' N ' HG13 ' A' ' 54' ' ' VAL . 33.6 mm -158.8 133.03 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.167 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 HG22 ' A' ' 52' ' ' VAL . 30.8 p -115.49 -34.47 4.9 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -178.81 161.21 1.21 Allowed 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 58' ' ' ILE . 9.3 tp -66.6 131.47 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 94.0 m -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.375 -0.53 . . . . 0.0 112.358 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -75.84 96.87 3.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.602 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -139.38 157.54 45.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.583 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -131.66 56.76 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.566 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' HB2' HD12 ' A' ' 64' ' ' LEU . 0.8 OUTLIER -158.72 -70.0 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.568 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.38 -10.64 56.47 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 56.9 t -56.24 -40.5 65.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.363 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.655 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.763 HD11 ' CD1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 133' ' ' PHE . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.526 ' O ' ' C ' ' A' ' 133' ' ' PHE . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.804 ' O ' ' C ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -27.38 130.85 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 175.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.804 ' C ' ' O ' ' A' ' 133' ' ' PHE . . . -11.08 104.6 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.549 -176.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.522 ' O ' ' CB ' ' A' ' 136' ' ' CYS . 0.7 OUTLIER -97.15 101.65 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 C-N-CA 122.69 0.396 . . . . 0.0 111.621 -177.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 135' ' ' ILE . 5.3 p 156.32 -169.83 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.507 1.13 . . . . 0.0 112.442 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.35 164.88 0.18 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 110.632 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_exo -42.81 96.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.821 2.347 . . . . 0.0 112.011 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -150.79 124.37 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.527 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm 52.51 27.48 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.582 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.549 ' CG ' ' CE1' ' A' ' 133' ' ' PHE . 0.4 OUTLIER -112.72 -51.85 2.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -41.42 64.75 Favored 'General case' 0 CA--C 1.494 -1.176 0 O-C-N 125.793 1.933 . . . . 0.0 110.563 -173.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.43 107.31 9.77 Favored 'General case' 0 N--CA 1.434 -1.248 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.067 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 90.8 m -132.79 133.25 43.17 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt 61.98 -166.72 0.21 Allowed 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.776 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 16.2 p -65.94 156.38 33.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.51 0.671 . . . . 0.0 111.738 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.692 ' O ' HG12 ' A' ' 152' ' ' VAL . 87.6 tttt -178.94 -29.23 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.715 -1.129 . . . . 0.0 110.133 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -67.97 -36.74 80.58 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.512 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -66.38 -39.14 88.91 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -173.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 149' ' ' LYS . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 0.7 OUTLIER -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.545 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.441 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.921 ' HB2' ' HG ' ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.43 ' N ' ' CG ' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.88 -32.24 73.85 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.9 mttt -68.76 -44.44 73.72 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 31.4 t -78.62 83.16 4.82 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -148.48 91.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.535 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 176.65 -169.07 41.4 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -91.38 126.59 36.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.575 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -78.16 146.02 35.31 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 121.892 0.853 . . . . 0.0 109.191 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -66.61 158.48 29.8 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.53 -54.38 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -172.12 -167.46 0.48 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.33 41.46 13.04 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.76 -54.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.2 p -70.6 160.91 31.66 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -87.99 -74.95 0.43 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 71.4 t -120.99 -57.08 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -81.3 145.61 30.81 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 115.126 -2.629 . . . . 0.0 111.475 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -130.17 144.73 51.52 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -61.68 -40.24 94.29 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.035 1.334 . . . . 0.0 108.411 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 174.19 179.06 44.57 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 95.8 mtm-85 -96.69 -32.08 12.36 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 58.5 p -136.54 160.25 39.33 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.44 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 146.24 35.71 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 116.792 -2.623 . . . . 0.0 110.489 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -64.19 -40.01 95.19 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.31 148.56 21.97 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 107.662 -2.175 . . . . 0.0 107.662 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -157.37 162.23 39.05 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 65.5 ttp85 54.36 37.76 28.18 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -102.75 -34.43 9.03 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 47.7 t -57.68 -44.16 85.57 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.741 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 12.2 t -63.85 -29.63 70.8 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 31.2 tptt -66.12 -39.81 90.18 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 -30.14 67.25 Favored 'General case' 0 CA--C 1.492 -1.279 0 C-N-CA 116.899 -1.92 . . . . 0.0 110.133 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.25 -72.52 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 127.608 2.363 . . . . 0.0 105.927 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.85 -33.2 75.15 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 125.973 2.046 . . . . 0.0 114.365 -179.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 266' ' ' CYS . 9.4 mttt -72.34 -50.19 28.66 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 116.135 -2.226 . . . . 0.0 110.671 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.03 -40.3 90.92 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -69.91 -38.42 76.28 Favored 'General case' 0 CA--C 1.49 -1.353 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.302 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.526 ' HE3' HG23 ' A' ' 274' ' ' THR . 0.0 OUTLIER -63.11 -45.72 90.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 C-N-CA 116.924 -1.911 . . . . 0.0 108.853 -179.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.18 -46.64 85.41 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.79 -44.05 97.64 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -71.44 -37.86 71.38 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 121.582 -0.699 . . . . 0.0 111.825 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.526 HG23 ' HE3' ' A' ' 270' ' ' LYS . 24.5 p -70.27 -45.01 67.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.921 ' HG ' ' HB2' ' A' ' 219' ' ' TYR . 5.0 mp -61.56 -43.77 98.26 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.583 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.99 -38.19 93.89 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.562 HG21 ' HD1' ' A' ' 326' ' ' TYR . 42.4 mt -70.15 -40.13 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.403 0.601 . . . . 0.0 110.78 -177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.864 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.34 -50.66 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.702 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.864 ' N ' HG22 ' A' ' 278' ' ' ILE . 11.6 ptt? -63.35 -40.95 98.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 118.373 -1.331 . . . . 0.0 111.632 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.53 -38.46 96.34 Favored Glycine 0 C--N 1.348 1.236 0 C-N-CA 121.621 -0.323 . . . . 0.0 112.456 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.1 p -69.0 -49.39 58.25 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-N 117.846 0.823 . . . . 0.0 108.848 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.534 ' CD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.06 -57.92 9.26 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.549 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.2 p -70.53 -46.66 63.18 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.492 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 80.8 mt -71.04 -21.5 62.26 Favored 'General case' 0 N--CA 1.433 -1.31 1 O-C-N 115.965 -4.209 . . . . 0.0 109.003 -175.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.915 ' HB3' ' O ' ' A' ' 314' ' ' ILE . 0.8 OUTLIER -154.67 109.13 2.99 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.665 -0.814 . . . . 0.0 111.167 -178.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.875 ' HA ' ' HE3' ' A' ' 286' ' ' TRP . 0.0 OUTLIER 137.09 -59.1 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.683 179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.58 -48.05 94.47 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.861 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.453 HG13 ' NE2' ' A' ' 299' ' ' GLN . 68.8 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.655 ' HG3' HD12 ' A' ' 302' ' ' LEU . 9.4 pm0 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 299' ' ' GLN . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 1.8 mp0 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.819 ' O ' HG12 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.96 -39.26 88.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.776 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -41.89 99.37 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.915 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 8.4 mm -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.835 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.472 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.62 -37.06 31.59 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -165.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.697 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.3 m-85 -68.22 -32.76 73.2 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 122.097 -0.649 . . . . 0.0 111.902 -170.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.4 m-80 -54.06 -48.37 94.27 Favored Pre-proline 0 N--CA 1.436 -1.158 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.66 -171.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.8 Cg_exo -61.19 -34.66 88.42 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 121.22 1.471 . . . . 0.0 112.697 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.1 mt -69.63 -44.32 70.87 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.746 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.7 mm -95.51 -64.18 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 123.216 0.606 . . . . 0.0 112.27 -173.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.562 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -44.53 -33.14 1.64 Allowed 'General case' 0 C--N 1.352 0.715 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -177.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 75.1 m -89.52 39.06 0.93 Allowed 'General case' 0 CA--C 1.494 -1.186 0 C-N-CA 124.719 1.208 . . . . 0.0 113.071 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -69.04 -22.6 64.04 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.532 1.133 . . . . 0.0 111.549 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -45.25 145.99 1.68 Allowed Pre-proline 0 C--N 1.369 1.418 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.46 -56.46 13.19 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.191 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.84 70.34 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.783 3.802 . . . . 0.0 109.262 -173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 3.2 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.758 HG21 HG23 ' A' ' 73' ' ' THR . 47.5 pt -130.51 157.29 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.197 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.545 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 0.2 OUTLIER 68.34 -167.49 0.19 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 56' ' ' THR . . . 73.7 64.62 0.09 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 59' ' ' CYS . 59.5 mt 64.71 148.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.436 ' N ' HG22 ' A' ' 58' ' ' ILE . 79.9 m -118.6 137.51 53.21 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.345 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -131.21 152.66 50.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.724 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.69 100.29 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.444 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -129.08 -178.73 4.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.668 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -95.3 5.91 50.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.455 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -68.11 -10.64 55.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.31 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.796 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.1 t -56.45 -40.25 66.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.911 -1.04 . . . . 0.0 112.34 -177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.04 -32.59 72.2 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.796 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.623 ' HZ ' ' H ' ' A' ' 150' ' ' ALA . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.758 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.619 HG12 ' O ' ' A' ' 114' ' ' VAL . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.452 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.413 ' HB2' HG13 ' A' ' 218' ' ' VAL . 2.7 t80 -54.13 -48.99 70.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -78.03 -84.89 0.07 Allowed 'General case' 0 CA--C 1.491 -1.32 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . 47.98 -162.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.306 -1.358 . . . . 0.0 110.512 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 136' ' ' CYS . 0.3 OUTLIER -52.26 162.73 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 122.679 0.392 . . . . 0.0 111.642 179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.619 ' H ' HG22 ' A' ' 135' ' ' ILE . 9.1 p 44.54 -114.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.2 0 O-C-N 124.393 1.058 . . . . 0.0 112.479 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.24 166.55 0.13 Allowed Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 123.332 0.395 . . . . 0.0 110.361 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -55.34 -34.26 88.12 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.948 2.432 . . . . 0.0 112.066 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -91.56 -87.83 0.2 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.719 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 mttt 173.86 169.83 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.812 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -121.47 -58.36 1.77 Allowed 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -41.42 81.22 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.563 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.69 HD23 ' SG ' ' A' ' 148' ' ' CYS . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.686 ' C ' ' O ' ' A' ' 144' ' ' LEU . 1.7 tt 20.81 68.31 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.0 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.5 m -139.28 -74.16 0.37 Allowed 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -94.98 -3.74 47.94 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.69 ' SG ' HD23 ' A' ' 144' ' ' LEU . 90.4 m -62.18 -40.78 97.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -168.42 116.22 0.69 Allowed 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 116.693 -3.754 . . . . 0.0 109.799 -173.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.623 ' H ' ' HZ ' ' A' ' 71' ' ' PHE . . . -166.96 161.48 15.05 Favored 'General case' 0 CA--C 1.494 -1.194 0 C-N-CA 119.444 -0.903 . . . . 0.0 110.468 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -59.18 -39.14 81.63 Favored 'General case' 0 C--N 1.301 -1.505 2 O-C-N 129.642 4.339 . . . . 0.0 107.673 176.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 2.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.5 m80 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 1.7 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.42 HD12 HG22 ' A' ' 254' ' ' THR . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.496 HG21 ' HA2' ' A' ' 255' ' ' GLY . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.42 -33.56 76.24 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.64 -45.29 75.77 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 46.2 t -63.83 136.09 57.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -173.88 130.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.543 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -158.21 177.73 34.78 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -124.93 147.62 48.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.671 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 59.66 -179.48 0.09 Allowed 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.926 0.869 . . . . 0.0 109.183 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 66.08 56.02 0.87 Allowed 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.3 p -137.49 143.17 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -72.15 142.81 49.11 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -68.31 135.79 52.44 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.51 156.57 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.57 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.4 p -71.67 158.99 35.18 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 62.94 170.76 0.14 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 248' ' ' VAL . 8.6 p -151.9 139.23 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.399 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -81.97 134.36 35.37 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 115.105 -2.638 . . . . 0.0 111.458 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -63.76 -40.98 98.01 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -163.06 176.53 9.99 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 125.079 1.352 . . . . 0.0 108.43 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -149.5 150.62 22.74 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 107.101 -2.4 . . . . 0.0 107.101 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 62.8 ttm-85 -108.63 -65.84 1.1 Allowed 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.42 HG22 HD12 ' A' ' 230' ' ' LEU . 47.4 m -133.36 136.1 45.14 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.434 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . 0.496 ' HA2' HG21 ' A' ' 233' ' ' ILE . . . 97.37 136.86 9.3 Favored Glycine 0 N--CA 1.428 -1.837 0 C-N-CA 116.737 -2.649 . . . . 0.0 110.419 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -108.47 -36.65 6.16 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 58.31 51.17 60.16 Favored Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.631 -2.187 . . . . 0.0 107.631 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -58.77 -49.63 76.95 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -153.18 157.17 39.9 Favored 'General case' 0 CA--C 1.487 -1.472 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 63.71 17.41 10.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.0 t -60.23 -44.22 95.37 Favored 'General case' 0 N--CA 1.432 -1.352 0 O-C-N 120.857 -1.152 . . . . 0.0 108.086 -177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 4.9 p -63.82 -29.62 70.8 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -66.14 -39.8 90.13 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.1 67.18 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 116.913 -1.915 . . . . 0.0 110.119 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.33 -72.55 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 127.605 2.362 . . . . 0.0 105.884 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . 0.432 ' SG ' ' N ' ' A' ' 267' ' ' LYS . 0.5 OUTLIER -63.8 -33.12 74.97 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 125.949 2.031 . . . . 0.0 114.429 -179.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . 0.552 ' HE2' HD12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -72.42 -50.16 28.41 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 116.141 -2.224 . . . . 0.0 110.655 -178.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.08 -40.31 90.75 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 54.5 m-70 -69.83 -38.47 76.55 Favored 'General case' 0 CA--C 1.49 -1.332 0 C-N-CA 118.791 -1.164 . . . . 0.0 109.331 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -63.07 -45.73 90.79 Favored 'General case' 0 N--CA 1.432 -1.363 0 C-N-CA 116.947 -1.901 . . . . 0.0 108.839 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.61 85.58 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -44.08 97.61 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.47 -37.86 71.3 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 121.555 -0.716 . . . . 0.0 111.82 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 21.0 p -70.32 -44.95 67.21 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.914 HD23 ' N ' ' A' ' 276' ' ' GLY . 0.1 OUTLIER -61.53 -43.82 98.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.592 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.914 ' N ' HD23 ' A' ' 275' ' ' LEU . . . -66.04 -38.12 93.77 Favored Glycine 0 N--CA 1.432 -1.616 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.627 HG21 ' CD1' ' A' ' 326' ' ' TYR . 23.1 mt -70.17 -40.11 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 CA-C-N 117.389 0.595 . . . . 0.0 110.813 -177.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.4 -50.6 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.666 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 14.8 ptt? -63.32 -40.96 98.79 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.391 -1.323 . . . . 0.0 111.647 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.6 -38.38 96.18 Favored Glycine 0 C--N 1.348 1.239 0 C-N-CA 121.606 -0.33 . . . . 0.0 112.492 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -69.05 -49.36 58.15 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.566 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.0 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.478 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.0 p -70.51 -46.7 63.18 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.472 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 84.3 mt -68.54 -23.07 64.47 Favored 'General case' 0 N--CA 1.432 -1.336 1 O-C-N 115.966 -4.209 . . . . 0.0 108.975 -176.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 1.066 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 1.3 p -156.87 115.52 3.32 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.257 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 1.066 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 3.0 m95 135.2 -59.22 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.609 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.33 -48.05 94.94 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.992 -0.683 . . . . 0.0 111.861 -176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.711 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 291' ' ' ILE . 68.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.4 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.0 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.83 ' O ' HG13 ' A' ' 314' ' ' ILE . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.82 -39.5 89.25 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.751 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -41.89 99.27 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.883 ' O ' ' CB ' ' A' ' 285' ' ' CYS . 65.8 mt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.916 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.655 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.12 -37.08 29.69 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -165.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.565 ' O ' HG12 ' A' ' 325' ' ' ILE . 7.1 m-85 -68.21 -32.77 73.22 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.329 0.652 . . . . 0.0 111.872 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.528 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 3.5 m-20 -54.04 -48.45 94.0 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.639 -171.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 52.6 Cg_exo -61.14 -34.72 88.81 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 CA-C-N 121.258 1.485 . . . . 0.0 112.666 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.5 mt -69.59 -44.34 70.98 Favored 'General case' 0 N--CA 1.433 -1.319 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.728 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 321' ' ' PHE . 4.6 mm -93.31 -63.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.211 0.604 . . . . 0.0 112.255 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.627 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -42.98 -34.39 0.98 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 119.988 3.329 . . . . 0.0 119.988 -177.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 79.1 p -88.61 35.93 0.78 Allowed 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 124.717 1.207 . . . . 0.0 113.009 -177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -67.37 -24.16 65.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 124.51 1.124 . . . . 0.0 111.597 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.62 145.99 1.37 Allowed Pre-proline 0 C--N 1.378 1.841 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.942 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.467 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.0 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 55.9 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.797 3.811 . . . . 0.0 109.262 -173.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' OG1' ' A' ' 56' ' ' THR . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -156.61 133.31 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.102 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.551 ' OG1' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 161.94 -85.78 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 58' ' ' ILE . . . -94.95 168.01 11.05 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.404 ' C ' ' O ' ' A' ' 57' ' ' ALA . 5.7 mt 40.84 51.38 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.4 p -75.97 43.06 0.26 Allowed 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.354 -0.539 . . . . 0.0 112.254 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -74.17 57.4 0.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.431 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -45.58 100.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.671 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' ARG . 75.8 mm-40 -77.98 83.02 4.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.619 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 20.7 ttm180 78.18 -4.13 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.548 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -67.32 -10.64 52.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.41 0.68 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.787 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 59.6 t -56.32 -40.44 66.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.856 -1.065 . . . . 0.0 112.319 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.1 -32.59 72.26 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.787 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 70' ' ' TYR . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.744 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.402 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.439 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 2.6 t80 -72.13 105.95 4.16 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 133' ' ' PHE . . . 63.53 117.24 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.519 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.405 ' N ' HD12 ' A' ' 135' ' ' ILE . 0.1 OUTLIER -142.72 -57.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 C-N-CA 122.735 0.414 . . . . 0.0 111.715 -178.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . 0.424 ' SG ' ' N ' ' A' ' 137' ' ' SER . 14.6 p -76.14 -37.71 57.66 Favored 'General case' 0 CA--C 1.52 -0.194 0 O-C-N 124.381 1.05 . . . . 0.0 112.523 -174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.424 ' N ' ' SG ' ' A' ' 136' ' ' CYS . 60.0 m -141.55 160.52 56.39 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.855 0.722 . . . . 0.0 109.838 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -62.33 -13.97 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.027 2.485 . . . . 0.0 112.472 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -47.07 140.66 4.82 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.002 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.71 49.33 12.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.922 0.391 . . . . 0.0 111.15 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -144.77 -54.85 0.32 Allowed 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.21 -41.42 70.25 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.563 -175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 131.72 41.84 Favored 'General case' 0 CA--C 1.492 -1.272 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.034 -178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -153.17 155.02 35.91 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt 60.06 27.1 16.5 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 120.471 -0.492 . . . . 0.0 109.729 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 76.1 m 49.14 45.04 23.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.416 177.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 150' ' ' ALA . 41.6 ttmt -60.3 127.5 32.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.265 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.557 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . 175.44 -31.2 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.135 0.493 . . . . 0.0 110.202 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -63.82 -39.14 93.52 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 5.4 tt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 3.4 mm? -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.9 m170 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.543 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 2.1 p90 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -65.37 -33.46 76.02 Favored 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -67.23 -45.11 77.76 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.8 m -64.5 140.96 58.92 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -176.95 122.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.639 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -70.64 153.75 51.79 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 31.4 tpt180 -114.97 126.74 55.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.869 0.366 . . . . 0.0 110.637 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -129.13 144.47 51.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 121.902 0.858 . . . . 0.0 109.18 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 31.8 p80 -143.98 32.07 1.26 Allowed 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.82 137.23 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 57.17 32.89 22.48 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -88.67 177.5 6.73 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -151.36 63.96 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.647 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.63 -171.98 0.11 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -111.07 110.58 21.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 35.1 m -134.24 157.33 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.38 -178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -81.28 137.02 35.83 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 115.06 -2.656 . . . . 0.0 111.429 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -137.32 124.21 21.35 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -117.18 13.34 14.67 Favored 'General case' 0 CA--C 1.49 -1.362 0 C-N-CA 125.051 1.34 . . . . 0.0 108.335 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.81 157.56 51.62 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 107.07 -2.412 . . . . 0.0 107.07 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 8.0 ppt_? -153.25 157.97 40.98 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 12.6 t -152.57 153.45 33.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 C-N-CA 118.914 -1.114 . . . . 0.0 108.43 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -179.47 177.28 48.2 Favored Glycine 0 N--CA 1.428 -1.867 0 C-N-CA 116.788 -2.625 . . . . 0.0 110.438 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -156.82 143.48 18.43 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 59.19 -129.04 48.79 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -149.65 159.65 44.16 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -143.34 -71.67 0.3 Allowed 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -150.23 -41.89 0.13 Allowed 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.2 t -57.87 -44.21 86.49 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 49.7 m -63.83 -29.6 70.77 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -66.15 -39.74 90.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -30.17 67.28 Favored 'General case' 0 CA--C 1.491 -1.297 0 C-N-CA 116.928 -1.909 . . . . 0.0 110.112 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.21 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 127.649 2.38 . . . . 0.0 105.9 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 15.2 p -63.83 -33.15 75.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 126.036 2.085 . . . . 0.0 114.396 -179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 20.3 pttt -72.4 -50.21 28.16 Favored 'General case' 0 CA--C 1.493 -1.232 0 C-N-CA 116.087 -2.245 . . . . 0.0 110.654 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -65.94 -40.37 91.3 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -69.82 -38.49 76.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.322 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 1.7 mmpm? -63.07 -45.74 90.73 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 116.984 -1.886 . . . . 0.0 108.825 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.61 85.6 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -44.04 97.68 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.55 -37.79 71.07 Favored 'General case' 0 CA--C 1.495 -1.137 0 O-C-N 121.621 -0.674 . . . . 0.0 111.802 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 19.1 p -70.31 -44.99 67.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.47 HD13 ' CG ' ' A' ' 219' ' ' TYR . 16.8 tp -61.48 -43.81 98.2 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.04 -38.14 93.78 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.551 HG21 ' HD1' ' A' ' 326' ' ' TYR . 34.7 mt -70.2 -40.07 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 117.365 0.582 . . . . 0.0 110.801 -177.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.857 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.43 -50.56 50.31 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.398 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.671 -177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.857 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.4 -40.92 98.51 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.588 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.59 -38.41 96.24 Favored Glycine 0 C--N 1.348 1.233 0 C-N-CA 121.618 -0.325 . . . . 0.0 112.45 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.0 p -69.01 -49.37 58.33 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.537 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.7 m-85 -54.11 -57.95 9.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.437 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.7 p -70.54 -46.64 63.2 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 10.5 tp -72.06 -20.57 61.65 Favored 'General case' 0 N--CA 1.432 -1.33 1 O-C-N 116.004 -4.185 . . . . 0.0 109.002 -174.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.97 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.8 OUTLIER -154.64 107.72 2.84 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.186 -178.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.97 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 0.6 OUTLIER 138.17 -59.33 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.647 179.348 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.67 -48.05 94.28 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.777 -0.769 . . . . 0.0 111.861 -176.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.703 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 291' ' ' ILE . 69.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.1 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 64.8 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.98 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 289' ' ' PHE . 0.0 OUTLIER -60.6 -39.94 89.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.736 -179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.32 -41.89 98.92 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.936 ' O ' ' HB3' ' A' ' 285' ' ' CYS . 0.9 OUTLIER -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.844 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -78.11 -37.71 28.1 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -165.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.663 ' O ' HG12 ' A' ' 325' ' ' ILE . 8.1 m-85 -68.29 -32.71 73.06 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.359 0.664 . . . . 0.0 111.864 -170.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.513 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 3.2 m-20 -54.16 -48.34 94.55 Favored Pre-proline 0 N--CA 1.437 -1.117 0 CA-C-O 118.48 -0.772 . . . . 0.0 112.606 -171.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 52.7 Cg_exo -61.18 -34.66 88.49 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 121.252 1.483 . . . . 0.0 112.707 -176.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 34.7 mt -69.64 -44.3 70.87 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 120.216 -0.594 . . . . 0.0 109.743 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 321' ' ' PHE . 1.8 mm -95.58 -63.77 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 C-N-CA 123.248 0.619 . . . . 0.0 112.25 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.551 ' HD1' HG21 ' A' ' 277' ' ' ILE . 0.3 OUTLIER -43.42 -33.32 1.04 Allowed 'General case' 0 C--N 1.353 0.736 0 N-CA-C 119.987 3.329 . . . . 0.0 119.987 -177.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 83.5 p -86.64 36.2 0.7 Allowed 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 124.762 1.225 . . . . 0.0 113.014 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -64.07 -24.38 67.68 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 124.574 1.15 . . . . 0.0 111.51 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -47.38 145.99 3.59 Favored Pre-proline 0 C--N 1.377 1.762 0 C-N-CA 118.977 -1.089 . . . . 0.0 110.942 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.478 ' CE2' HD23 ' A' ' 64' ' ' LEU . 2.1 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -51.45 -56.49 13.0 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.174 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.84 70.29 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.69 3.744 . . . . 0.0 109.262 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.6 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.735 HG21 HG23 ' A' ' 73' ' ' THR . 35.9 pt -138.53 162.23 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.071 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.178 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.9 m 66.84 30.8 7.67 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.56 ' C ' HD12 ' A' ' 58' ' ' ILE . . . -112.11 -81.16 0.59 Allowed 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.56 HD12 ' C ' ' A' ' 57' ' ' ALA . 3.1 mp -124.05 118.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 34.2 m -85.67 148.36 25.92 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.273 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.1 mttt 57.31 36.37 27.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.066 0.46 . . . . 0.0 109.798 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.529 ' CD1' HG21 ' A' ' 58' ' ' ILE . 15.1 t80 -72.84 -42.73 63.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.12 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -156.82 -157.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.307 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -80.84 26.64 0.4 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.669 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -66.02 -10.64 41.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.3 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.799 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 28.2 m -56.5 -40.26 66.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.307 -177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.4 ' N ' HG23 ' A' ' 67' ' ' VAL . 11.7 t -60.96 -32.59 72.12 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.718 -0.793 . . . . 0.0 108.863 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.799 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.735 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.694 HG23 ' CH2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.406 HG21 ' OH ' ' A' ' 326' ' ' TYR . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG22 ' A' ' 218' ' ' VAL . 0.0 OUTLIER -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -44.71 140.9 2.28 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.2 140.24 57.1 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 118.299 -1.36 . . . . 0.0 110.506 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 40.2 pt -148.96 22.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 122.76 0.424 . . . . 0.0 111.701 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -103.5 -67.37 0.89 Allowed 'General case' 0 C--N 1.332 -0.179 0 O-C-N 124.376 1.048 . . . . 0.0 112.539 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.1 m -74.73 153.79 87.24 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.5 -21.3 13.27 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.36 2.707 . . . . 0.0 112.628 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -64.96 -38.91 92.53 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.192 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -94.34 175.85 6.53 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.063 0.459 . . . . 0.0 111.58 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.1 t80 72.86 -55.83 0.67 Allowed 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.03 -41.42 74.28 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 118.915 -1.114 . . . . 0.0 110.563 -176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 88.6 mt -83.39 110.43 18.14 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.06 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.6 p -135.92 167.21 21.62 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? 69.09 -84.87 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.797 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 1.3 m -162.88 -79.61 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.692 ' O ' ' HB3' ' A' ' 150' ' ' ALA . 72.5 mmtt 60.27 -161.86 0.27 Allowed 'General case' 0 C--N 1.407 3.107 0 C-N-CA 118.464 -1.295 . . . . 0.0 109.816 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.692 ' HB3' ' O ' ' A' ' 149' ' ' LYS . . . 77.23 -53.25 0.55 Allowed 'General case' 0 CA--C 1.494 -1.21 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.534 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.56 -39.14 92.71 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.261 1.8 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 m-70 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 132' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.863 ' CD1' HD11 ' A' ' 275' ' ' LEU . 1.0 OUTLIER -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 219' ' ' TYR . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.69 -32.26 73.72 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -68.32 -46.97 68.79 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 43.6 t -62.52 136.89 58.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -172.94 125.32 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.874 0.369 . . . . 0.0 110.571 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -129.06 139.45 10.98 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.56 138.29 44.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.823 0.344 . . . . 0.0 110.654 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -149.63 113.47 5.09 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.852 0.834 . . . . 0.0 109.174 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 55.7 p-80 -159.64 164.83 33.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.4 t -136.06 28.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 57.23 31.59 20.33 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 245' ' ' VAL . 83.4 m-20 -140.23 137.41 34.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 244' ' ' ASN . 6.3 t 68.29 131.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.602 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 83.3 p -69.86 160.13 32.36 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -131.44 149.4 52.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 248' ' ' VAL . 10.0 p -138.83 140.49 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.32 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 51.2 mp0 -145.93 30.04 1.08 Allowed 'General case' 0 N--CA 1.433 -1.317 0 C-N-CA 115.026 -2.669 . . . . 0.0 111.442 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -61.68 -42.64 99.2 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 178.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -166.42 157.59 12.97 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 125.021 1.329 . . . . 0.0 108.371 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 68.41 31.52 74.19 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 107.154 -2.379 . . . . 0.0 107.154 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.55 -45.74 90.93 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 81.5 p -124.98 -29.47 3.34 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 118.803 -1.159 . . . . 0.0 108.467 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 68.83 26.08 74.82 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 116.705 -2.664 . . . . 0.0 110.454 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -157.39 144.03 18.09 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 70.54 29.54 69.71 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -96.43 19.51 12.01 Favored 'General case' 0 CA--C 1.49 -1.345 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -115.51 -32.66 5.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -60.98 -43.85 98.21 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 48.0 t -57.75 -44.17 85.92 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 6.2 p -63.82 -29.66 70.83 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -66.12 -39.8 90.18 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -30.21 67.4 Favored 'General case' 0 CA--C 1.491 -1.302 0 C-N-CA 116.996 -1.881 . . . . 0.0 110.074 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.27 -72.53 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 127.651 2.38 . . . . 0.0 105.918 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 13.9 p -63.88 -33.08 74.89 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 126.013 2.071 . . . . 0.0 114.425 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.39 -50.21 28.14 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 116.12 -2.232 . . . . 0.0 110.629 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -69.87 -38.44 76.41 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.331 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.728 ' HE2' HG23 ' A' ' 274' ' ' THR . 0.0 OUTLIER -63.08 -45.7 90.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 116.997 -1.881 . . . . 0.0 108.861 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . . . . . . . . . . . -58.22 -46.63 85.54 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.69 -44.07 97.64 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.47 -37.84 71.29 Favored 'General case' 0 CA--C 1.495 -1.173 0 O-C-N 121.578 -0.701 . . . . 0.0 111.836 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.728 HG23 ' HE2' ' A' ' 270' ' ' LYS . 25.5 p -70.29 -44.98 67.25 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.974 ' O ' HD23 ' A' ' 275' ' ' LEU . 5.1 tt -61.41 -43.86 98.13 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.581 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -66.12 -38.15 93.69 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.61 HG21 ' CD1' ' A' ' 326' ' ' TYR . 29.9 mt -70.14 -40.12 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 117.396 0.598 . . . . 0.0 110.791 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.867 HG22 ' N ' ' A' ' 279' ' ' MET . 1.2 mp -69.44 -50.54 50.44 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.402 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.706 -177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.867 ' N ' HG22 ' A' ' 278' ' ' ILE . 16.5 ptm -63.37 -40.95 98.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 118.364 -1.334 . . . . 0.0 111.653 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.52 -38.53 96.45 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 122.216 -0.302 . . . . 0.0 112.44 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 285' ' ' CYS . 7.5 p -68.95 -49.34 58.81 Favored 'General case' 0 CA--C 1.494 -1.183 0 O-C-N 121.822 -0.811 . . . . 0.0 108.835 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.57 ' HD2' HD13 ' A' ' 212' ' ' LEU . 7.5 m-85 -53.75 -58.26 7.88 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.493 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 63.5 p -70.54 -46.74 62.99 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 80.4 mt -69.34 -22.73 63.74 Favored 'General case' 0 N--CA 1.432 -1.351 1 O-C-N 115.983 -4.198 . . . . 0.0 109.007 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.976 ' O ' ' CG ' ' A' ' 286' ' ' TRP . 0.9 OUTLIER -156.18 113.86 3.27 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.238 -178.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.976 ' CG ' ' O ' ' A' ' 285' ' ' CYS . 1.3 m95 135.71 -58.91 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.39 -48.05 94.83 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.861 -176.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.725 ' O ' HG23 ' A' ' 292' ' ' VAL . 2.0 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . 0.658 ' HB2' HD12 ' A' ' 311' ' ' LEU . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 291' ' ' ILE . 60.3 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 0.3 OUTLIER -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 311' ' ' LEU . 65.5 t -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.61 93.99 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.809 ' O ' HG22 ' A' ' 314' ' ' ILE . 0.1 OUTLIER -61.07 -39.19 88.95 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.684 -179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -41.89 99.61 Favored 'General case' 0 C--N 1.282 -2.365 0 O-C-N 121.433 -0.792 . . . . 0.0 109.183 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.882 ' O ' HG12 ' A' ' 317' ' ' VAL . 2.8 tt -57.69 -40.43 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -177.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.877 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.28 -35.91 92.56 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . . . . . . . . . 22.7 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.882 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.463 ' CG ' ' HE1' ' A' ' 286' ' ' TRP . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -77.43 -35.62 36.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -166.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . 0.681 ' O ' HG12 ' A' ' 325' ' ' ILE . 11.5 m-85 -68.26 -32.75 73.16 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 123.345 0.658 . . . . 0.0 111.82 -171.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.511 ' CB ' ' HD3' ' A' ' 323' ' ' PRO . 1.2 m-80 -54.09 -48.38 94.32 Favored Pre-proline 0 N--CA 1.436 -1.126 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.654 -171.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 322' ' ' ASN . 51.3 Cg_exo -61.19 -34.66 88.38 Favored 'Trans proline' 0 C--N 1.301 -1.97 0 CA-C-N 121.254 1.484 . . . . 0.0 112.715 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 35.1 mt -69.65 -44.29 70.87 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.74 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.681 HG12 ' O ' ' A' ' 321' ' ' PHE . 2.1 mm -94.8 -64.13 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 C-N-CA 123.237 0.615 . . . . 0.0 112.309 -173.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.61 ' CD1' HG21 ' A' ' 277' ' ' ILE . 0.2 OUTLIER -43.44 -30.88 0.6 Allowed 'General case' 0 C--N 1.352 0.699 0 N-CA-C 119.979 3.326 . . . . 0.0 119.979 -177.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 81.7 p -93.03 36.1 1.05 Allowed 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.024 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -67.94 -23.09 65.03 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 124.531 1.132 . . . . 0.0 111.607 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -44.87 145.99 1.46 Allowed Pre-proline 0 C--N 1.374 1.649 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.461 ' CE2' HD23 ' A' ' 64' ' ' LEU . 1.3 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 88.4 m -51.42 -56.55 12.63 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.153 178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 61' ' ' PHE . . . -56.2 -37.84 70.18 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.743 3.777 . . . . 0.0 109.262 -173.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 1.7 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 CA--C 1.491 -1.289 0 CA-C-O 121.295 0.569 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -68.91 -26.42 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 C-N-CA 125.351 1.46 . . . . 0.0 108.53 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' NE1' ' SD ' ' A' ' 36' ' ' MET . 60.0 t-105 -57.15 -37.79 72.59 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.063 0.945 . . . . 0.0 112.017 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.617 HG13 ' N ' ' A' ' 34' ' ' VAL . 10.8 p -57.86 -51.0 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 C-N-CA 118.607 -1.237 . . . . 0.0 111.478 -174.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.617 ' N ' HG13 ' A' ' 33' ' ' VAL . 93.3 t -67.8 -39.9 82.75 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.274 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . . . -61.14 -41.13 99.37 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 1.018 ' HG2' ' HE2' ' A' ' 40' ' ' MET . 13.8 ttt -71.3 -38.55 71.76 Favored 'General case' 0 N--CA 1.427 -1.584 0 O-C-N 121.945 -0.738 . . . . 0.0 110.977 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.56 99.46 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.867 HD13 HD13 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -64.03 -45.12 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 122.347 -0.502 . . . . 0.0 109.723 -177.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.652 HG12 HD13 ' A' ' 43' ' ' ILE . 93.9 t -62.76 -41.62 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.018 ' HE2' ' HG2' ' A' ' 36' ' ' MET . 36.1 mtt -61.06 -37.45 82.7 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.7 t -63.69 -44.56 93.31 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.867 HD13 HD13 ' A' ' 38' ' ' ILE . 8.2 mp -64.32 -42.88 96.08 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.376 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.652 HD13 HG12 ' A' ' 39' ' ' VAL . 2.0 mp -65.44 -46.04 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 C-N-CA 119.416 -0.913 . . . . 0.0 110.722 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 40' ' ' MET . 78.4 t -59.75 -39.01 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.646 ' O ' HD23 ' A' ' 45' ' ' LEU . 3.4 tt -66.8 -45.0 79.77 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -45.15 91.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 O-C-N 121.987 -0.446 . . . . 0.0 111.133 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.516 HD12 HG11 ' A' ' 87' ' ' VAL . 97.0 mt -63.54 -46.69 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.826 -175.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -66.82 -50.66 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.12 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.788 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.847 ' CE2' HD11 ' A' ' 53' ' ' LEU . 63.5 t80 -61.29 -44.52 97.09 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -174.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -65.24 -51.03 53.41 Favored Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.355 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.782 ' O ' HG12 ' A' ' 54' ' ' VAL . 64.5 m-80 -66.47 -43.89 84.21 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-N 118.15 0.975 . . . . 0.0 109.448 -175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 49' ' ' PHE . 5.4 p -61.29 -40.86 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.52 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.847 HD11 ' CE2' ' A' ' 49' ' ' PHE . 16.9 mt -60.86 -43.98 97.64 Favored 'General case' 0 CA--C 1.487 -1.444 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.937 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.782 HG12 ' O ' ' A' ' 51' ' ' ASN . 9.3 p -65.14 -47.32 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 118.912 -1.115 . . . . 0.0 110.893 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.721 HG22 ' N ' ' A' ' 56' ' ' THR . 1.6 mm -146.57 159.04 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.188 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.721 ' N ' HG22 ' A' ' 55' ' ' ILE . 7.2 p 72.14 151.31 0.11 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 56' ' ' THR . . . 70.89 95.83 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.9 mt 61.98 99.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.0 p -129.13 126.88 40.27 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.364 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CB ' ' A' ' 61' ' ' PHE . 7.6 mmtt 174.5 -161.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.53 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CB ' ' O ' ' A' ' 60' ' ' LYS . 4.5 t80 83.37 -6.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.504 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 63' ' ' ARG . 60.1 mm-40 48.21 -154.59 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.523 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 63.8 mtp85 72.15 -55.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.569 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 64' ' ' LEU . 6.9 mp -67.31 -10.64 52.89 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' CE1' ' A' ' 70' ' ' TYR . 52.6 mm-40 -59.39 -18.71 41.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.552 1.941 . . . . 0.0 113.23 -173.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' ASN . 46.5 p -40.61 140.36 0.69 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 124.321 1.048 . . . . 0.0 111.219 -176.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.788 ' HA ' ' CD1' ' A' ' 70' ' ' TYR . 61.0 t -56.3 -40.45 66.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.328 -177.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -61.06 -32.59 72.22 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 66' ' ' THR . 6.1 m-20 -63.91 -29.54 70.71 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.658 1.183 . . . . 0.0 111.25 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.788 ' CD1' ' HA ' ' A' ' 67' ' ' VAL . 73.3 m-85 -57.68 -40.55 79.67 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 121.452 -0.78 . . . . 0.0 109.633 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' A' ' 153' ' ' ILE . 67.9 m-85 -60.48 -46.29 90.63 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.56 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 75' ' ' LEU 0.257 0.0 OUTLIER -64.21 -28.2 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.284 0 C-N-CA 118.375 -1.33 . . . . 0.0 109.843 179.828 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.423 HG23 HG21 ' A' ' 55' ' ' ILE . 87.1 m -60.66 -42.76 97.65 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.753 ' O ' HG12 ' A' ' 77' ' ' VAL . 47.7 t -61.27 -40.23 93.33 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.749 HD21 ' CD2' ' A' ' 124' ' ' LEU . 0.9 OUTLIER -58.99 -46.0 89.23 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HB1' ' CG1' ' A' ' 54' ' ' VAL . . . -62.69 -43.62 98.33 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 122.732 0.413 . . . . 0.0 110.398 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 74' ' ' SER . 9.6 p -66.21 -42.45 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 120.179 -0.609 . . . . 0.0 109.766 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.73 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -60.78 -42.13 96.91 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' ' OD1' ' A' ' 51' ' ' ASN . 92.7 m-20 -71.86 -28.72 63.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 123.744 0.817 . . . . 0.0 111.562 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 80' ' ' LEU . 3.4 tt -68.24 -42.33 79.86 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.473 -175.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.73 HG12 ' O ' ' A' ' 78' ' ' ALA . 11.4 p -64.3 -26.71 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.799 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 49.2 ttm -63.03 -51.3 67.29 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.732 -177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.876 ' HA2' HG12 ' A' ' 87' ' ' VAL . . . -73.25 -24.91 74.47 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 125.031 1.3 . . . . 0.0 111.928 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' PRO . 55.2 tp -78.89 -65.54 0.98 Allowed 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.488 ' O ' ' HD1' ' A' ' 89' ' ' PHE . . . -83.14 -58.89 2.66 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.754 HG22 HG23 ' A' ' 112' ' ' ILE . 88.8 t -64.8 -57.07 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -168.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.876 HG12 ' HA2' ' A' ' 83' ' ' GLY 0.311 1.2 p -70.93 -39.7 8.92 Favored Pre-proline 0 N--CA 1.432 -1.373 0 C-N-CA 117.457 -1.697 . . . . 0.0 113.272 -170.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.644 ' HD3' ' CG1' ' A' ' 87' ' ' VAL 0.256 9.5 Cg_endo -70.44 -32.98 14.78 Favored 'Trans proline' 0 N--CA 1.432 -2.088 0 CA-C-N 123.215 2.184 . . . . 0.0 113.293 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.618 ' HD2' ' CZ ' ' A' ' 101' ' ' PHE . 43.8 m-85 -67.7 -37.72 82.66 Favored 'General case' 0 CA--C 1.488 -1.417 0 C-N-CA 118.826 -1.149 . . . . 0.0 108.018 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.36 -40.96 99.51 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB1' ' SD ' ' A' ' 40' ' ' MET . . . -63.1 -45.99 89.44 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.17 -36.36 81.61 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -60.05 -45.49 92.67 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HD12 ' CE ' ' A' ' 36' ' ' MET . 27.9 pt -67.54 -35.3 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 O-C-N 122.407 -0.183 . . . . 0.0 110.995 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 71.2 mt -66.2 -47.73 72.94 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.79 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG22 ' OG1' ' A' ' 98' ' ' THR . 62.4 m -70.83 -31.0 67.57 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 124.489 1.116 . . . . 0.0 111.48 -175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 97' ' ' LYS . 2.9 tppp? 70.53 17.38 6.78 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' OG1' HG22 ' A' ' 96' ' ' THR . 78.3 p -158.65 166.12 32.79 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.771 ' O ' HG23 ' A' ' 189' ' ' THR . 2.3 t-105 -105.23 109.57 21.6 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 100' ' ' THR . 90.0 m -80.48 -24.01 39.76 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.973 2.109 . . . . 0.0 112.703 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.618 ' CZ ' ' HD2' ' A' ' 89' ' ' PHE . 99.3 m-85 -64.84 -30.19 71.19 Favored 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 126.082 1.753 . . . . 0.0 114.679 -168.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.55 167.06 21.01 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 117.723 -2.179 . . . . 0.0 107.963 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.756 ' HB2' ' HA ' ' A' ' 188' ' ' GLU . 38.5 t-20 -71.04 -53.87 13.19 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -62.49 -43.83 97.86 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.55 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 64.8 t-105 -67.04 -32.11 73.1 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.9 t -61.81 -39.56 92.18 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.797 ' O ' HG22 ' A' ' 110' ' ' THR . 99.1 mt-10 -66.1 -43.91 85.92 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -59.88 -47.84 84.12 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.825 ' O ' HG22 ' A' ' 112' ' ' ILE . 79.6 t90 -61.86 -45.74 92.46 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.038 0.535 . . . . 0.0 110.337 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 107' ' ' GLU . 10.7 t -62.69 -40.0 95.73 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 119.248 -0.981 . . . . 0.0 108.772 -176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 166' ' ' PHE . 69.9 m -62.81 -45.19 93.77 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.825 HG22 ' O ' ' A' ' 109' ' ' TRP . 10.3 tp -62.53 -35.58 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 112' ' ' ILE . 66.2 t0 -60.35 -53.47 57.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.992 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.956 HG23 ' HB3' ' A' ' 165' ' ' SER . 15.8 m -62.56 -39.44 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.721 HD23 ' HA2' ' A' ' 162' ' ' GLY . 3.0 tm? -62.38 -43.32 99.09 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 82' ' ' MET . 52.1 t -64.55 -42.41 95.71 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -176.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.931 HG23 ' CZ2' ' A' ' 286' ' ' TRP . 6.5 p -65.49 -46.85 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 C-N-CA 118.416 -1.314 . . . . 0.0 110.098 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.465 ' N ' HG13 ' A' ' 117' ' ' VAL . 86.5 m -61.73 -44.66 96.47 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.72 -41.84 98.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.3 m -62.0 -57.55 11.24 Favored 'General case' 0 CA--C 1.496 -1.125 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.744 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.819 HD11 ' NE1' ' A' ' 286' ' ' TRP . 49.7 mm -60.66 -45.93 96.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TRP . . . . . 0.813 ' CD1' HG22 ' A' ' 157' ' ' VAL . 64.7 t-105 -61.71 -42.33 98.8 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 -175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 97.0 m -61.05 -41.71 97.11 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.749 ' CD2' HD21 ' A' ' 75' ' ' LEU . 77.6 mt -59.44 -41.72 90.25 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 211' ' ' PRO . 2.4 p -65.26 -35.28 80.55 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 118.33 -1.348 . . . . 0.0 109.219 -178.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 122' ' ' TRP . 94.6 t -61.58 -43.85 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 28.5 mm -61.24 -42.25 92.75 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.156 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.3 -40.93 83.3 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 125' ' ' CYS . 97.9 t -63.42 -38.17 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.3 -48.21 82.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 271' ' ' ALA . 11.0 mtp85 -66.63 -38.15 86.32 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.44 ' HB2' HG13 ' A' ' 218' ' ' VAL . 1.9 t80 -60.35 -44.43 95.55 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -67.31 -45.15 77.35 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.04 63.36 4.54 Favored 'General case' 0 N--CA 1.431 -1.394 0 C-N-CA 118.264 -1.375 . . . . 0.0 110.598 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.424 HG21 ' OE2' ' A' ' 225' ' ' GLU . 70.7 mt -63.32 -65.4 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 122.76 0.424 . . . . 0.0 111.681 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 19.0 p -178.03 -28.67 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 O-C-N 124.391 1.057 . . . . 0.0 112.501 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 52.7 m -81.42 121.28 79.89 Favored Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 123.504 0.502 . . . . 0.0 110.288 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.53 -13.89 22.45 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.885 2.39 . . . . 0.0 112.224 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -66.02 -29.68 70.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.58 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -100.75 10.96 40.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.631 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -117.62 -55.35 2.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -70.43 -41.42 72.91 Favored 'General case' 0 CA--C 1.494 -1.176 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.563 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -55.8 14.9 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -175.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 13.6 tp -66.55 -51.44 56.52 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.459 HD23 ' C ' ' A' ' 145' ' ' LEU . 7.7 tt -96.54 116.45 29.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 119.491 -0.883 . . . . 0.0 109.014 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 20.5 p -144.72 -55.8 0.34 Allowed 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.9 -46.04 92.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 120.46 -0.496 . . . . 0.0 109.773 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . 0.407 ' O ' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER 173.46 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 68.9 mttm 53.04 65.31 1.56 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 118.982 -2.324 . . . . 0.0 109.776 -170.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.55 ' HA ' HD12 ' A' ' 153' ' ' ILE . . . -158.21 -61.53 0.08 Allowed 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.493 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 151' ' ' ARG . 61.2 mtt180 -62.76 -39.14 93.23 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.59 -34.62 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.207 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.761 ' O ' HG23 ' A' ' 157' ' ' VAL . 75.3 mt -63.5 -42.77 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 96.3 mt -64.47 -46.09 93.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 C-N-CA 120.34 -0.544 . . . . 0.0 109.562 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 64.6 tp -62.79 -38.3 90.08 Favored 'General case' 0 CA--C 1.489 -1.382 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.789 ' O ' HG22 ' A' ' 159' ' ' ILE . 37.6 mtm -62.31 -41.61 98.67 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.778 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.813 HG22 ' CD1' ' A' ' 122' ' ' TRP . 93.8 t -59.92 -48.9 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.646 ' CZ3' HD11 ' A' ' 115' ' ' LEU . 97.0 m95 -66.29 -38.74 88.48 Favored 'General case' 0 N--CA 1.433 -1.291 0 O-C-N 122.184 -0.322 . . . . 0.0 110.231 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 156' ' ' MET . 8.6 tp -64.81 -46.65 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.342 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.657 HG12 ' O ' ' A' ' 157' ' ' VAL . 5.4 p -65.77 -35.96 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.691 ' O ' HG22 ' A' ' 164' ' ' THR . 47.1 t -65.03 -41.65 95.05 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.721 ' HA2' HD23 ' A' ' 115' ' ' LEU . . . -69.25 -42.25 76.07 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.2 mt -63.77 -33.63 76.09 Favored 'General case' 0 CA--C 1.493 -1.246 0 C-N-CA 123.349 0.66 . . . . 0.0 110.213 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 161' ' ' SER . 11.6 t -78.71 -16.14 57.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 124.139 0.976 . . . . 0.0 111.854 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.956 ' HB3' HG23 ' A' ' 114' ' ' VAL . 49.2 m -115.8 -77.15 0.57 Allowed 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.418 0.628 . . . . 0.0 111.641 -170.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.715 ' CE1' ' HB2' ' A' ' 115' ' ' LEU . 72.7 m-85 -59.29 -48.02 83.21 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.822 -172.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . 0.26 2.6 mp -63.84 -46.03 81.58 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 118.504 -1.279 . . . . 0.0 111.028 -175.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -66.02 -37.87 24.49 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 120.542 0.828 . . . . 0.0 112.607 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.881 ' HA ' ' CE2' ' A' ' 174' ' ' TYR . 37.1 mm -69.35 -48.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 O-C-N 123.759 0.662 . . . . 0.0 111.051 -176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 166' ' ' PHE . 89.6 mm-40 -64.61 -35.52 81.26 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -174.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.771 ' HG2' ' NE1' ' A' ' 173' ' ' TRP . 35.7 tpp -70.48 -21.61 62.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 C-N-CA 125.271 1.428 . . . . 0.0 111.042 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 70.76 31.48 2.72 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.771 ' NE1' ' HG2' ' A' ' 171' ' ' MET . 37.1 m0 -69.62 -39.42 77.18 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.072 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.881 ' CE2' ' HA ' ' A' ' 169' ' ' ILE . 53.5 p90 -70.05 -29.12 66.06 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.22 1.008 . . . . 0.0 111.855 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.53 129.06 40.28 Favored 'General case' 0 CA--C 1.487 -1.447 0 C-N-CA 118.831 -1.147 . . . . 0.0 110.853 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.027 ' HB3' ' HE2' ' A' ' 194' ' ' PHE . . . -101.21 136.57 40.84 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 177' ' ' THR . 9.8 t -74.53 109.77 8.28 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 117.086 -1.846 . . . . 0.0 108.353 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.789 ' CD2' ' H ' ' A' ' 180' ' ' GLU . 71.6 t60 -143.48 154.63 43.85 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.557 ' HG3' HD21 ' A' ' 183' ' ' ASN . 11.3 tp-100 -64.56 -46.31 83.32 Favored 'General case' 0 N--CA 1.427 -1.593 0 C-N-CA 117.351 -1.74 . . . . 0.0 108.646 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.789 ' H ' ' CD2' ' A' ' 178' ' ' HIS . 98.1 mt-10 -66.72 -40.45 88.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.404 ' O ' ' CD1' ' A' ' 185' ' ' TYR . . . -63.35 -46.4 86.73 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.07 -177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 178' ' ' HIS . 90.9 mt -62.47 -40.83 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASN . . . . . 0.557 HD21 ' HG3' ' A' ' 179' ' ' GLN . 88.6 m-20 -62.81 -49.61 74.24 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.89 -176.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 53.0 t -66.76 -40.74 88.38 Favored 'General case' 0 N--CA 1.437 -1.094 0 O-C-N 121.96 -0.462 . . . . 0.0 109.876 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.404 ' CD1' ' O ' ' A' ' 181' ' ' ALA . 55.8 m-85 -63.85 -47.97 78.63 Favored 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.44 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.62 -36.99 82.32 Favored 'General case' 0 N--CA 1.433 -1.295 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.688 ' OE1' ' HB ' ' A' ' 189' ' ' THR . 0.7 OUTLIER -68.0 132.93 48.19 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 103' ' ' ASN . 37.6 mm-40 -66.8 -46.74 74.29 Favored 'General case' 0 N--CA 1.437 -1.099 0 O-C-N 121.74 -0.6 . . . . 0.0 111.416 -176.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 99' ' ' TRP . 88.3 m -74.88 -29.74 61.1 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 127.246 2.218 . . . . 0.0 115.173 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' CYS . . . . . . . . . . . . . 34.5 t -84.4 106.64 16.15 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 121.209 -0.932 . . . . 0.0 108.956 -175.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' CYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 99' ' ' TRP . 31.0 t -110.12 98.23 7.55 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -129.2 149.67 50.91 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.523 ' CZ ' HG21 ' A' ' 195' ' ' THR . 84.6 t80 -88.59 117.46 27.57 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -175.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 1.027 ' HE2' ' HB3' ' A' ' 176' ' ' ALA . 68.1 t80 -133.27 135.1 44.71 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.523 HG21 ' CZ ' ' A' ' 193' ' ' PHE . 72.1 p -142.89 144.27 32.39 Favored 'General case' 0 CA--C 1.493 -1.23 0 C-N-CA 118.024 -1.471 . . . . 0.0 110.341 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.716 HD21 ' HB2' ' A' ' 199' ' ' TYR . 1.8 p30 -73.14 158.44 35.29 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.743 ' HG2' HG21 ' A' ' 297' ' ' VAL . 15.5 tm0? -60.34 -41.4 93.52 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -175.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.612 ' HA ' ' CD1' ' A' ' 201' ' ' ILE . . . -60.32 -39.72 88.04 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 196' ' ' ASN . 90.3 t80 -67.98 -42.44 80.81 Favored 'General case' 0 N--CA 1.435 -1.196 0 O-C-N 121.941 -0.475 . . . . 0.0 109.839 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.61 92.08 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.65 HD13 ' H ' ' A' ' 201' ' ' ILE . 0.2 OUTLIER -66.26 -49.44 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 C-N-CA 115.294 -2.562 . . . . 0.0 111.412 -175.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.606 ' O ' HG22 ' A' ' 206' ' ' VAL . . . -66.46 -41.1 89.55 Favored 'General case' 0 N--CA 1.435 -1.189 0 O-C-N 122.038 -0.414 . . . . 0.0 110.035 -177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 47.8 t -61.16 -48.39 81.82 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' SER . . . . . 0.442 ' OG ' ' HE1' ' A' ' 209' ' ' TYR . 9.9 t -67.4 -44.41 78.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.03 -176.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.82 ' HA ' ' HD1' ' A' ' 209' ' ' TYR . 47.6 pt -61.67 -44.79 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 121.724 -0.61 . . . . 0.0 109.705 -176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 202' ' ' ALA . 24.1 m -68.46 -45.19 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 O-C-N 121.881 -0.512 . . . . 0.0 111.421 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 206' ' ' VAL . 75.5 m -68.34 -60.29 2.56 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.328 -174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.485 ' CE2' HD22 ' A' ' 287' ' ' LEU . 84.5 t80 -93.27 -54.95 3.49 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 119.579 3.178 . . . . 0.0 119.579 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.82 ' HD1' ' HA ' ' A' ' 205' ' ' ILE . 87.4 m-85 -62.61 -50.17 72.3 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -164.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.918 ' HB ' ' HD3' ' A' ' 211' ' ' PRO . 95.5 t -62.02 -46.47 91.76 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 118.542 -1.263 . . . . 0.0 109.138 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PRO . . . . . 0.918 ' HD3' ' HB ' ' A' ' 210' ' ' VAL . 89.3 Cg_exo -62.84 -29.4 76.49 Favored 'Trans proline' 0 N--CA 1.433 -2.069 0 N-CA-C 110.127 -0.759 . . . . 0.0 110.127 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.818 ' O ' HG23 ' A' ' 216' ' ' VAL . 61.1 tp -65.2 -45.77 83.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 -46.9 92.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.566 HD13 HG12 ' A' ' 210' ' ' VAL . 1.8 mp -60.4 -45.23 96.98 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.361 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.977 -177.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' MET . . . . . 0.665 ' HG2' ' O ' ' A' ' 211' ' ' PRO . 6.6 ptp -64.47 -38.56 91.45 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 117.799 -1.56 . . . . 0.0 110.888 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 212' ' ' LEU . 96.5 t -59.52 -50.13 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.145 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.288 -176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -63.23 -42.99 99.3 Favored 'General case' 0 N--CA 1.433 -1.278 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.157 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 219' ' ' TYR . 0.9 OUTLIER -61.34 -56.05 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.119 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -175.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.83 ' O ' HG12 ' A' ' 222' ' ' VAL . 75.6 m-85 -63.05 -32.59 73.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -177.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 72.9 m -59.33 -51.21 70.91 Favored 'General case' 0 N--CA 1.432 -1.343 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.338 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.4 ttt85 -63.41 -39.86 95.63 Favored 'General case' 0 CA--C 1.494 -1.192 0 C-N-CA 119.119 -1.032 . . . . 0.0 109.845 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.83 HG12 ' O ' ' A' ' 219' ' ' TYR . 5.2 p -61.75 -39.3 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.321 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' N ' ' CG1' ' A' ' 222' ' ' VAL . 75.0 t80 -59.7 -42.74 93.68 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.45 -38.75 91.0 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 118.39 -1.324 . . . . 0.0 108.72 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' OE2' HG21 ' A' ' 135' ' ' ILE . 4.1 tp10 -62.29 -43.64 98.35 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.7 -43.15 99.41 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -60.07 -44.22 94.88 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . 0.929 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 25.4 mtm180 -62.89 -45.5 92.24 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.242 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -62.7 -44.54 95.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 119.269 -0.973 . . . . 0.0 110.137 -174.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.74 -37.31 86.87 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.219 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.43 -43.55 90.13 Favored 'General case' 0 N--CA 1.434 -1.252 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.775 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.929 ' HE2' ' HB3' ' A' ' 228' ' ' ARG . 45.5 mttm -61.97 -40.98 97.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 91.3 mt -62.5 -39.31 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.542 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -65.69 -33.12 75.14 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.98 -45.64 77.04 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 48.0 t -64.09 131.62 48.06 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -177.95 138.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.551 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 158.79 -92.88 0.12 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . 0.428 ' O ' HG22 ' A' ' 242' ' ' VAL . 99.8 mtt180 55.08 40.21 31.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.755 0.312 . . . . 0.0 110.635 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -83.54 -2.52 56.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.791 0.805 . . . . 0.0 109.182 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -62.26 -39.44 92.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 239' ' ' ARG . 18.9 m -62.04 -27.38 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.9 tm0? 67.02 109.94 0.04 OUTLIER 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASN . . . . . . . . . . . . . 63.9 t30 62.8 85.95 0.12 Allowed 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 18.1 m -59.48 -31.14 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 8.1 t 60.87 -167.59 0.19 Allowed 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -108.04 154.78 21.17 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 2.3 t 54.66 45.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.385 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -68.76 155.99 39.13 Favored 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 115.098 -2.641 . . . . 0.0 111.492 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 70.35 100.84 0.06 Allowed 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -68.89 147.64 51.39 Favored 'General case' 0 CA--C 1.491 -1.323 0 C-N-CA 124.955 1.302 . . . . 0.0 108.344 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -85.1 -1.56 88.53 Favored Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 107.108 -2.397 . . . . 0.0 107.108 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -62.33 -39.26 92.5 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 98.8 m -61.34 -44.46 97.15 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.355 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . -174.89 -178.53 44.83 Favored Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 116.771 -2.633 . . . . 0.0 110.473 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.62 145.45 51.5 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 129.93 163.25 11.05 Favored Glycine 0 N--CA 1.431 -1.684 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -126.24 134.86 51.08 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 260' ' ' ARG . 96.7 mtm-85 -137.05 153.25 50.66 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 259' ' ' ARG . 86.4 mtt180 73.46 -76.04 0.07 Allowed 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 259' ' ' ARG . 48.1 t -57.43 -44.16 84.43 Favored 'General case' 0 N--CA 1.432 -1.354 0 O-C-N 120.75 -1.219 . . . . 0.0 108.105 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 265' ' ' ALA . 0.9 OUTLIER -63.89 -29.63 70.79 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -178.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -66.1 -39.8 90.27 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -30.18 67.36 Favored 'General case' 0 CA--C 1.491 -1.303 0 C-N-CA 116.964 -1.894 . . . . 0.0 110.136 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 262' ' ' SER . . . -50.29 -72.54 0.05 OUTLIER 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 127.644 2.378 . . . . 0.0 105.885 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' CYS . . . . . . . . . . . . . 1.7 p -63.82 -33.22 75.18 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 126.009 2.068 . . . . 0.0 114.359 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' LYS . . . . . . . . . . . . . 1.2 pttp -72.35 -50.21 28.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 116.127 -2.229 . . . . 0.0 110.629 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -66.02 -40.39 91.04 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.177 -0.327 . . . . 0.0 111.86 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' HIS . . . . . . . . . . . . . 55.1 m-70 -69.78 -38.48 76.72 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.338 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.1 -45.69 90.89 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 116.964 -1.894 . . . . 0.0 108.864 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ALA . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 131' ' ' ARG . . . -58.3 -46.6 85.81 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.76 -44.02 97.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -71.55 -37.8 71.06 Favored 'General case' 0 CA--C 1.496 -1.129 0 O-C-N 121.589 -0.694 . . . . 0.0 111.816 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 88.0 m -70.3 -44.96 67.25 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 219' ' ' TYR . 6.6 tt -61.45 -43.89 98.08 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.631 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -65.93 -38.21 93.99 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 277' ' ' ILE . 0.3 OUTLIER -70.19 -40.09 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 117.327 0.563 . . . . 0.0 110.805 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.858 HG22 ' N ' ' A' ' 279' ' ' MET . 1.1 mp -69.4 -50.54 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.673 -177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' MET . . . . . 0.858 ' N ' HG22 ' A' ' 278' ' ' ILE . 9.3 ptt? -63.47 -40.84 98.17 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 118.354 -1.338 . . . . 0.0 111.634 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLY . . . . . . . . . . . . . . . -63.57 -38.44 96.29 Favored Glycine 0 C--N 1.348 1.218 0 C-N-CA 121.614 -0.327 . . . . 0.0 112.479 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' THR . . . . . . . . . . . . . 7.3 p -68.99 -49.37 58.44 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 117.813 0.806 . . . . 0.0 108.856 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 212' ' ' LEU . 5.5 m-85 -54.05 -57.96 9.1 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.468 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' THR . . . . . . . . . . . . . 74.8 p -70.53 -46.72 63.07 Favored 'General case' 0 CA--C 1.499 -1.01 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.667 ' O ' ' CG2' ' A' ' 314' ' ' ILE . 83.1 mt -72.27 -20.17 61.57 Favored 'General case' 0 N--CA 1.432 -1.347 1 O-C-N 115.92 -4.238 . . . . 0.0 108.97 -174.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' CYS . . . . . 0.891 ' HB2' ' HA2' ' A' ' 315' ' ' GLY . 0.8 OUTLIER -154.99 107.97 2.79 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.321 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.931 ' CZ2' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER 138.45 -59.91 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.015 179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 1.003 HD13 HD13 ' A' ' 291' ' ' ILE . 1.5 tm? -60.74 -48.05 94.15 Favored Pre-proline 0 N--CA 1.439 -1.018 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.861 -176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.759 ' HB2' HD22 ' A' ' 311' ' ' LEU . 1.9 Cg_endo -62.39 -34.16 77.65 Favored 'Trans proline' 0 N--CA 1.431 -2.149 0 CA-C-N 119.947 1.017 . . . . 0.0 111.145 -176.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -69.4 -54.69 13.15 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.26 0.624 . . . . 0.0 111.653 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -64.3 -37.67 88.33 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 122.05 -0.406 . . . . 0.0 111.778 -173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 1.003 HD13 HD13 ' A' ' 287' ' ' LEU . 1.6 mp -67.12 -41.1 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 288' ' ' PRO . 39.4 t -59.96 -30.02 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.24 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -59.43 -48.51 81.37 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 119.56 -0.856 . . . . 0.0 108.914 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ILE . . . . . 0.633 ' O ' HG12 ' A' ' 297' ' ' VAL . 46.1 mm -63.88 -35.42 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.189 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 291' ' ' ILE . 74.7 t -61.3 -45.14 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' HIS . . . . . 0.635 ' HA ' HD11 ' A' ' 303' ' ' ILE . 6.2 t-160 -69.77 -36.55 75.84 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.15 -177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.743 HG21 ' HG2' ' A' ' 197' ' ' GLN . 2.3 p -68.48 -45.05 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.801 -178.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 294' ' ' ILE . 94.9 mt -68.26 -49.77 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 O-C-N 121.907 -0.496 . . . . 0.0 111.492 -177.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.04 121.87 37.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -70.78 -39.82 72.94 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 119.383 3.105 . . . . 0.0 119.383 -170.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ASN . . . . . 0.583 ' H ' HD22 ' A' ' 301' ' ' ASN . 0.3 OUTLIER -120.73 27.82 8.3 Favored 'General case' 0 CA--C 1.487 -1.451 0 C-N-CA 114.269 -2.972 . . . . 0.0 109.475 -173.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 302' ' ' LEU . 11.8 mt -78.89 -24.27 44.31 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.698 ' H ' HD13 ' A' ' 303' ' ' ILE . 0.2 OUTLIER -120.02 153.81 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 C-N-CA 118.141 -1.424 . . . . 0.0 114.561 -174.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ARG . . . . . 0.812 ' O ' HG22 ' A' ' 307' ' ' VAL . 0.2 OUTLIER -88.43 154.86 20.03 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . 0.28 25.7 mttm -72.77 -24.98 61.02 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.67 ' O ' HD13 ' A' ' 310' ' ' LEU . 6.5 mm-40 -64.41 -39.15 93.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.267 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 304' ' ' ARG . 5.3 m -61.56 -38.37 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' TYR . . . . . 0.539 ' N ' HG23 ' A' ' 307' ' ' VAL . 42.8 t80 -60.18 -50.49 73.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ILE . . . . . . . . . . . . . 91.5 mt -67.08 -46.18 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 O-C-N 121.996 -0.44 . . . . 0.0 110.839 -177.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.67 HD13 ' O ' ' A' ' 306' ' ' GLU . 10.7 mp -61.11 -45.67 93.72 Favored 'General case' 0 CA--C 1.482 -1.641 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.087 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.759 HD22 ' HB2' ' A' ' 288' ' ' PRO . 94.4 mt -61.25 -38.87 88.23 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.784 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -41.89 99.42 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' TRP . . . . . 0.528 ' CH2' HG22 ' A' ' 87' ' ' VAL . 36.0 m95 -64.7 -39.05 92.99 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 109.858 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ILE . . . . . 0.906 ' O ' HG12 ' A' ' 317' ' ' VAL . 0.9 OUTLIER -57.49 -40.77 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 -178.196 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.891 ' HA2' ' HB2' ' A' ' 285' ' ' CYS . . . -64.21 -35.91 92.57 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' TYR . . . . . 0.473 ' HD2' ' HA ' ' A' ' 316' ' ' TYR . 22.3 m-30 -61.0 -38.21 85.23 Favored 'General case' 0 CA--C 1.497 -1.074 0 O-C-N 121.886 -0.773 . . . . 0.0 110.327 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.906 HG12 ' O ' ' A' ' 314' ' ' ILE . 9.0 p -59.63 -26.71 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 O-C-N 122.071 -0.393 . . . . 0.0 110.217 -174.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 315' ' ' GLY . 0.1 OUTLIER -55.97 -35.63 66.94 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -34.96 74.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.97 13.73 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 110.851 -0.899 . . . . 0.0 110.851 -163.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -68.29 -32.7 73.04 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 123.343 0.657 . . . . 0.0 111.886 -169.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ASN . . . . . 0.559 ' HB2' ' HD3' ' A' ' 323' ' ' PRO . 8.3 m-20 -54.11 -48.44 94.16 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-O 118.498 -0.763 . . . . 0.0 112.597 -171.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 322' ' ' ASN . 62.0 Cg_exo -61.14 -34.7 88.87 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 121.273 1.49 . . . . 0.0 112.707 -176.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 33.8 mt -69.58 -44.31 71.06 Favored 'General case' 0 N--CA 1.433 -1.3 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.777 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 277' ' ' ILE . 8.8 mm -97.94 -70.87 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 123.211 0.604 . . . . 0.0 112.266 -173.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' TYR . . . . . 0.441 ' CD1' HG21 ' A' ' 277' ' ' ILE . 2.0 t80 -18.79 -57.49 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 120.03 3.344 . . . . 0.0 120.03 -176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' SER . . . . . . . . . . . . . 13.1 m -98.73 55.52 1.06 Allowed 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 124.738 1.215 . . . . 0.0 113.031 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -68.37 -0.7 5.17 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 124.485 1.114 . . . . 0.0 111.516 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 330' ' ' PRO . 47.7 t -40.73 145.99 0.49 Allowed Pre-proline 0 CA--C 1.5 -0.977 0 CA-C-O 122.34 1.067 . . . . 0.0 110.942 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 329' ' ' SER . 88.1 Cg_exo -59.8 -38.22 81.56 Favored 'Trans proline' 0 N--CA 1.436 -1.869 0 C-N-CA 121.704 1.603 . . . . 0.0 113.731 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.83 -40.67 79.33 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 64' ' ' LEU . 5.7 m-85 -59.33 -44.28 92.62 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.384 -177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ARG . . . . . 0.437 ' O ' ' HG3' ' A' ' 337' ' ' GLN . 55.9 mtp180 -63.18 -49.9 72.46 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.097 -174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' CYS . . . . . . . . . . . . . 12.9 m -51.51 -56.38 13.72 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.204 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ALA . . . . . . . . . . . . . . . -56.31 -37.84 70.46 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 128.717 3.76 . . . . 0.0 109.262 -173.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' PHE . . . . . 0.413 ' O ' HD13 ' A' ' 340' ' ' LEU . 21.0 m-85 -66.79 -46.21 76.01 Favored 'General case' 0 CA--C 1.496 -1.124 0 C-N-CA 120.182 -0.607 . . . . 0.0 111.915 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 333' ' ' ARG . 85.4 mt-30 -63.0 -38.12 89.93 Favored 'General case' 0 CA--C 1.489 -1.388 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -59.92 -38.25 81.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.61 -42.18 95.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 O-C-N 121.997 -0.439 . . . . 0.0 110.592 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 340' ' ' LEU . 7.1 mp -67.32 -42.33 83.82 Favored 'General case' 0 CA--C 1.495 -1.162 0 O-C-N 121.854 -0.529 . . . . 0.0 111.899 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.637 0 CA-C-O 118.386 -0.816 . . . . 0.0 108.82 -177.587 . . . . . . . . 0 0 . 1 stop_ save_